KANDA Tatsuo
| Department of Medicine | Associate Professor |
| School of Medicine | Associate Professor |
Researcher Information
Degree
Research Keyword
Field Of Study
Career
- Apr. 2024 - Present
Niigata University Medical and Dental Hospital, Uonuma Institute of Community Medicine, Department of Gastroenterology and Hepatology, Professor - Apr. 2024 - Present
Uonuma Kikan Hospital, Department of Gastroenterology and Hepatology, Professor - Apr. 2019 - Mar. 2024
Nihon University School of Medicine, Division of Gastroenterology and Hepatology, Department of Medicine, Associate Professor, Professor, Clinical - Mar. 2018 - Feb. 2024
Chiba University, Visiting Associate Professor - Aug. 2017 - Mar. 2019
Nihon University, School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Associate Professor - Jul. 2017 - Jul. 2017
Chiba University, Graduate School of Medicine, Department of Gastroenterology, Associate Professor - Jun. 2017 - Jul. 2017
Nihon University, School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Associate Professor - Apr. 2017 - Jun. 2017
Chiba University, Graduate School of Medicine, Department of Gastroenterology, Associate Professor - Feb. 2013 - Apr. 2017
Chiba University, Graduate School of Medicine, Department of Gastroenterology and Nephrology, Associate Professor - Jul. 2012 - Jan. 2013
Chiba University, Graduate School of Medicine, Department of Gastroenterology and Nephrology, Associate Professor - Dec. 2008 - Jun. 2012
Chiba University, Graduate School of Medicine, Department of Medicine and Clinical Oncology, Associate Professor - Jul. 2005 - Jun. 2008
Saint Louis University, School of Medicine, St. Louis, MO, USA, Department of Pathology, Faculty - Apr. 2004 - Jun. 2005
Chiba University, Safety and Health Organization, Assistant Professor - Dec. 2000 - Jun. 2005
千葉大学, 医学部附属病院, Assistant Professor - Dec. 2000 - Mar. 2004
Chiba University, Health Science Center, Assistant Professor
Educational Background
Research activity information
Award
- Mar. 2024
Asian Pacific Association for the Study of the Liver [APASL], APASL 2024 Powell-Sarin Achievement Award
Recent advances of viral hepatitis, and current situation of hepatitis A and E in Japan
Tatsuo Kanda - Jul. 2023
日本内科学会, 第688回日本内科学会関東地方会 (2023年7月9日(日)) 指導医賞
演題番号16 演者：羽尾 裕平 指導医：神田 達郎 / 日本大学消化器肝臓内科 COVID-19治療中に非昏睡型肝不全を併発したアラジール症候群の1例 - Aug. 2021
日本肝がん分子標的治療研究会, 第24回日本肝がん分子標的治療研究会 優秀論文「各種分子標的薬が肝癌細胞TLRシグナル伝達経路に与える影響に関して」 - Nov. 2019
Asian Pacific Association for the Study of the Liver (APASL), Asian Pacific Association for the Study of the Liver (APASL) Appreciation Award - Jul. 2013
第11回消化器病における性差医学・医療研究会, 第11回消化器病における性差医学・医療研究会優秀演題賞 - Nov. 2011
かなえ医薬振興財団, 2012年度第40回かなえ医薬振興財団アジア・オセアニア交流研究助成金受賞 - Jun. 2011
日本肝臓学会, 平成23年度日本肝臓学会 研究奨励賞 - Mar. 2010
ウイルス肝炎研究財団, ウイルス肝炎研究財団平成21年度研究奨励賞 - Dec. 2009
国際科学振興財団フォーラム第16回浜名湖シンポジウム, 国際科学振興財団フォーラム第16回浜名湖シンポジウム特別賞(アイデアの独創性部門) - Jul. 2006
American Society for Virology, American Society for Virology 2006 Postdoctoral Fellow Travel Award - Dec. 2004
国際科学振興財団フォーラム第12回浜名湖シンポジウム, 国際科学振興財団フォーラム第12回浜名湖シンポジウム 第17位 - Dec. 2004
Asian Pacific Association for the Study of the Liver, Asian Pacific Association for the Study of the Liver, 14th Biennial Conference, Young Investigator Award - Nov. 2004
日本肝臓学会, 平成16年度国際学会に伴う費用一部助成 - Oct. 2004
日本消化器関連学会週間(JDDW), 第12回日本消化器関連学会週間(DDW-Japan 2004 Fukuoka)ポスター演題優秀賞 - Nov. 2003
日本肝臓学会, 平成15年度国際学会に伴う費用一部助成 - Apr. 2003
財団法人ちば県民保健財団, 平成15年度結核予防千葉基金助成金 研究奨励金
慢性C型肝炎の病態進展と結核既往との関連について
千葉大学保健管理センター 神田達郎 - Nov. 2002
日本肝臓学会, First JSH Single Topic Conference Award - Nov. 2001
日本肝臓学会, 平成13年度国際学会に伴う費用一部助成
Paper
- Elderly patient with unresectable advanced‑stage hepatocellular carcinoma who received atezolizumab plus bevacizumab and achieved a complete response: A case report
Shuhei Arima; Tatsuo Kanda; Mai Totsuka; Masayuki Honda; Shini Kanezawa; Reina Sasaki‑Tanaka; Naoki Matsumoto; Ryota Masuzaki; Hiroaki Yamagami; Masahiro Ogawa; Hirofumi Kogure
Medicine International, Mar. 2024, Refereed, Not invited
Corresponding - Severe hepatitis E virus genotype 3b in a patient with alcohol‑associated liver disease: A case report
Tatsuo Kanda; Shuhei Arima; Reina Sasaki‑Tanaka; Mai Totsuka; Masayuki Honda; Ryota Masuzaki; Naoki Matsumoto; Masahiro Ogawa; Masaharu Takahashi; Hiroaki Okamoto; Hirofumi Kogure
Medicine International, Mar. 2024, Refereed, Not invited
Lead - ウイルス性肝炎(HBV, HCV)
神田達郎; 早川智
臨床婦人科産科, Jan. 2024, Not refereed, Invited
Lead - Hepatitis E Virus Infection Caused Elevation of Alanine Aminotransferase Levels in a Patient with Chronic Hepatitis B and Choledocholithiasis
Rei Hirano; Tatsuo Kanda; Masayuki Honda; Shuhei Arima; Mai Totsuka; Ryota Masuzaki; Shini Kanezawa; Reina Sasaki-Tanaka; Naoki Matsumoto; Hiroaki Yamagami; Tomotaka Ishii; Masahiro Ogawa; Shuzo Nomura; Mariko Fujisawa; Kei Saito; Masaharu Takahashi; Hiroaki Okamoto; Hirofumi Kogure
Reports, Nov. 2023, Refereed, Not invited
Corresponding - Recent advances in hepatitis A virus (HAV) research and clinical practice guidelines for HAV infection in Japan
Tatsuo Kanda; Reina Sasaki‐Tanaka; Koji Ishii; Ryosuke Suzuki; Jun Inoue; Atsunori Tsuchiya; Shingo Nakamoto; Ryuzo Abe; Keiichi Fujiwara; Osamu Yokosuka; Tian‐Cheng Li; Satoshi Kunita; Hiroshi Yotsuyanagi; Hiroaki Okamoto
Hepatology Research, Oct. 2023, Refereed, Not invited
Lead - Muscle Cramps in Outpatients with Liver Diseases in Tokyo, Japan
Tatsuo Kanda; Reina Sasaki-Tanaka; Naoki Matsumoto; Shuhei Arima; Shini Kanezawa; Masayuki Honda; Mai Totsuka; Tomotaka Ishii; Ryota Masuzaki; Masahiro Ogawa; Hiroaki Yamagami; Hirofumi Kogure
Medicina, Aug. 2023, Refereed, Not invited
Lead - E型肝炎の予防 (ウイルス性肝炎学2023 -最新の病態・診断・治療情報- V.各論)
神田達郎; 田中佐々木玲奈
日本臨床, Jul. 2023, Not refereed, Invited
Lead - Masitinib Inhibits Hepatitis A Virus Replication
Reina Sasaki-Tanaka; Toshikatsu Shibata; Mitsuhiko Moriyama; Hirofumi Kogure; Asuka Hirai-Yuki; Hiroaki Okamoto; Tatsuo Kanda
International Journal of Molecular Sciences, Jun. 2023, Refereed
Last - Molecular Mechanisms, Diagnosis and Treatments in Digestive Malignancy
Tatsuo Kanda; Ryota Masuzaki; Reina Sasaki-Tanaka; Hirofumi Kogure; Mitsuhiko Moriyama
International Journal of Molecular Sciences, Mar. 2023 - Molecular Mechanism of Chronic Viral and Non-Viral Liver Diseases
Tatsuo Kanda
International Journal of Molecular Sciences, Mar. 2023, Refereed, Invited
Lead - Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors.
Ogawa K; Chiba T; Nakamura M; Arai J; Zhang J; Ma Y; Qiang NA; Ao J; Yumita S; Ishino T; Kan M; Iwanaga T; Nakagawa M; Fujiwara K; Sakuma T; Kanzaki H; Koroki K; Kusakabe Y; Kobayashi K; Kanogawa N; Kiyono S; Kondo T; Nakagawa R; Ogasawara S; Muroyama R; Nakamoto S; Kanda T; Maruyama H; Kato J; Matsumoto S; Arai T; Motohashi S; Kato N.
Anticancer Res., Mar. 2023, Refereed, Not invited - Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication
Reina Sasaki-Tanaka; Ryota Masuzaki; Hiroaki Okamoto; Toshikatsu Shibata; Mitsuhiko Moriyama; Hirofumi Kogure; Tatsuo Kanda
Journal of Virology, Feb. 2023, Refereed, Not invited
Last - Gut-Microbiota Dysbiosis in Stroke-Prone Spontaneously Hypertensive Rats with Diet-Induced Steatohepatitis
Shini Kanezawa; Mitsuhiko Moriyama; Tatsuo Kanda; Akiko Fukushima; Ryota Masuzaki; Reina Sasaki-Tanaka; Akiko Tsunemi; Takahiro Ueno; Noboru Fukuda; Hirofumi Kogure
International Journal of Molecular Sciences, Feb. 2023, Refereed, Not invited
Corresponding - Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells.
Iwanaga T; Chiba T; Nakamura M; Kaneko T; Ao J; Qiang N; Ma Y; Zhang J; Kogure T; Yumita S; Ishino T; Ogawa K; Kan M; Nakagawa M; Fujiwara K; Fujita N; Sakuma T; Kanzaki H; Koroki K; Kusakabe Y; Inoue M; Kobayashi K; Kanogawa N; Kiyono S; Kondo T; Nakagawa R; Ogasawara S; Nakamoto S; Muroyama R; Kato J; Kanda T; Maruyama H; Mimura N; Honda T; Murayama T; Nakamura H; Kato N.
Biochem Biophys Res Commun., Jan. 2023, Refereed, Not invited - Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare.
Kanda T; Matsumoto N; Ishii T; Arima S; Shibuya S; Honda M; Sasaki-Tanaka R; Masuzaki R; Kanezawa S; Nishizawa T; Gon Y; Ogawa M; Kogure H.
Viruses, Jan. 2023, Refereed, Not invited
Lead - Thirty-two years' experience of treating fulminant hepatitis in a Japanese single center.
Keiichi Fujiwara; Shin Yasui; Takayuki Kondo; Masato Nakamura; Makoto Arai; Tatsuo Kanda; Osamu Yokosuka; Masayuki Ohtsuka; Ryuzo Abe; Naoya Kato
Hepatology research : the official journal of the Japan Society of Hepatology, Dec. 2022, Refereed - Tumor stiffness measurement using magnetic resonance elastography can predict recurrence and survival after curative resection of hepatocellular carcinoma.
Abe H; Shibutani K; Yamazaki S; Kanda T; Moriyama M; Okada M; Sugitani M; Tsuji S; Takayama T; Okamura Y.
Surgery, Dec. 2022, Refereed, Not invited - Liver Transplantation from a Human Leukocyte Antigen-Matched Sibling Donor: Effectiveness of Direct-Acting Antiviral Therapy against Hepatitis C Virus Infection
Tatsuo Kanda; Naoki Matsumoto; Tomotaka Ishii; Shuhei Arima; Shinji Shibuya; Masayuki Honda; Reina Sasaki-Tanaka; Ryota Masuzaki; Shini Kanezawa; Masahiro Ogawa; Shintaro Yamazaki; Osamu Aramaki; Hirofumi Kogure; Yukiyasu Okamura
Reports, Dec. 2022, Refereed, Not invited
Lead - The proliferation of atypical hepatocytes and CDT1 expression in noncancerous tissue are associated with the postoperative recurrence of hepatocellular carcinoma.
Moriyama M; Kanda T; Midorikawa Y; Matsumura H; Masuzaki R; Nakamura H; Ogawa M; Matsuoka S; Shibata T; Yamazaki M; Kuroda K; Nakayama H; Higaki T; Kanemaru K; Miki T; Sugitani M; Takayama T.
Scientific Reports, Nov. 2022, Refereed, Not invited - Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy
Reina Sasaki-Tanaka; Toshikatsu Shibata; Mitsuhiko Moriyama; Hiroaki Okamoto; Hirofumi Kogure; Tatsuo Kanda
Journal of Virology, Sep. 2022, Refereed, Not invited
Last - Effects of Let-7c on the processing of hepatitis B virus associated liver diseases
Zhang L; Jiang X; Wang G; Kanda T; Yokosuka O; Zhai C; Zhang L; Liu P; Zhao Z; Li Z
Infect Agent Cancer, Sep. 2022, Refereed, Not invited - 肝機能が比較的安定していたが肝発癌を認めたB型肝炎症例について
神田 達郎; 森山 光彦; 有間 修平; 本田 真之; 石井 大雄; 松本 直樹; 佐々木 玲奈; 増崎 亮太; 木暮 宏史; 小川 眞広
日本がん検診・診断学会誌, Sep. 2022 - No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.
215.Korenaga M; Murata K; Izumi N; Tamaki N; Yokosuka O; Takehara T; Sakamoto N; Suda G; Nishiguchi S; Enomoto H; Ikeda F; Yanase M; Toyoda H; Genda T; Umemura T; Yatsuhashi H; Yamazaki K; Ide T; Toda N; Kanda T; Nirei K; Ueno Y; Haga H; Nishigaki Y; Nakane K; Omata M; Mochizuki H; Aoki Y; Imamura M; Kanto T.
Glob Health Med., Aug. 2022, Refereed, Not invited - Molecular Changes in Relation to Alcohol Consumption and Hepatocellular Carcinoma
Reina Sasaki-Tanaka; Ranjit Ray; Mitsuhiko Moriyama; Ratna Ray; Tatsuo Kanda
International Journal of Molecular Sciences, Aug. 2022, Refereed, Invited
Last - Acute Liver Failure and Acute-on-Chronic Liver Failure in COVID-19 Era.
Tatsuo Kanda; Reina Sasaki-Tanaka; Tomotaka Ishii; Hayato Abe; Masahiro Ogawa; Hirayuki Enomoto
Journal of clinical medicine, Jul. 2022, Refereed
Lead - The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma Cells.
Hiroaki Kanzaki; Tetsuhiro Chiba; Tatsuya Kaneko; Junjie Ao; Motoyasu Kan; Ryosuke Muroyama; Shingo Nakamoto; Tatsuo Kanda; Hitoshi Maruyama; Jun Kato; Yoh Zen; Ai Kotani; Kazuma Sekiba; Motoyuki Otsuka; Masayuki Ohtsuka; Naoya Kato
International journal of molecular sciences, Jul. 2022, Refereed - A型肝炎の予防と治療 A型・E型肝炎の最新動向.
佐々木玲奈; 神田達郎
週刊 医学のあゆみ, Jul. 2022, Not refereed, Invited - Hepatitis A Virus Infection and Molecular Research
Tatsuo Kanda; Reina Sasaki-Tanaka; Shingo Nakamoto
International Journal of Molecular Sciences, Jun. 2022, Refereed, Invited
Lead - Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking
Reina Sasaki-Tanaka; Kalyan C. Nagulapalli Venkata; Hiroaki Okamoto; Mitsuhiko Moriyama; Tatsuo Kanda
International Journal of Molecular Sciences, May 2022, Refereed, Not invited
Last - Suppressors of Cytokine Signaling and Hepatocellular Carcinoma.
Masuzaki R; Kanda T; Sasaki R; Matsumoto N; Nirei K; Ogawa M; Karp SJ; Moriyama M; Kogure H.
Cancers (Basel), May 2022, Refereed, Not invited - Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience.
213.Ogawa K; Kanzaki H; Chiba T; Ao J; Qiang N; Ma Y; Zhang J; Yumita S; Ishino T; Unozawa H; Kan M; Iwanaga T; Nakagawa M; Fujiwara K; Fujita N; Sakuma T; Koroki K; Kusakabe Y; Kobayashi K; Kanogawa N; Kiyono S; Nakamura M; Kondo T; Saito T; Nakagawa R; Ogasawara S; Suzuki E; Nakamoto S; Muroyama R; Kanda T; Maruyama H; Mimura N; Kato J; Motohashi S; Kato N.
J Cancer., May 2022, Refereed, Not invited - Contrast-enhanced ultrasonography for blood flow detection in hepatocellular carcinoma during lenvatinib therapy.
Matsumoto N; Ogawa M; Kaneko M; Arima S; Kumagawa M; Watanabe Y; Hirayama M; Masuzaki R; Kanda T; Moriyama M.
J Med Ultrason (2001), Mar. 2022, Refereed - A Case of Recent Liver Injury Induced by Benzbromarone
Tomotaka Ishii; Keijiro Hoshino; Masayuki Honda; Yoichiro Yamana; Reina Sasaki-Tanaka; Mariko Kumagawa; Shini Kanezawa; Taku Mizutani; Naoki Matsumoto; Ryota Masuzaki; Kazushige Nirei; Hiroaki Yamagami; Mitsuhiko Moriyama; Tatsuo Kanda
Reports, Mar. 2022, Refereed, Invited
Last - Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes
Reina Sasaki-Tanaka; Toshikatsu Shibata; Hiroaki Okamoto; Mitsuhiko Moriyama; Tatsuo Kanda
International Journal of Molecular Sciences, Feb. 2022, Refereed, Not invited
Last - イムノクロマト法によるHBs抗原偽陰性症例に対するHBV-DNA解析
柳田 昂平; 嵐田 恵美子; 相馬 史; 竹島 秀美; 武居 宣尚; 宮下 徹夫; 神田 達郎; 森山 光彦; 中山 智祥
医療検査と自動化, Feb. 2022 - 特集高齢者の消化器疾患- 適切な診断法と治療法を目指して 慢性ウイルス性肝炎
神田達郎; 石井大雄; 増﨑亮太; 松本直樹; 楡井和重; 森山光彦
臨床消化器内科, Feb. 2022, Not refereed, Invited
Lead - Left Gastric Vein Width is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients.
Mizutani T; Nirei K; Kanda T; Honda M; Ishii T; Arima S; Yamana Y; Matsumoto N; Matsuoka S; Moriyama M.
Medicina, Jan. 2022, Refereed, Not invited - COVID-19 After Treatment With Direct-Acting Antivirals for HCV Infection and Decompensated Cirrhosis: A Case Report.
Ikegami C; Kanda T; Ishii T; Honda M; Yamana Y; Sasaki Tanaka R; Kumagawa M; Kanezawa S; Mizutani T; Yamagami H; Matsumoto N; Masuzaki R; Hayashi K; Nirei K; Takayama T; Moriyama M.
In Vivo, 2022, Refereed, Not invited
Corresponding - Immune Checkpoint Inhibitor as a Therapeutic Choice for Double Cancer: A Case Series.
Aoki H; Matsumoto N; Takahashi H; Honda M; Kaneko T; Arima S; Ishii T; Mizutani T; Masuzaki R; Nirei K; Yamagami H; Ogawa M; Kanda T; Moriyama M; Miura K.
Anticancer Research, Dec. 2021, Refereed, Not invited - Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan.
Yamana Y; Kanda T; Matsumoto N; Honda M; Kumagawa M; Sasaki R; Kanezawa S; Mizutani T; Yamagami H; Masuzaki R; Ishii T; Nirei K; Moriyama M.
Journal of Clinical Medicine, Nov. 2021, Refereed, Not invited
Corresponding - Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells.
Patra T; Meyer K; Ray RB; Kanda T; Ray R.
Cell death & disease, Nov. 2021, Refereed, Not invited - The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus Infection.
Amano H; Kanda T; Mochizuki H; Kojima Y; Suzuki Y; Hosoda K; Ashizawa H; Miura Y; Tsunoda S; Hirotsu Y; Ohyama H; Kato N; Moriyama M; Obi S; Omata M.
Viruses, Nov. 2021, Refereed, Not invited
Corresponding - EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma.
Kusakabe Y; Chiba T; Oshima M; Koide S; Rizq O; Aoyama K; Ao J; Kaneko T; Kanzaki H; Kanayama K; Maeda T; Saito T; Nakagawa R; Kobayashi K; Kiyono S; Nakamura M; Ogasawara S; Suzuki E; Nakamoto S; Yasui S; Mikata R; Muroyama R; Kanda T; Maruyama H; Kato J; Mimura N; Ma A; Jin J; Zen Y; Otsuka M; Kaneda A; Iwama A; Kato N.
Scientific Reports, Nov. 2021, Refereed, Not invited - Laparoscopic bypass surgery as palliative treatment for duodenal obstruction due to lymph node metastasis invasion of hepatocellular carcinoma
Kurosugi Akane; Chiba Tetsuhiro; Iwanaga Terunao; Unozawa Hidemi; Sakuma Takafumi; Fujita Naoto; Kanayama Kengo; Kanzaki Hiroaki; Koroki Keisuke; Kobayashi Kazufumi; Kiyono Soichiro; Nakagawa Ryo; Kanogawa Naoya; Nakamura Masato; Kondo Takayuki; Saito Tomoko; Kusakabe Yuko; Ogasawara Sadahisa; Suzuki Eiichiro; Nakamoto Shingo; Tawada Akinobu; Muroyama Ryosuke; Kato Jun; Yokota Hajime; Kanda Tatsuo; Maruyama Hitoshi; Matsubara Hisahiro; Kato Naoya
Kanzo, Oct. 2021, Refereed - 肝細胞癌に対するマイクロ波焼灼療法術後にたこつぼ型心筋症を発症した1例
岩永 光巨; 千葉 哲博; 黒杉 茜; 宇野澤 秀美; 佐久間 崇文; 藤田 尚人; 金山 健剛; 神崎 洋彰; 興梠 慧輔; 小林 和史; 清野 宗一郎; 中川 良; 叶川 直哉; 中村 昌人; 近藤 孝行; 齊藤 朋子; 日下部 裕子; 小笠原 定久; 鈴木 英一郎; 中本 晋吾; 太和田 暁之; 室山 良介; 加藤 順; 神田 達郎; 丸山 紀史; 加藤 直也
肝臓, Sep. 2021, Refereed - An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
Cordell HJ; Fryett JJ; Ueno K; Darlay R; Aiba Y; Hitomi Y; Kawashima M; Nishida N; Khor SS; Gervais O; Kawai Y; Nagasaki M; Tokunaga K; Tang R; Shi Y; Li Z; Juran BD; Atkinson EJ; Gerussi A; Carbone M; Asselta R; Cheung A; de Andrade M; Baras A; Horowitz J; Ferreira MAR; Sun D; Jones DE; Flack S; Spicer A; Mulcahy VL; Byan J; Han Y; Sandford RN; Lazaridis KN; Amos CI; Hirschfield GM; Seldin MF; Invernizzi P; Siminovitch KA; Ma X; Nakamura M; Mells GF; PBC Consortia; Canadian PBC Consortium; Chinese PBC Consortium; Italian PBC Study Group; Japan-PBC-GWAS Consortium; US PBC Consortium; UK-PBC Consortium.
Journal of Hepatology, Sep. 2021, Refereed, Not invited - Follow-up of patients who achieved sustained virologic response after interferon-free treatment against hepatitis C virus: focus on older patients.
Nirei K; Kanda T; Masuzaki R; Mizutani T; Moriyama M
Medicina (Kaunas), Jul. 2021, Refereed, Not invited - Knockdown of Mitogen-Activated Protein Kinase Kinase 3 Negatively Regulates Hepatitis A Virus Replication
Tatsuo Kanda; Reina Sasaki-Tanaka; Ryota Masuzaki; Naoki Matsumoto; Hiroaki Okamoto; Mitsuhiko Moriyama
International Journal of Molecular Sciences, Jul. 2021, Refereed, Not invited
Lead - No additive effects of peginterferon on the short-term improvement of liver histology by entecavir monotherapy in chronic hepatitis B patients
Tatsuo Kanda
Hepatology International, Jun. 2021, Refereed, Invited
Lead - Ultrasonographic grayscale findings related to fibrosis in patients with non-alcoholic fatty liver disease: comparison with transient elastography and Fib-4 index.
Matsumoto N; Kumagawa M; Ogawa M; Kaneko M; Watanabe Y; Nakagawara H; Masuzaki R; Kanda T; Moriyama M; Sugitani M.
J Med Ultrason (2001)., Jun. 2021, Refereed, Not invited - Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer.
Asatani S; Kanda T; Honda M; Ishii T; Yamana Y; Kaneko T; Mizutani T; Takahashi H; Kumagawa M; Sasaki R; Masuzaki R; Kanezawa S; Matsumoto N; Nirei K; Yamagami H; Moriyama M.
JGH Open, May 2021, Refereed, Not invited
Corresponding - Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.
Koroki K; Kanogawa N; Maruta S; Ogasawara S; Iino Y; Obu M; Okubo T; Itokawa N; Maeda T; Inoue M; Haga Y; Seki A; Okabe S; Koma Y; Azemoto R; Atsukawa M; Itobayashi E; Ito K; Sugiura N; Mizumoto H; Unozawa H; Iwanaga T; Sakuma T; Fujita N; Kanzaki H; Kobayashi K; Kiyono S; Nakamura M; Saito T; Kondo T; Suzuki E; Ooka Y; Nakamoto S; Tawada A; Chiba T; Arai M; Kanda T; Maruyama H; Kato J; Kato N.
Liver Cancer, Apr. 2021, Refereed, Not invited - Large-volume cell-free and concentrated ascites reinfusion therapy improves venous flow in patients with liver cirrhosis.
Matsumoto N; Ogawa M; Kanda T; Matsuoka S; Moriyama M; Matsusaki K.
J Med Ultrason (2001)., Apr. 2021, Refereed, Not invited - Magnetic resonance elastography-based prediction of hepatocellular carcinoma recurrence after curative resection.
Abe H; Midorikawa Y; Higaki T; Yamazaki S; Aramaki O; Nakayama H; Moriguchi M; Kanda T; Moriyama M; Okada M; Nishimaki H; Sugitani M; Tsuji S; Takayama T.
Surgery, Mar. 2021, Refereed, Not invited - Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma.
Ao J; Chiba T; Kanzaki H; Kanayama K; Shibata S; Kurosugi A; Iwanaga T; Kan M; Sakuma T; Qiang N; Ma Y; Kojima R; Kusakabe Y; Nakamura M; Kobayashi K; Kiyono S; Kanogawa N; Saito T; Nakagawa R; Kondo T; Ogasawara S; Suzuki E; Nakamoto S; Muroyama R; Tawada A; Kato J; Kanda T; Maruyama H; Kato N.
J Cancer, Mar. 2021, Refereed, Not invited - The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma.
Kanzaki H; Chiba T; Ao J; Koroki K; Kanayama K; Maruta S; Maeda T; Kusakabe Y; Kobayashi K; Kanogawa N; Kiyono S; Nakamura M; Kondo T; Saito T; Nakagawa R; Ogasawara S; Suzuki E; Ooka Y; Muroyama R; Nakamoto S; Yasui S; Tawada A; Arai M; Kanda T; Maruyama H; Mimura N; Kato J; Zen Y; Ohtsuka M; Iwama A; Kato N.
Scientific Reports, Mar. 2021, Refereed, Not invited - X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis.
Asselta R; Paraboschi EM; Gerussi A; Cordell HJ; Mells GF; Sandford RN; Jones DE; Nakamura M; Ueno K; Hitomi Y; Kawashima M; Nishida N; Tokunaga K; Nagasaki M; Tanaka A; Tang R; Li Z; Shi Y; Liu X; Xiong M; Hirschfield G; Siminovitch KA; Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium; Japan PBC-GWAS Consortium; Carbone M; Cardamone G; Duga S; Gershwin ME; Seldin MF; Invernizzi P.
Gastroenterology, Mar. 2021, Refereed, Not invited - Acquisition of mesenchymal-like phenotypes and overproduction of angiogenic factors in lenvatinib-resistant hepatocellular carcinoma cells.
Ao J; Chiba T; Shibata S; Kurosugi A; Qiang N; Ma Y; Kan M; Iwanaga T; Sakuma T; Kanzaki H; Kanayama K; Kojima R; Kusakabe Y; Nakamura M; Saito T; Nakagawa R; Kondo T; Ogasawara S; Suzuki E; Muroyama R; Kato J; Mimura N; Kanda T; Maruyama H; Kato N.
Biochemical and Biophysical Research Communications, Mar. 2021, Refereed, Not invited - Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines.
Nishida N; Sugiyama M; Ohashi J; Kawai Y; Khor SS; Nishina S; Yamasaki K; Yazaki H; Okudera K; Tamori A; Eguchi Y; Sakai A; Kakisaka K; Sawai H; Tsuchiura T; Ishikawa M; Hino K; Sumazaki R; Takikawa Y; Kanda T; Yokosuka O; Yatsuhashi H; Tokunaga K; Mizokami M.
Scientific Reports, Mar. 2021, Refereed, Not invited - HCV GT1b-patient with alanine aminotransferase elevation and sustained virologic response achieved by grazoprevir/elbasvir discontinuation
Hiroshi Takahashi; Tatsuo Kanda; Naoki Matsumoto; Taku Mizutani; Tomohiro Kaneko; Masayuki Honda; Yoichiro Yamana; Tomotaka Ishii; Mariko Kumagawa; Reina Sasaki; Ryota Masuzaki; Kazushige Nirei; Hiroaki Yamagami; Masahiro Ogawa; Shunichi Matsuoka; Mitsuhiko Moriyama
Future Virology, Mar. 2021, Refereed, Not invited
Corresponding - Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites.
Kanda T; Sasaki R; Masuzaki R; Moriyama M.
Artif Intell Gastroenterol., Feb. 2021, Refereed, Invited
Lead - Japanese man with HCV genotype 4 infection and cirrhosis who was successfully treated by the combination of glecaprevir and pibrentasvir.
Totsuka M; Honda M; Kanda T; Ishii T; Matsumoto N; Yamana Y; Kaneko T; Mizutani T; Takahashi H; Kumagawa M; Sasaki R; Masuzaki R; Kanezawa S; Nirei K; Yamagami H; Matsuoka S; Ohnishi H; Okamoto H; Moriyama M.
Intern Medicine, Feb. 2021, Refereed, Not invited
Corresponding - Male-dominant hepatitis A outbreak observed among non-HIV-infected persons in the northern part of Tokyo, Japan.
Honda M; Asakura H; Kanda T; Somura Y; Ishii T; Yamana Y; Kaneko T; Mizutani T; Takahashi H; Kumagawa M; Sasaki R; Masuzaki R; Kanezawa S; Nirei K; Yamagami H; Matsumoto N; Nagashima M; Chiba T; Moriyama M.
Viruses, Jan. 2021, Refereed, Not invited
Corresponding - Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma.
Chen M; Cao J; Hu J; Topatana W; Li S; Juengpanich S; Lin J; Tong C; Shen J; Zhang B; Wu J; Pocha C; Kudo M; Amedei A; Trevisani F; Sung P.S; Zaydfudim V.M; Kanda T; Cai X; AME Hepatocellular Carcinoma Collaborative Group.
Liver Cancer, Jan. 2021, Refereed, Not invited - 根治的アブレーション治療後に異時性に孤立性肺転移および骨転移を来した肝細胞癌の1例
佐久間 崇文; 千葉 哲博; 鈴木 英一郎; 大岡 美彦; 神崎 洋彰; 金山 健剛; 丸田 享; 興梠 慧輔; 叶川 直哉; 小林 和史; 清野 宗一郎; 中村 昌人; 近藤 孝行; 齊藤 明子; 日下部 裕子; 小笠原 定久; 中本 晋吾; 太和田 暁之; 加藤 順; 神田 達郎; 丸山 紀史; 吉野 一郎; 岸本 充; 加藤 直也
肝臓, Jan. 2021, Refereed - Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma.
Kobayashi K; Ogasawara S; Takahashi A; Seko Y; Unozawa H; Sato R; Watanabe S; Moriguchi M; Norimoto N; Tsuchiya S; Iwai K; Inoue M; Ogawa K; Ishino T; Iwanaga T; Sakuma T; Fujita N; Kanzaki H; Koroki K; Nakamura M; Kanogawa N; Kiyono S; Kondo T; Saito T; Nakagawa R; Suzuki E; Ooka Y; Nakamoto S; Tawada A; Chiba T; Arai M; Kanda T; Maruyama H; Nagashima K; Kato J; Isoda N; Aramaki T; Itoh Y; Kato N.
Liver Cancer, 2021, Refereed, Not invited - 血行異常. Budd-Chiari症候群.
神田達郎; 増﨑亮太; 佐々木玲奈; 楡井和重; 森山光彦.
別冊日本臨床 領域別症候群シリーズ No.13 肝・胆道系症候群 (第3版) I 肝臓編(上), 2021, Not refereed, Invited
Lead - トルバプタン投与により遷延する肝機能障害をきたした1例
佐々木玲奈; 神田達郎; 本田真之; 高橋央; 金子朋弘; 山名陽一郎; 熊川まり子; 石井大雄; 水谷卓; 増崎亮太; 楡井和重; 山上裕晃; 松本直樹; 森山光彦
肝臓, 2021, Refereed, Not invited - Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma.
Kanogawa N; Ogasawara S; Ooka Y; Inoue M; Wakamatsu T; Yokoyama M; Maruta S; Unozawa H; Iwanaga T; Sakuma T; Fujita N; Koroki K; Kanzaki H; Maeda T; Kobayashi K; Kiyono S; Nakamura M; Kondo T; Saito T; Motoyama T; Suzuki E; Nakamoto S; Tawada A; Chiba T; Arai M; Kanda T; Maruyama H; Kato J; Takemura R; Nozaki-Taguchi N; Shiroh I; Yokosuka O; Kato N.
JGH Open., Dec. 2020, Refereed, Not invited - Association of Genetic Polymorphisms With Hepatitis C Virus-related Liver Cirrhosis in Japan.
Kamimura S; Tamura A; Ishii T; Kanda T; Moriyama M.
In Vivo., Nov. 2020, Refereed, Not invited
Corresponding - Additive Effects of Zinc Chloride on the Suppression of Hepatitis A Virus Replication by Interferon in Human Hepatoma Huh7 Cells.
Kanda T; Sasaki R; Masuzaki R; Takahashi H; Fujisawa M; Matsumoto N; Okamoto H; Moriyama M.
In Vivo., Nov. 2020, Refereed, Not invited
Lead - Quantitative Ultrasound Image Analysis Helps in the Differentiation of Hepatocellular Carcinoma (HCC) From Borderline Lesions and Predicting the Histologic Grade of HCC and Microvascular Invasion.
Tatsuo Kanda
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, Aug. 2020, Refereed, Not invited - Involvement of the Interferon Signaling Pathways in Pancreatic Cancer Cells.
Fujisawa M; Kanda T; Shidata T; Sasaki R; Masuzaki R; Matsumoto N; Nirei K; Imazu H; Kuroda K; Sugitani M; Takayama T; Moriyama M.
Anticancer Res., Aug. 2020, Refereed, Not invited
Corresponding - Application of artificial intelligence in hepatology: Minireview
Tatsuo Kanda
Artificial Intelligence in Gastroenterology, Jul. 2020, Refereed, Invited
Corresponding - High platelet count as a poor prognostic factor for liver cancer patients without cirrhosis.
Tatsuo Kanda
Bioscience trends, Jul. 2020, Refereed, Not invited - Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials
Koroki K; Ogasawara S; Ooka Y; Kanzaki H; Kanayama K; Maruta S; Maeda T; Yokoyama M; Wakamatsu T; Inoue M; Kobayashi K; Kiyono S; Nakamura M; Kanogawa N; Saito T; Kondo T; Suzuki E; Nakamoto S; Yasui S; Tawada A; Chiba T; Arai M; Kanda T; Maruyama H; Kato J; Kuboki S; Ohtsuka M; Miyazaki M; Yokosuka O; Kato N.
Liver Cancer, Jul. 2020, Refereed, Not invited - Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B.
Akihiro Matsumoto; Shuhei Nishiguchi; Hirayuki Enomoto; Yasuhito Tanaka; Noboru Shinkai; Chiaki Okuse; Jong-Hon Kang; Takeshi Matsui; Shiho Miyase; Hiroshi Yatsuhashi; Shinya Nagaoka; Tatsuo Kanda; Masaru Enomoto; Ryoko Yamada; Naoki Hiramatsu; Satoru Saito; Koichi Takaguchi; Kiyoaki Ito; Tsutomu Masaki; Daisuke Morihara; Masataka Tsuge; Kazuaki Chayama; Fusao Ikeda; Tatehiro Kagawa; Yasuteru Kondo; Kazumoto Murata; Eiji Tanaka
Journal of gastroenterology, Jul. 2020, Refereed, Not invited - Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives.
Masuzaki R; Kanda T; Sasaki R; Matsumoto N; Ogawa M; Matsuoka S; Karp SJ; Moriyama M.
Int J Mol Sci., Jul. 2020, Refereed, Not invited - Analysis of full-length hepatitis B virus genome from chronic hepatitis B-patients with higher alanine aminotransferase elevation
Hiroshi Takahashi; Tatsuo Kanda; Naoki Matsumoto; Toshikatsu Shibata; Kazushige Nirei; Akinori Tamura; Shunichi Matsuoka; Kazumichi Kuroda; Mitsuhiko Moriyama
Future Virology, Jul. 2020, Refereed, Not invited
Corresponding - Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing.
Tomotaka Ishii; Akinori Tamura; Toshikatsu Shibata; Kazumichi Kuroda; Tatsuo Kanda; Masaya Sugiyama; Masashi Mizokami; Mitsuhiko Moriyama
Genes, Jun. 2020, Refereed, Not invited
Corresponding - Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations.
Tatsuo Kanda
Hepatology International, May 2020, Refereed, Invited - Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.
Kanda T; Sasaki R; Masuzaki R; Matsumoto N; Ogawa M; Moriyama M.
Viruses, May 2020, Refereed, Not invited
Lead - Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines.
Sasaki R; Kanda T; Fujisawa M; Matsumoto N; Masuzaki R; Ogawa M; Matsuoka S; Kuroda K; Moriyama M.
International Journal of Molecular Sciences, May 2020, Refereed, Not invited
Corresponding - Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Tatsuo Kanda; Taichiro Goto; Yosuke Hirotsu; Ryota Masuzaki; Mitsuhiko Moriyama; Masao Omata
International journal of molecular sciences, Feb. 2020, Refereed, Not invited
Lead - Hy’s Lawとは. 肝疾患 vs. 薬物療法. 第6章 緊急性の高い肝障害
神田達郎; 森山光彦
月刊薬事, Jan. 2020, Not refereed, Invited
Lead - 3. ワクチン各論. 17) A型肝炎.
神田達郎
小児科臨床, 2020, Not refereed, Invited - A型肝炎.
神田達郎; 本田真之; 森山光彦.
診断と治療, 2020, Not refereed, Invited
Lead - Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.
Kanda T; Sasaki R; Masuzaki R; Takahashi H; Mizutani T; Matsumoto N; Nirei K; Moriyama M.
Int J Mol Sci., 2020, Refereed, Not invited
Lead - Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma.
Maruta S; Ogasawara S; Ooka Y; Obu M; Inoue M; Itokawa N; Haga Y; Seki A; Okabe S; Azemoto R; Itobayashi E; Atsukawa M; Sugiura N; Mizumoto H; Koroki K; Kanayama K; Kanzaki H; Kobayashi K; Kiyono S; Nakamura M; Kanogawa N; Saito T; Kondo T; Suzuki E; Nakamoto S; Tawada A; Chiba T; Arai M; Kanda T; Maruyama H; Kato N.
Liver Cancer, 2020, Refereed, Not invited - Long-term administration of Tolvaptan to patients with decompensated cirrhosis.
Kengo Kanayama; Tetsuhiro Chiba; Kazufumi Kobayashi; Keisuke Koroki; Susumu Maruta; Hiroaki Kanzaki; Yuko Kusakabe; Tomoko Saito; Soichiro Kiyono; Masato Nakamura; Sadahisa Ogasawara; Eiichiro Suzuki; Yoshihiko Ooka; Shingo Nakamoto; Shin Yasui; Tatsuo Kanda; Hitoshi Maruyama; Jun Kato; Naoya Kato
International journal of medical sciences, 2020, Refereed, Not invited - ニボルマブ投与後に急性増悪したC 型慢性肝炎の1 例
高橋幸治; 神田達郎; 中村昌人; 安井伸; 新井誠人; 加藤直也
肝臓, Dec. 2019, Refereed, Not invited - Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma.
Maeda T; Kanzaki H; Chiba T; Ao J; Kanayama K; Maruta S; Kusakabe Y; Saito T; Kobayashi K; Kiyono S; Nakamura M; Ogasawara S; Suzuki E; Ooka Y; Nakamoto S; Nakagawa R; Muroyama R; Kanda T; Maruyama H; Kato N.
BMC Cancer., Nov. 2019, Refereed, Not invited - APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
Tatsuo Kanda
Hepatology International, Nov. 2019, Refereed, Not invited
Lead - Long-term follow-up of a Japanese patient with hepatitis B virus genotype H and human immunodeficiency virus coinfection
Masahiro Ogawa; Shinya Kamimura; Tatsuo Kanda; Hiroshi Takahashi; Taku Mizutani; Naoki Matsumoto; Toshiki Yamamoto; Kazushige Nirei; Shunichi Matsuoka; Masami Takei; Mitsuhiko Moriyama
Future Virology, Oct. 2019 - Long-term follow-up of a Japanese patient with hepatitis B virus genotype H and human immunodeficiency virus coinfection
Tatsuo Kanda
Future Virology, Oct. 2019 - Successful Management of a Patient with Multiple Nucleos(t)ide Analogue-Resistant Hepatitis B Virus and Diffuse Large B Cell Lymphoma Using Tenofovir Disoproxil Fumarate: A Case Report
Tatsuo Kanda
Journal of Nihon University Medical Association, Oct. 2019, Refereed, Not invited - Prognostic four-gene signature for overall survival in patients with hepatocellular carcinoma
Tatsuo Kanda; Osamu Yokosuka; Mitsuhiko Moriyama
Hepatology International, Sep. 2019, Refereed, Invited
Lead - Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma.
Tatsuo Kanda
BMC gastroenterology, Aug. 2019, Refereed, Not invited - Are direct-acting antivirals against hepatitis C virus infection not associated with the recurrence of hepatocellular carcinoma?
Tatsuo Kanda
Hepatobiliary surgery and nutrition, Aug. 2019, Refereed, Invited
Corresponding - Follow-up Results of HCV GT2 Patients after Sofosbuvir/Ribavirin Therapy: Careful Attention to Occurrence of HCC.
Kaneko T; Kanda T; Nirei K; Matsumoto N; Yamazaki M; Shibata T; Tamura A; Ogawa M; Nakajima N; Matsuoka S; Kuroda K; Komoriya T; Yamamoto T; Takayama T; Moriyama M.
Anticancer Res., Jul. 2019, Refereed, Not invited
Corresponding - Antiviral activity of zinc sulfate against hepatitis A virus replication
Masahiro Ogawa; Tatsuo Kanda; Akiko Suganami; Shingo Nakamoto; Nan Nwe Win; Yutaka Tamura; Masato Nakamura; Shunichi Matsuoka; Osamu Yokosuka; Naoya Kato; Osamu Ohara; Hiroaki Okamoto; Mitsuhiko Moriyama; Hiroshi Shirasawa
Future Virology, Jun. 2019, Refereed, Not invited
Corresponding - Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan.
Ogasawara S; Ooka Y; Itokawa N; Inoue M; Okabe S; Seki A; Haga Y; Obu M; Atsukawa M; Itobayashi E; Mizumoto H; Sugiura N; Azemoto R; Kanayama K; Kanzaki H; Maruta S; Maeda T; Kusakabe Y; Yokoyama M; Kobayashi K; Kiyono S; Nakamura M; Saito T; Suzuki E; Nakamoto S; Yasui S; Tawada A; Chiba T; Arai M; Kanda T; Maruyama H; Kato N.
Invest New Drugs., Jun. 2019, Refereed, Not invited - Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease.
Ogawa M; Kanda T; Higuchi T; Takahashi H; Kaneko T; Matsumoto N; Nirei K; Yamagami H; Matsuoka S; Kuroda K; Moriyama M.
Int J Med Sci., Jun. 2019, Refereed, Not invited
Corresponding - Exosomes and Hepatocellular Carcinoma: From Bench to Bedside.
Sasaki R; Kanda T; Yokosuka O; Kato N; Matsuoka S; Moriyama M.
Int J Mol Sci., Mar. 2019, Refereed, Invited
Corresponding - Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
Tatsuo Kanda; Taichiro Goto; Yosuke Hirotsu; Mitsuhiko Moriyama; Masao Omata
International journal of molecular sciences, Mar. 2019, Refereed, Invited - Rapid hepatitis C virus clearance by antivirals correlates with immune status of infected patients
Reina Sasaki; Keith Meyer; Mitsuhiko Moriyama; Naoya Kato; Osamu Yokosuka; Ratna B. Ray; Rajeev Aurora; Ranjit Ray; Tatsuo Kanda
Journal of Medical Virology, Mar. 2019, Refereed, Not invited
Last - Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial.
Takehara T; Sakamoto N; Nishiguchi S; Ikeda F; Tatsumi T; Ueno Y; Yatsuhashi H; Takikawa Y; Kanda T; Sakamoto M; Tamori A; Mita E; Chayama K; Zhang G; De-Oertel S; Dvory-Sobol H; Matsuda T; Stamm LM; Brainard DM; Tanaka Y; Kurosaki M.
J Gastroenterol., Jan. 2019, Refereed, Not invited - POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.
Hitomi Y; Ueno K; Kawai Y; Nishida N; Kojima K; Kawashima M; Aiba Y; Nakamura H; Kouno H; Kouno H; Ohta H; Sugi K; Nikami T; Yamashita T; Katsushima S; Komeda T; Ario K; Naganuma A; Shimada M; Hirashima N; Yoshizawa K; Makita F; Furuta K; Kikuchi M; Naeshiro N; Takahashi H; Mano Y; Yamashita H; Matsushita K; Tsunematsu S; Yabuuchi I; Nishimura H; Shimada Y; Yamauchi K; Komatsu T; Sugimoto R; Sakai H; Mita E; Koda M; Nakamura Y; Kamitsukasa H; Sato T; Nakamuta M; Masaki N; Takikawa H; Tanaka A; Ohira H; Zeniya M; Abe M; Kaneko S; Honda M; Arai K; Arinaga-Hino T; Hashimoto E; Taniai M; Umemura T; Joshita S; Nakao K; Ichikawa T; Shibata H; Takaki A; Yamagiwa S; Seike M; Sakisaka S; Takeyama Y; Harada M; Senju M; Yokosuka O; Kanda T; Ueno Y; Ebinuma H; Himoto T; Murata K; Shimoda S; Nagaoka S; Abiru S; Komori A; Migita K; Ito M; Yatsuhashi H; Maehara Y; Uemoto S; Kokudo N; Nagasaki M; Tokunaga K; Nakamura M.
Sci Rep., Jan. 2019, Refereed, Not invited - Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus.
Win NN; Kanda T; Ogawa M; Nakamoto S; Haga Y; Sasaki R; Nakamura M; Wu S; Matsumoto N; Matsuoka S; Kato N; Shirasawa H; Yokosuka O; Okamoto H; Moriyama M.
Int J Med Sci., 2019, Refereed, Not invited
Corresponding - Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response.
Sasaki R; Kanda T; Kato N; Yokosuka O; Moriyama M.
World J Hepatol., Dec. 2018, Refereed, Invited
Corresponding - APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?
Tatsuo Kanda
Hepatology International, Dec. 2018, Refereed, Not invited
Lead - Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection.
Ooka Y; Miho K; Shuntaro O; Nakamura M; Ogasawara S; Suzuki E; Yasui S; Chiba T; Arai M; Kanda T; Maruyama H; Yokosuka O; Kato N; Mochizuki H; Omata M.
Hepatol Int., Nov. 2018, Refereed, Not invited - Determination of serum carbohydrate-deficient transferrin by a nephelometric immunoassay for differential diagnosis of alcoholic and non-alcoholic liver diseases.
Fumio Nomura; Tatsuo Kanda; Masanori Seimiya; Mamoru Satoh; Youko Kageyama; Takeshi Yamashita; Osamu Yokosuka; Naoya Kato; Katsuya Maruyama
Clinica chimica acta; international journal of clinical chemistry, Oct. 2018, Refereed, Not invited - Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection.
Tatsuo Kanda
Hepatology international, Sep. 2018 - Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine.
Nao Nishida; Masaya Sugiyama; Hiromi Sawai; Sohji Nishina; Aiko Sakai; Jun Ohashi; Seik-Soon Khor; Keisuke Kakisaka; Takayo Tsuchiura; Keisuke Hino; Ryo Sumazaki; Yasuhiro Takikawa; Kazumoto Murata; Tatsuo Kanda; Osamu Yokosuka; Katsushi Tokunaga; Masashi Mizokami
Hepatology (Baltimore, Md.), Sep. 2018, Refereed, Not invited - Hepatitis C virus genotype 4-infection and interferon-free treatment in Egypt
Tatsuo Kanda
Hepatology International, Jul. 2018, Refereed, Invited
Lead - Apoptosis and non-alcoholic fatty liver diseases.
Tatsuo Kanda
World journal of gastroenterology, Jul. 2018, Refereed, Invited
Lead - Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
Hiromi Sawai; Nao Nishida; Seik-Soon Khor; Masao Honda; Masaya Sugiyama; Natsumi Baba; Kayoko Yamada; Norie Sawada; Shoichiro Tsugane; Kazuhiko Koike; Yuji Kondo; Hiroshi Yatsuhashi; Shinya Nagaoka; Akinobu Taketomi; Moto Fukai; Masayuki Kurosaki; Namiki Izumi; Jong-Hon Kang; Kazumoto Murata; Keisuke Hino; Sohji Nishina; Akihiro Matsumoto; Eiji Tanaka; Naoya Sakamoto; Koji Ogawa; Kazuhide Yamamoto; Akihiro Tamori; Osamu Yokosuka; Tatsuo Kanda; Isao Sakaida; Yoshito Itoh; Yuichiro Eguchi; Satoshi Oeda; Satoshi Mochida; Man-Fung Yuen; Wai-Kay Seto; Yong Poovorawan; Nawarat Posuwan; Masashi Mizokami; Katsushi Tokunaga
Scientific reports, May 2018, Refereed, Not invited - Case of lipoatrophic diabetes induced by juvenile dermatomyositis
Yusuke Baba; Hiyori Kaneko; Minoru Takemoto; Kana Ide; Yuki Haga; Tatsuo Kanda; Shinsuke Akita; Yoshitaka Kubota; Masayuki Kuroda; Yutaka Kitagawa; Koutaro Yokote
Journal of Diabetes Investigation, May 2018, Refereed, Not invited - Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma
Kentaro Ishikawa; Tetsuhiro Chiba; Yoshihiko Ooka; Eiichiro Suzuki; Sadahisa Ogasawara; Takahiro Maeda; Masayuki Yokoyama; Masanori Inoue; Toru Wakamatsu; Yuko Kusakabe; Tomoko Saito; Akinobu Tawada; Makoto Arai; Tatsuo Kanda; Hitoshi Maruyama; Fumio Imazeki; Naoya Kato
Oncotarget, Apr. 2018, Refereed, Not invited - Interferon-Free Treatment for Chronic Hepatitis C in Japan
Tatsuo Kanda
Journal of Nihon University Medical Association, Apr. 2018 - 静脈管開存合併I型先天性門脈欠損症を呈した原発性胆汁性胆管炎の一成人例
清野 宗一郎; 丸山 紀史; 小林 和史; 嶋田 太郎; 高橋 正憲; 中村 昌人; 中本 晋吾; 安井 伸; 神田 達郎; 齊藤 朋子; 日下部 裕子; 小笠原 定久; 鈴木 英一郎; 大岡 美彦; 太和田 暁之; 千葉 哲博; 加藤 直也
肝臓, Apr. 2018, Refereed - Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment
Sadahisa Ogasawara; Tetsuhiro Chiba; Yoshihiko Ooka; Eiichiro Suzuki; Takahiro Maeda; Masayuki Yokoyama; Toru Wakamatsu; Masanori Inoue; Tomoko Saito; Kazufumi Kobayashi; Soichiro Kiyono; Masato Nakamura; Shingo Nakamoto; Shin Yasui; Akinobu Tawada; Makoto Arai; Tatsuo Kanda; Hitoshi Maruyama; Osamu Yokosuka; Naoya Kato
Investigational New Drugs, Apr. 2018, Refereed, Not invited - Early occurrence and recurrence of hepatocellular carcinoma in hepatitis C virus-infected patients after sustained virological response
Tatsuo Kanda; Shunichi Matsuoka; Mitsuhiko Moriyama
Hepatology International, Mar. 2018, Refereed, Invited
Lead - Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: Higher SVR rates with special precautions for deterioration of autoimmune hepatitis
Tatsuo Kanda; Shin Yasui; Masato Nakamura; Shingo Nakamoto; Koji Takahashi; Shuang Wu; Reina Sasaki; Yuki Haga; Sadahisa Ogasawara; Tomoko Saito; Kazufumi Kobayashi; Soichiro Kiyono; Yoshihiko Ooka; Eiichiro Suzuki; Tetsuhiro Chiba; Hitoshi Maruyama; Fumio Imazeki; Mitsuhiko Moriyama; Naoya Kato
Oncotarget, Feb. 2018, Refereed, Not invited
Lead - Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.
Akihiro Matsumoto; Shuhei Nishiguchi; Hirayuki Enomoto; Jong-Hon Kang; Yasuhito Tanaka; Noboru Shinkai; Masayuki Kurosaki; Masaru Enomoto; Tatsuo Kanda; Osamu Yokosuka; Hiroshi Yatsuhashi; Shinya Nagaoka; Chiaki Okuse; Tatehiro Kagawa; Tetsuya Mine; Koichi Takaguchi; Satoru Saito; Keisuke Hino; Fusao Ikeda; Shotaro Sakisaka; Daisuke Morihara; Shiho Miyase; Masataka Tsuge; Kazuaki Chayama; Naoki Hiramatsu; Yoshiyuki Suzuki; Kazumoto Murata; Eiji Tanaka
Journal of gastroenterology, Feb. 2018, Refereed, Not invited - Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure Due to Transient Hepatitis B Virus Infection.
Fujiwara K; Yasui S; Haga Y; Nakamura M; Yonemitsu Y; Arai M; Kanda T; Oda S; Yokosuka O; Kato N.
Intern Med., Jan. 2018, Refereed, Not invited - 自己免疫性肝炎とステロイド薬投与
神田達郎; 森山光彦
内科総合誌 Medical Practice M.P., 2018, Not refereed, Invited
Lead - C型慢性肝炎の最新治療～肝硬変・肝がん撲滅を目指して～
神田達郎
日大医誌, 2018, Refereed, Invited
Lead - A型肝炎の最近の動向.
神田達郎; 松本直樹; 中村仁美; 山名陽一郎; 水谷卓; 高橋央; 金子朋弘; 有間修平; 金澤芯依; 上村慎也; 樋口晃久; 楡井和重; 山上裕晃; 松岡俊一; 石井孝司; 森山光彦.
消化器・肝臓内科, 2018, Not refereed, Invited
Lead - Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature
Yuki Haga; Tatsuo Kanda; Shin Yasui; Masato Nakamura; Yoshihiko Ooka; Koji Takahashi; Shuang Wu; Shingo Nakamoto; Makoto Arai; Tetsuhiro Chiba; Hitoshi Maruyama; Osamu Yokosuka; Nobuo Takada; Mitsuhiko Moriyama; Fumio Imazeki; Naoya Kato
Oncotarget, 2018, Refereed, Not invited
Corresponding - Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection.
Nirei K; Kanda T; Nakamura H; Matsuoka S; Takayama T; Sugitani M; Moriyama M.
Int J Med Sci, 2018, Refereed, Not invited - Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events.
Kanda T; Yasui S; Nakamura M; Nakamoto S; Takahashi K; Wu S; Sasaki R; Haga Y; Ogasawara S; Saito T; Kobayashi K; Kiyono S; Ooka Y; Suzuki E; Chiba T; Maruyama H; Imazeki F; Moriyama M; Kato N.
Oncotarget, 2018, Refereed, Not invited
Lead - Case of Portal-Systemic Encephalopathy due to Complicated Spleno-renal Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration Using a Double Coaxial Balloon Catheter System and Shape-memory Coils.
Matsuoka S; Yamana Y; Ishii T; Kumagawa M; Mizutani T; Kamimura S; Matsumoto N; Nakamura H; Nirei K; Tatsuo K; Moriyama M.
Intern Med, 2018, Refereed, Not invited - Association of mRNA expression of iron metabolism-associated genes and progression of non-alcoholic steatohepatitis in rats
Teruhisa Higuchi; Mitsuhiko Moriyama; Akiko Fukushima; Hiroshi Matsumura; Shunichi Matsuoka; Tatsuo Kanda; Masahiko Sugitani; Akiko Tsunemi; Takahiro Ueno; Noboru Fukuda
Oncotarget, 2018, Refereed, Not invited - Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression.
Nan Nwe Win; Tatsuo Kanda; Shingo Nakamoto; Mitsuhiko Moriyama; Xia Jiang; Akiko Suganami; Yutaka Tamura; Hiroaki Okamoto; Hiroshi Shirasawa
International journal of medical sciences, 2018, Refereed, Not invited
Corresponding - Hepatitis B Virus Genotype C is Predominant in Myanmar
Nan Nwe Win; Shingo Nakamoto; Myint Myint Sein; Mitsuhiko Moriyama; Tatsuo Kanda; Hiroshi Shirasawa
Diseases, Dec. 2017, Refereed, Not invited
Corresponding - Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
Tatsuo Kanda; Kazushige Nirei; Naoki Matsumoto; Teruhisa Higuchi; Hitomi Nakamura; Hiroaki Yamagami; Shunichi Matsuoka; Mitsuhiko Moriyama
WORLD JOURNAL OF GASTROENTEROLOGY, Dec. 2017, Refereed, Invited - Anemia during Direct-Acting Antiviral Regimens in Kidney Transplant Recipients with Hepatitis C.
Kanda T; Matsuoka S; Moriyama M.
OBM Hepatology and Gastroenterology., Oct. 2017, Refereed, Not invited
Lead - Odalasvir Nonstructural protein 5A (NS5A) inhibitor Treatment of hepatitis C virus (HCV)
T. Kanda; M. Moriyama
DRUGS OF THE FUTURE, Sep. 2017, Refereed, Invited
Lead - Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
Tatsuo Kanda; Mitsuhiko Moriyama
WORLD JOURNAL OF GASTROENTEROLOGY, Aug. 2017, Refereed, Invited
Lead - Successful Treatment with Tenofovir Disoproxil Fumarate for A Pregnant Woman with Chronic Active Hepatitis B.
Takahashi K; Kanda T; Haga Y; Sasaki R; Nakamura M; Shuang Wu; Nakamoto S; Yasui S; Kamezaki H; Yokosuka O.
OBM Hepatology and Gastroenterology., Jul. 2017, Refereed, Not invited
Corresponding - Treatment of real-world HCV genotype 2-infected Japanese patients with sofosbuvir plus ribavirin
Tatsuo Kanda; Masato Nakamura; Shin Yasui; Yuki Haga; Akinobu Tawada; Eiichiro Suzuki; Yoshihiko Ooka; Koji Takahashi; Reina Sasaki; Shuang Wu; Shingo Nakamoto; Makoto Arai; Fumio Imazeki; Osamu Yokosuka
Biology, Jun. 2017, Refereed, Invited
Lead - Overexpression of the androgen receptor in human hepatoma cells and its effect on fatty acid metabolism
Tatsuo Kanda; Xia Jiang; Masato Nakamura; Yuki Haga; Reina Sasaki; Shuang Wu; Shingo Nakamoto; Fumio Imazeki; Osamu Yokosuka
ONCOLOGY LETTERS, Jun. 2017, Refereed, Not invited
Lead - Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication
Xia Jiang; Tatsuo Kanda; Yuki Haga; Reina Sasaki; Masato Nakamura; Shuang Wu; Shingo Nakamoto; Hiroshi Shirasawa; Hiroaki Okamoto; Osamu Yokosuka
EXPERIMENTAL AND THERAPEUTIC MEDICINE, Jun. 2017, Refereed, Not invited
Corresponding - Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma
Tatsuo Kanda; Koji Takahashi; Masato Nakamura; Shingo Nakamoto; Shuang Wu; Yuki Haga; Reina Sasaki; Xia Jiang; Osamu Yokosuka
CANCERS, May 2017, Refereed, Not invited
Lead - Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors
Tatsuo Kanda; Shin Yasui; Masato Nakamura; Eiichiro Suzuki; Makoto Arai; Yoshihiko Ooka; Sadahisa Ogasawara; Tetsuhiro Chiba; Tomoko Saito; Yuki Haga; Koji Takahashi; Reina Sasaki; Shuang Wu; Shingo Nakamoto; Akinobu Tawada; Hitoshi Maruyama; Fumio Imazeki; Naoya Kato; Osamu Yokosuka
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, May 2017, Refereed, Not invited
Lead - Interferon induces interleukin 8 and bone marrow stromal cell antigen 2 expression, inhibiting the production of hepatitis B virus surface antigen from human hepatocytes
Yuki Haga; Tatsuo Kanda; Shingo Nakamoto; Masato Nakamura; Reina Sasaki; Shuang Wu; Osamu Yokosuka
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, May 2017, Refereed, Not invited
Corresponding - Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis
Masato Nakamura; Tatsuo Kanda; Xia Jiang; Yuki Haga; Koji Takahashi; Shuang Wu; Shin Yasui; Shingo Nakamoto; Osamu Yokosuka
PLOS ONE, May 2017, Refereed, Not invited
Corresponding - Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines
Yuki Haga; Tatsuo Kanda; Masato Nakamura; Shingo Nakamoto; Reina Sasaki; Koji Takahashi; Shuang Wu; Osamu Yokosuka
PLOS ONE, Mar. 2017, Refereed, Not invited
Corresponding - Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population
Minae Kawashima; Yuki Hitomi; Yoshihiro Aiba; Nao Nishida; Kaname Kojima; Yosuke Kawai; Hitomi Nakamura; Atsushi Tanaka; Mikio Zeniya; Etsuko Hashimoto; Hiromasa Ohira; Kazuhide Yamamoto; Masanori Abe; Kazuhiko Nakao; Satoshi Yamagiwa; Shuichi Kaneko; Masao Honda; Takeji Umemura; Takafumi Ichida; Masataka Seike; Shotaro Sakisaka; Masaru Harada; Osamu Yokosuka; Yoshiyuki Ueno; Michio Senju; Tatsuo Kanda; Hidetaka Shibata; Takashi Himoto; Kazumoto Murata; Yasuhiro Miyake; Hirotoshi Ebinuma; Makiko Taniai; Satoru Joshita; Toshiki Nikami; Hajime Ota; Hiroshi Kouno; Hirotaka Kouno; Makoto Nakamuta; Nobuyoshi Fukushima; Motoyuki Kohjima; Tatsuji Komatsu; Toshiki Komeda; Yukio Ohara; Toyokichi Muro; Tsutomu Yamashita; Kaname Yoshizawa; Yoko Nakamura; Masaaki Shimada; Noboru Hirashima; Kazuhiro Sugi; Keisuke Ario; Eiichi Takesaki; Atsushi Naganuma; Hiroshi Mano; Haruhiro Yamashita; Kouki Matsushita; Kazuhiko Yamauchi; Fujio Makita; Hideo Nishimura; Kiyoshi Furuta; Naohiro Takahashi; Masahiro Kikuchi; Naohiko Masaki; Tomohiro Tanaka; Sumito Tamura; Akira Mori; Shintaro Yagi; Ken Shirabe; Atsumasa Komori; Kiyoshi Migita; Masahiro Ito; Shinya Nagaoka; Seigo Abiru; Hiroshi Yatsuhashi; Michio Yasunami; Shinji Shimoda; Kenichi Harada; Hiroto Egawa; Yoshihiko Maehara; Shinji Uemoto; Norihiro Kokudo; Hajime Takikawa; Hiromi Ishibashi; Kazuaki Chayama; Masashi Mizokami; Masao Nagasaki; Katsushi Tokunaga; Minoru Nakamura
HUMAN MOLECULAR GENETICS, Feb. 2017, Refereed, Not invited - Hepatitis A virus genotype IA-infected patient with marked elevation of aspartate aminotransferase levels
Yoshifumi Miura; Tatsuo Kanda; Shin Yasui; Koji Takahashi; Yuki Haga; Reina Sasaki; Masato Nakamura; Shuang Wu; Shingo Nakamoto; Makoto Arai; Tsutomu Nishizawa; Hiroaki Okamoto; Osamu Yokosuka
Clinical Journal of Gastroenterology, Feb. 2017, Refereed, Not invited
Corresponding - Response-Guided Treatment with an Ultrarapid Virological Response Creates the Future of Interferon-Free Treatment against Hepatitis C
Tatsuo Kanda; Osamu Yokosuka
OBM Hepatology and Gastroenterology., Jan. 2017, Refereed, Invited
Lead - Pneumocystis jirovecii pneumonia Suspected Due to Low-Dosage Prednisolone Treatment for Acute Autoimmune Hepatitis: Case Report and Literature Review
Hidehiro Kamezaki; Tatsuo Kanda; Osamu Yokosuka; Masanori Tsukahara; Yasunori Kasahara; Takayuki Sakurai
OBM Hepatology and Gastroenterology., Jan. 2017, Refereed, Not invited - The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study
Takashi Taida; Makoto Arai; Tatsuo Kanda; Shuhei Hige; Yoshiyuki Ueno; Fumio Imazeki; Namiki Izumi; Eiji Tanaka; Noboru Shinkai; Kentaro Yoshioka; Yasunari Nakamoto; Shuhei Nishiguchi; Masataka Tsuge; Masanori Abe; Michio Sata; Hiroshi Yatsuhashi; Akio Ido; Kazuhiko Kita; Ryousaku Azemoto; Yoshio Kitsukawa; Nobuaki Goto; Osamu Yokosuka
Journal of Gastroenterology, Jan. 2017, Refereed, Not invited - Interferon-free treatment for HCV-infected patients with decompensated cirrhosis
Tatsuo Kanda
HEPATOLOGY INTERNATIONAL, Jan. 2017, Refereed, Not invited
Lead - A型肝炎の現状とトピックス
神田達郎
Medical Practice, 2017, Not refereed, Invited
Lead - Discrepancy between Hepatitis C Virus Genotypes and NS4-Based Serotypes: Association with Their Subgenomic Sequences
Nan Nwe Win; Shingo Nakamoto; Tatsuo Kanda; Hiroki Takahashi; Azusa Takahashi-Nakaguchi; Shin Yasui; Masato Nakamura; Shuang Wu; Fumio Imazeki; Shigeru Mikami; Osamu Yokosuka; Tohru Gonoi; Hiroshi Shirasawa
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Jan. 2017, Refereed, Not invited - Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy
Shingo Nakamoto; Fumio Imazeki; Tatsuo Kanda; Shuang Wu; Masato Nakamura; Shin Yasui; Akinobu Tawada; Rintaro Mikata; Tetsuhiro Chiba; Makoto Arai; Osamu Yokosuka; Hiroshi Shirasawa
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2017, Refereed, Not invited - Free fatty acids or high-concentration glucose enhances hepatitis A virus replication in association with a reduction in glucose-regulated protein 78 expression
Nan Nwe Win; Tatsuo Kanda; Masato Nakamura; Shingo Nakamoto; Hiroaki Okamoto; Osamu Yokosuka; Hiroshi Shirasawa
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Jan. 2017, Refereed, Not invited
Corresponding - Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Could Not Always Predict Early Cirrhosis in Non-Viral Liver Diseases.
Haga Y; Kanda T; Sasaki R; Nakamura M; Takahashi K; Wu S; Yasui S; Arai M; Nakamoto S; Yokosuka O.
Diseases., Dec. 2016, Refereed, Not invited
Corresponding - Infectious complications, steroid use and timing for emergency liver transplantation in acute liver failure: analysis in a Japanese center
Shin Yasui; Keiichi Fujiwara; Yuuki Haga; Masato Nakamura; Rintaro Mikata; Makoto Arai; Tatsuo Kanda; Shigeto Oda; Osamu Yokosuka
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Dec. 2016, Refereed, Not invited - Drug-induced liver injury associated with complementary and alternative medicines
Koji Takahashi; Tatsuo Kanda; Shin Yasui; Yuki Haga; Junichiro Kumagai; Reina Sasaki; Shuang Wu; Shingo Nakamoto; Masato Nakamura; Makoto Arai; Osamu Yokosuka
Case Reports in Gastroenterology, Oct. 2016, Refereed, Not invited
Corresponding - Two-dimensional shear wave elastography with propagation-based reliability assessment for grading hepatic fibrosis and portal hypertension
Hitoshi Maruyama; Kazufumi Kobayashi; Soichiro Kiyono; Tadashi Sekimoto; Tatsuo Kanda; Osamu Yokosuka
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Sep. 2016, Refereed, Not invited - APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing
Masao Omata; Tatsuo Kanda; Lai Wei; Ming-Lung Yu; Wang-Long Chuang; Alaaeldin Ibrahim; Cosmas Rinaldi Adithya Lesmana; Jose Sollano; Manoj Kumar; Ankur Jindal; Barjesh Chander Sharma; Saeed S. Hamid; A. Kadir Dokmeci; Mamun Al-Mahtab; Geofferey W. McCaughan; Jafri Wasim; Darrell H. G. Crawford; Jia-Horng Kao; Osamu Yokosuka; George K. K. Lau; Shiv Kumar Sarin
HEPATOLOGY INTERNATIONAL, Sep. 2016, Refereed, Not invited - APASL consensus statements and recommendation on treatment of hepatitis C
Masao Omata; Tatsuo Kanda; Lai Wei; Ming-Lung Yu; Wang-Long Chuang; Alaaeldin Ibrahim; Cosmas Rinaldi Adithya Lesmana; Jose Sollano; Manoj Kumar; Ankur Jindal; Barjesh Chander Sharma; Saeed S. Hamid; A. Kadir Dokmeci; Mamun-Al-Mahtab; Geofferey W. McCaughan; Jafri Wasim; Darrell H. G. Crawford; Jia-Horng Kao; Osamu Yokosuka; George K. K. Lau; Shiv Kumar Sarin
HEPATOLOGY INTERNATIONAL, Sep. 2016, Refereed, Not invited - Cooperative effects of hepatitis B virus and TNF may play important roles in the activation of metabolic pathways through the activation of NF-B
Shuang Wu; Tatsuo Kanda; Shingo Nakamoto; Xia Jiang; Masato Nakamura; Reina Sasaki; Yuki Haga; Hiroshi Shirasawa; Osamu Yokosuka
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, Aug. 2016, Refereed, Not invited
Corresponding - Hepatitis C virus genotypes in Myanmar
Nan Nwe Win; Tatsuo Kanda; Shingo Nakamoto; Osamu Yokosuka; Hiroshi Shirasawa
WORLD JOURNAL OF GASTROENTEROLOGY, Jul. 2016, Refereed, Invited
Corresponding - Prevention of hepatitis B virus-associated liver diseases by antiviral therapy
Akinobu Tawada; Tatsuo Kanda; Fumio Imazeki; Osamu Yokosuka
HEPATOLOGY INTERNATIONAL, Jul. 2016, Refereed, Not invited
Corresponding - Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report
Yuki Ohta; Tatsuo Kanda; Tatsuro Katsuno; Shin Yasui; Yuki Haga; Reina Sasaki; Masato Nakamura; Shuang Wu; Shingo Nakamoto; Makoto Arai; Osamu Yokosuka
BMC GASTROENTEROLOGY, Jul. 2016, Refereed, Not invited
Corresponding - Autoimmune hepatitis following drug-induced liver injury in an elderly patient.
Tatsuo Kanda
Clinical journal of gastroenterology, May 2016 - Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan.
Kanda T; Yasui S; Nakamura M; Suzuki E; Arai M; Haga Y; Sasaki R; Wu S; Nakamoto S; Imazeki F; Yokosuka O
Int J Med Sci., May 2016, Refereed, Not invited - Daclatasvir plus asunaprevir treatment for real-world HCV genotype 1-infected patients in Japan
Tatsuo Kanda; Shin Yasui; Masato Nakamura; Eiichiro Suzuki; Makoto Arai; Yuki Haga; Reina Sasaki; Shuang Wu; Shingo Nakamoto; Fumio Imazeki; Osamu Yokosuka
International Journal of Medical Sciences, May 2016, Refereed, Not invited
Lead - Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure
Keiichi Fujiwara; Shin Yasui; Yutaka Yonemitsu; Makoto Arai; Tatsuo Kanda; Yoshihiro Fukuda; Masayuki Nakano; Shigeto Oda; Osamu Yokosuka
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Apr. 2016, Refereed, Not invited - Sofosbuvir treatment and hepatitis C virus infection
Masato Nakamura; Tatsuo Kanda; Yuki Haga; Reina Sasaki; Shuang Wu; Shingo Nakamoto; Shin Yasui; Makoto Arai; Fumio Imazeki; Osamu Yokosuka
World Journal of Hepatology, 2016, Refereed, Invited
Corresponding - Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells
Reina Sasaki; Tatsuo Kanda; Masato Nakamura; Shingo Nakamoto; Yuki Haga; Shuang Wu; Hiroshi Shirasawa; Osamu Yokosuka
PLOS ONE, Jan. 2016, Refereed, Not invited
Corresponding - Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin
Tatsuo Kanda; Shingo Nakamoto; Reina Sasaki; Masato Nakamura; Shin Yasui; Yuki Haga; Sadahisa Ogasawara; Akinobu Tawada; Makoto Arai; Shigeru Mikami; Fumio Imazeki; Osamu Yokosuka
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2016, Refereed, Not invited
Lead - Successful Management of Acute Liver Failure Patients Waiting for Liver Transplantation by On-Line Hemodiafiltration with an Arteriovenous Fistula
Yuki Haga; Shin Yasui; Tatsuo Kanda; Noriyuki Hattori; Toru Wakamatsu; Masato Nakamura; Reina Sasaki; Shuang Wu; Shingo Nakamoto; Makoto Arai; Hitoshi Maruyama; Masayuki Ohtsuka; Shigeto Oda; Masaru Miyazaki; Osamu Yokosuka
Case Reports in Gastroenterology, 2016, Refereed, Not invited
Corresponding - Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation
Reina Sasaki; Tatsuo Kanda; Shin Yasui; Yuki Haga; Masato Nakamura; Mutsumi Yamato; Shuang Wu; Shingo Nakamoto; Makoto Arai; Shigeru Mikami; Hideaki Miyauchi; Hisahiro Matsubara; Osamu Yokosuka
Case Reports in Gastroenterology, 2016, Refereed, Not invited
Corresponding - Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin
Reina Sasaki; Tatsuo Kanda; Masayuki Ohtsuka; Shin Yasui; Yuki Haga; Masato Nakamura; Masayuki Yokoyama; Shuang Wu; Shingo Nakamoto; Makoto Arai; Hitoshi Maruyama; Masaru Miyazaki; Osamu Yokosuka
Case Reports in Gastroenterology, 2016, Refereed, Not invited
Corresponding - Autoimmune hepatitis following drug-induced liver injury in an elderly patient.
Kumagai J; Kanda T; Yasui S; Haga Y; Sasaki R; Nakamura M; Wu S; Nakamoto S; Arai M; Iino Y; Yokosuka O.
Clin J Gastroenterol., 2016, Refereed, Not invited
Corresponding - Utility of Prediction Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogues
Akinobu Tawada; Tetsuhiro Chiba; Tomoko Saito; Sadahida Ogasawara; Eiichiro Suzuki; Yoshihiko Ooka; Makoto Arai; Tatsuo Kanda; Masami Shinozaki; Nobuaki Goto; Kengo Nagashima; Osamu Yokosuka
ONCOLOGY, 2016, Refereed, Not invited - [History of the discovery of viral hepatitis].
Tatsuo Kanda
Nihon rinsho. Japanese journal of clinical medicine, Dec. 2015 - [New antivirals for hepatitis B virus infection].
Tatsuo Kanda
Nihon rinsho. Japanese journal of clinical medicine, Dec. 2015 - Nonalcoholic fatty liver disease and hepatic cirrhosis: comparison with viral hepatitis-associated steatosis
Yuki Haga; Tatsuo Kanda; Reina Sasaki; Masato Nakamura; Shingo Nakamoto; Osamu Yokosuka
WORLD JOURNAL OF GASTROENTEROLOGY, Dec. 2015, Refereed, Not invited
Corresponding - Factors associated with the effect of interferon-alpha sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B
Akihiro Matsumoto; Hiroshi Yatsuhashi; Shinya Nagaoka; Yoshiyuki Suzuki; Tetsuya Hosaka; Masataka Tsuge; Kazuaki Chayama; Tatsuo Kanda; Osamu Yokosuka; Shuhei Nishiguchi; Masaki Saito; Shiho Miyase; Jong-Hon Kang; Noboru Shinkai; Yasuhito Tanaka; Takeji Umemura; Eiji Tanaka
HEPATOLOGY RESEARCH, Dec. 2015, Refereed, Not invited - MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells
Masato Nakamura; Tatsuo Kanda; Reina Sasaki; Yuki Haga; Xia Jiang; Shuang Wu; Shingo Nakamoto; Osamu Yokosuka
PLOS ONE, Dec. 2015, Refereed, Not invited
Corresponding - 【ウイルス肝炎・肝癌研究の新展開】ウイルス肝炎の最新治療
中村 昌人; 神田 達郎; 横須賀 收
細胞, Oct. 2015 - 【C型慢性肝炎治療のパラダイムシフト-治療から治癒へ-】Genotype2型に対する新薬NS5Bポリメラーゼ阻害薬Sofosbuvir 臨床効果
横須賀 收; 中村 昌人; 神田 達郎
肝胆膵, Oct. 2015 - Severe and fulminant hepatitis of indeterminate etiology in a Japanese center
Keiichi Fujiwara; Shin Yasui; Masayuki Nakano; Yutaka Yonemitsu; Makoto Arai; Tatsuo Kanda; Yoshihiro Fukuda; Shigeto Oda; Osamu Yokosuka
HEPATOLOGY RESEARCH, Oct. 2015, Refereed, Not invited - Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries
Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K. K. Lau; Barjesh C. Sharma; Saeed S. Hamid; Wan-Long Chuang; A. Kadir Dokmeci
HEPATOLOGY INTERNATIONAL, Oct. 2015, Refereed, Not invited
Corresponding - Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-beta in hepatocytes
N. Sarkar; R. Panigrahi; A. Pal; A. Biswas; S. P. Singh; S. K. Kar; M. Bandopadhyay; D. Das; D. Saha; T. Kanda; M. Sugiyama; S. Chakrabarti; A. Banerjee; R. Chakravarty
JOURNAL OF VIRAL HEPATITIS, Oct. 2015, Refereed, Not invited - Reappearance of Serum Hepatitis B Viral DNA in Patients With Hepatitis B Surface Antigen Seroclearance
Masato Nakamura; Tatsuo Kanda; Shingo Nakamoto; Yuki Haga; Reina Sasaki; Xia Jiang; Shin Yasui; Makoto Arai; Osamu Yokosuka
HEPATOLOGY, Oct. 2015, Refereed, Not invited
Corresponding - The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity
Tatsuo Kanda; Reina Sasaki; Shingo Nakamoto; Yuki Haga; Masato Nakamura; Hiroshi Shirasawa; Hiroaki Okamoto; Osamu Yokosuka
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Oct. 2015, Refereed, Not invited
Lead - Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.
Kanda T; Nakamoto S; Wu S; Nakamura M; Jiang X; Haga Y; Sasaki R; Yokosuka O.
J Clin Transl Hepatol., Sep. 2015, Refereed, Invited
Lead - HBV Core Protein Enhances Cytokine Production.
Kanda T; Wu S; Sasaki R; Nakamura M; Haga Y; Jiang X; Nakamoto S; Yokosuka O.
Diseases., Sep. 2015, Refereed, Not invited
Lead - [112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Viral Infection and Tumors: Hepatitis B Virus Infection and Hepatocellular Carcinoma].
Tatsuo Kanda
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, Sep. 2015 - Association between hepatitis B virus and MHC class I polypeptide-related chain A in human hepatocytes derived from human-mouse chimeric mouse liver
Reina Sasaki; Tatsuo Kanda; Shuang Wu; Shingo Nakamoto; Yuki Haga; Xia Jiang; Masato Nakamura; Hiroshi Shirasawa; Osamu Yokosuka
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Sep. 2015, Refereed, Not invited
Corresponding - Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy
Shingo Nakamoto; Fumio Imazeki; Makoto Arai; Shin Yasui; Masato Nakamura; Yuki Haga; Reina Sasaki; Tatsuo Kanda; Hiroshi Shirasawa; Osamu Yokosuka
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Sep. 2015, Refereed, Not invited - Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C?
Tatsuo Kanda
World journal of virology, Aug. 2015, Refereed, Not invited
Lead - Importance of the poor prognosis of severe and fulminant hepatitis in the elderly in an era of a highly aging society: Analysis in a Japanese center
Keiichi Fujiwara; Shin Yasui; Yutaka Yonemitsu; Makoto Arai; Tatsuo Kanda; Masayuki Nakano; Shigeto Oda; Osamu Yokosuka
HEPATOLOGY RESEARCH, Aug. 2015, Refereed, Not invited - Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-kappa B-Nuclear Translocation
Xia Jiang; Tatsuo Kanda; Shuang Wu; Shingo Nakamoto; Masato Nakamura; Reina Sasaki; Yuki Haga; Takaji Wakita; Hiroshi Shirasawa; Osamu Yokosuka
PLOS ONE, Jul. 2015, Refereed, Not invited
Corresponding - HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b
Yosuke Hirotsu; Tatsuo Kanda; Hiroshi Matsumura; Mitsuhiko Moriyama; Osamu Yokosuka; Masao Omata
HEPATOLOGY INTERNATIONAL, Jul. 2015, Refereed, Not invited
Corresponding - Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor
Naoya Kanogawa; Sadahisa Ogasawara; Tetsuhiro Chiba; Tomoko Saito; Tenyu Motoyama; Eiichiro Suzuki; Yoshihiko Ooka; Akinobu Tawada; Tatsuo Kanda; Shigeru Mikami; Ryosaku Azemoto; Takashi Kaiho; Masami Shinozaki; Masayuki Ohtsuka; Masaru Miyazaki; Osamu Yokosuka
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Jul. 2015, Refereed, Not invited - The androgen receptor as an emerging target in hepatocellular carcinoma.
Tatsuo Kanda
Journal of hepatocellular carcinoma, Jun. 2015, Refereed, Invited
Lead - Sustained virological response after 8-week treatment of simeprevir with peginterferon α-2a plus ribavirin in a Japanese female with Hepatitis C virus genotype 1b and IL28B minor genotype
Tatsuo Kanda; Masato Nakamura; Reina Sasaki; Shin Yasui; Shingo Nakamoto; Yuki Haga; Xia Jiang; Shuang Wu; Akinobu Tawada; Makoto Arai; Fumio Imazeki; Osamu Yokosuka
Case Reports in Gastroenterology, May 2015, Refereed, Not invited
Lead - Faldaprevir for the Treatment of Hepatitis C
Tatsuo Kanda; Osamu Yokosuka; Masao Omata
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Mar. 2015, Refereed, Not invited
Lead - A semi-supervised tensor regression model for siRNA efficacy prediction
Bui Ngoc Thang; Tu Bao Ho; Tatsuo Kanda
BMC BIOINFORMATICS, Mar. 2015, Refereed, Not invited - Fixed point observation of etiology of acute liver failure according to the novel Japanese diagnostic criteria
Keiichi Fujiwara; Shin Yasui; Yutaka Yonemitsu; Makoto Arai; Tatsuo Kanda; Masayuki Nakano; Shigeto Oda; Osamu Yokosuka
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Mar. 2015, Refereed, Not invited - The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells
Xia Jiang; Tatsuo Kanda; Shingo Nakamoto; Kengo Saito; Masato Nakamura; Shuang Wu; Yuki Haga; Reina Sasaki; Naoya Sakamoto; Hiroshi Shirasawa; Hiroaki Okamoto; Osamu Yokosuka
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Mar. 2015, Refereed, Not invited
Corresponding - Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B
S. Yasui; K. Fujiwara; M. Nakamura; T. Miyamura; Y. Yonemitsu; R. Mikata; M. Arai; T. Kanda; F. Imazeki; S. Oda; O. Yokosuka
JOURNAL OF VIRAL HEPATITIS, Feb. 2015, Refereed, Not invited - Mosapride Citrate Increases Postprandial Glucagon-Like Peptide-1, Insulin, and Gene Expression of Sweet Taste Receptors
Daisuke Maruoka; Makoto Arai; Takeshi Tanaka; Kenichiro Okimoto; Arata Oyamada; Shoko Minemura; Masaru Tsuboi; Tomoaki Matsumura; Tomoo Nakagawa; Tatsuo Kanda; Tatsuro Katsuno; Fumio Imazeki; Osamu Yokosuka
DIGESTIVE DISEASES AND SCIENCES, Feb. 2015, Refereed, Not invited - Antiviral therapies for chronic hepatitis C virus infection with cirrhosis
Shingo Nakamoto; Tatsuo Kanda; Hiroshi Shirasawa; Osamu Yokosuka
World Journal of Hepatology, 2015, Refereed, Invited
Corresponding - Natural interferon-beta treatment for patients with chronic hepatitis C in Japan
Reina Sasaki; Tatsuo Kanda; Shingo Nakamoto; Yuki Haga; Masato Nakamura; Shin Yasui; Xia Jiang; Shuang Wu; Makoto Arai; Osamu Yokosuka
World Journal of Hepatology, 2015, Refereed, Not invited
Corresponding - Current and future directions for treating hepatitis B virus infection
Akinobu Tawada; Tatsuo Kanda; Osamu Yokosuka
World Journal of Hepatology, 2015, Refereed, Invited
Corresponding - Current management of patients with hepatocellular carcinoma
Tatsuo Kanda; Sadahisa Ogasawara; Tetsuhiro Chiba; Yuki Haga; Masao Omata; Osamu Yokosuka
World Journal of Hepatology, 2015, Refereed, Invited
Lead - Recent trend of Hepatitis E virus infection in Chiba Area, Japan: 3 of 5 cases with rheumatoid arthritis
Tatsuo Kanda; Shin Yasui; Masato Nakamura; Makoto Arai; Reina Sasaki; Yuki Haga; Shuang Wu; Shingo Nakamoto; Hiroaki Okamoto; Osamu Yokosuka
Case Reports in Gastroenterology, 2015, Refereed, Not invited
Lead - IFNL4 ss469415590 variant is associated with treatment response in Japanese HCV genotype 1 infected individuals treated with IFN-including regimens
Tatsuo Miyamura; Tatsuo Kanda; Shingo Nakamoto; Makoto Arai; Masato Nakamura; Shuang Wu; Xia Jiang; Reina Sasaki; Yuki Haga; Shin Yasui; Yoshihiko Ooka; Tetsuhiro Chiba; Fumio Imazeki; Shigeru Mikami; Osamu Yokosuka
International Journal of Hepatology, Dec. 2014, Refereed, Not invited
Corresponding - Knockdown of glucose-regulated protein 78 enhances poly(ADP-ribose) polymerase cleavage in human pancreatic cancer cells exposed to endoplasmic reticulum stress
Xia Jiang; Tatsuo Kanda; Shingo Nakamoto; Yuki Haga; Reina Sasaki; Masato Nakamura; Shuang Wu; Rintaro Mikata; Osamu Yokosuka
ONCOLOGY REPORTS, Dec. 2014, Refereed, Not invited
Corresponding - Hepatitis C Virus Nonstructural Protein 5A Inhibits Thapsigargin-Induced Apoptosis
Xia Jiang; Tatsuo Kanda; Shuang Wu; Shingo Nakamoto; Takaji Wakita; Hiroshi Shirasawa; Osamu Yokosuka
PLOS ONE, Nov. 2014, Refereed, Not invited
Corresponding - Reactivation of Hepatitis B Virus in Hematopoietic Stem Cell Transplant Recipients in Japan: Efficacy of Nucleos(t)ide Analogues for Prevention and Treatment
Shingo Nakamoto; Tatsuo Kanda; Chiaki Nakaseko; Emiko Sakaida; Chikako Ohwada; Masahiro Takeuchi; Yusuke Takeda; Naoya Mimura; Tohru Iseki; Shuang Wu; Makoto Arai; Fumio Imazeki; Kengo Saito; Hiroshi Shirasawa; Osamu Yokosuka
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Nov. 2014, Refereed, Invited
Corresponding - Fixed point observation of etiology of acute liver failure according to the novel Japanese diagnostic criteria.
Tatsuo Kanda
Journal of hepato-biliary-pancreatic sciences, Oct. 2014 - Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers
Tatsuo Kanda; Xia Jiang; Osamu Yokosuka
WORLD JOURNAL OF GASTROENTEROLOGY, Jul. 2014, Refereed, Invited
Lead - Suppression of La Antigen Exerts Potential Antiviral Effects against Hepatitis A Virus
Xia Jiang; Tatsuo Kanda; Shuang Wu; Shingo Nakamoto; Kengo Saito; Hiroshi Shirasawa; Tomoko Kiyohara; Koji Ishii; Takaji Wakita; Hiroaki Okamoto; Osamu Yokosuka
PLOS ONE, Jul. 2014, Refereed, Not invited
Corresponding - 18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis
Akinobu Tawada; Tatsuo Kanda; Takashi Oide; Toshio Tsuyuguchi; Fumio Imazeki; Yukio Nakatani; Osamu Yokosuka
International Medical Case Reports Journal, Jun. 2014, Refereed, Not invited
Corresponding - Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity
Xia Jiang; Tatsuo Kanda; Shuang Wu; Masato Nakamura; Tatsuo Miyamura; Shingo Nakamoto; Arup Banerjee; Osamu Yokosuka
WORLD JOURNAL OF GASTROENTEROLOGY, Jun. 2014, Refereed, Invited
Corresponding - Downregulation of microRNA-431 by human interferon-beta inhibits viability of medulloblastoma and glioblastoma cells via upregulation of SOCS6
Takeshi Tanaka; Makoto Arai; Xia Jiang; Shigeru Sugaya; Tatsuo Kanda; Katsunori Fujii; Kazuko Kita; Katsuo Sugita; Fumio Imazeki; Toshiyuki Miyashita; Atsushi Kaneda; Osamu Yokosuka
INTERNATIONAL JOURNAL OF ONCOLOGY, May 2014, Refereed, Not invited - Efficacy of high-dose corticosteroid in the early stage of viral acute liver failure
Keiichi Fujiwara; Shin Yasui; Yutaka Yonemitsu; Rintaro Mikata; Makoto Arai; Tatsuo Kanda; Fumio Imazeki; Shigeto Oda; Osamu Yokosuka
HEPATOLOGY RESEARCH, May 2014, Refereed, Not invited - Involvement of androgen receptor and glucose-regulated protein 78 KDa in human hepatocarcinogenesis
Xia Jiang; Tatsuo Kanda; Shingo Nakamoto; Tatsuo Miyamura; Shuang Wu; Osamu Yokosuka
EXPERIMENTAL CELL RESEARCH, May 2014, Refereed, Not invited
Corresponding - New therapies for patients infected with hepatitis C virus
神田 達郎; 宮村 達雄; 安井 伸; 呉 霜; 中本 晋吾; 新井 誠人; 今関 文夫; 横須賀 收
千葉医学雑誌 = Chiba medical journal, Apr. 2014, Refereed, Invited
Lead - Opportunistic infection in patients with acute liver failure
Makoto Arai; Tatsuo Kanda; Shin Yasui; Keiichi Fujiwara; Fumio Imazeki; Akira Watanabe; Takeyuki Sato; Shigeto Oda; Osamu Yokosuka
HEPATOLOGY INTERNATIONAL, Apr. 2014, Refereed, Not invited - Expression level of sonic hedgehog correlated with the speed of gastric mucosa regeneration in artificial gastric ulcers
Takeshi Tanaka; Makoto Arai; Shoko Minemura; Arata Oyamada; Keiko Saito; Xia Jiang; Masaru Tsuboi; Sayuri Sazuka; Daisuke Maruoka; Tomoaki Matsumura; Tomoo Nakagawa; Shigeru Sugaya; Tatsuo Kanda; Tatsuro Katsuno; Kazuko Kita; Takashi Kishimoto; Fumio Imazeki; Atsushi Kaneda; Osamu Yokosuka
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Apr. 2014, Refereed, Not invited - Occurrence and recurrence of hepatocellular carcinoma were not rare events during phlebotomy in older hepatitis C virus-infected patients
Tatsuo Kanda; Shingo Nakamoto; Shin Yasui; Masato Nakamura; Tatsuo Miyamura; Shuang Wu; Xia Jiang; Makoto Arai; Fumio Imazeki; Osamu Yokosuka
Case Reports in Oncology, Mar. 2014, Refereed, Not invited
Lead - Hepatitis C virus NS5A inhibitors and drug resistance mutations
Shingo Nakamoto; Tatsuo Kanda; Shuang Wu; Hiroshi Shirasawa; Osamu Yokosuka
WORLD JOURNAL OF GASTROENTEROLOGY, Mar. 2014, Refereed, Invited
Corresponding - Pulmonary nocardiosis associated with the treatment of severe liver injury
YAMATO Mutsumi; KANDA Tatsuo; YASUI Shin; NAKAMURA Masato; MIYAMURA Tatsuo; ARAI Makoto; MARUYAMA Hitoshi; YOKOSUKA Osamu
Nippon Shokakibyo Gakkai Zasshi, 2014, Refereed
Corresponding - New treatments for genotype 1 chronic hepatitis C - focus on simeprevir
Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Osamu Yokosuka
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, Refereed, Not invited
Lead - Paradoxical Role Of Helicobacter Pylori In Gastric Cancer
Tatsuo Kanda
Biohelikon: Cancer and Clinical Research, Jan. 2014, Refereed, Invited
Lead - Acute liver injury in a patient with alcohol dependence: A case resembling autoimmune hepatitis or drug-induced liver injury
Masahiro Hayashi; Tatsuo Kanda; Masato Nakamura; Tatsuo Miyamura; Shin Yasui; Shingo Nakamoto; Shuang Wu; Makoto Arai; Fumio Imazeki; Osamu Yokosuka
Case Reports in Gastroenterology, 2014, Refereed, Not invited
Corresponding - Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma
Tomoko Saito; Tetsuhiro Chiba; Eiichiro Suzuki; Masami Shinozaki; Nobuaki Goto; Naoya Kanogawa; Tenyu Motoyama; Sadahisa Ogasawara; Yoshihiko Ooka; Akinobu Tawada; Tatsuo Kanda; Masaru Miyazaki; Osamu Yokosuka
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, Refereed, Not invited - Impact of Aging on Liver Histological Findings of Autoimmune Liver Diseases
Tatsuo Kanda
Diseases, 2014, Refereed, Not invited
Corresponding - Autoimmune hepatitis in a patient with pulmonary arterial hypertension treated with endothelin receptor antagonists.
Akira Naito; Jiro Terada; Nobuhiro Tanabe; Toshihiko Sugiura; Seiichiro Sakao; Tatsuo Kanda; Osamu Yokosuka; Koichiro Tatsumi
Internal medicine (Tokyo, Japan), 2014, Refereed, Not invited - Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection.
Kanda T; Nakamoto S; Nakamura M; Jiang X; Miyamura T; Wu S; Yokosuka O.
J Clin Transl Hepatol., 2014, Refereed, Not invited
Lead - Ultra-Deep Sequencing Analysis of the Hepatitis A Virus 5 '-Untranslated Region among Cases of the Same Outbreak from a Single Source
Shuang Wu; Shingo Nakamoto; Tatsuo Kanda; Xia Jiang; Masato Nakamura; Tatsuo Miyamura; Hiroshi Shirasawa; Nobuyuki Sugiura; Azusa Takahashi-Nakaguchi; Tohru Gonoi; Osamu Yokosuka
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, Refereed, Not invited
Corresponding - Hepatitis C virus protease inhibitor-resistance mutations: Our experience and review
Shuang Wu; Tatsuo Kanda; Shingo Nakamoto; Fumio Imazeki; Osamu Yokosuka
WORLD JOURNAL OF GASTROENTEROLOGY, Dec. 2013, Refereed, Invited
Corresponding - No Correlation between PNPLA3 rs738409 Genotype and Fatty Liver and Hepatic Cirrhosis in Japanese Patients with HCV
Masato Nakamura; Tatsuo Kanda; Shingo Nakamoto; Tatsuo Miyamura; Xia Jiang; Shuang Wu; Osamu Yokosuka
PLOS ONE, Dec. 2013, Refereed, Not invited
Corresponding - Role ofIL28Bgenotype in older hepatitis C virus-infected patients
Tatsuo Kanda
World Journal of Immunology, Nov. 2013, Refereed, Invited
Lead - IL-28B polymorphisms and treatment response in hepatitis c virus patients with persistently normal alanine aminotransferase
Tatsuo Miyamura; Tatsuo Kanda; Masato Nakamura; Xia Jiang; Shuang Wu; Shingo Nakamoto; Shigeru Mikami; Nobuo Takada; Fumio Imazeki; Osamu Yokosuka
World Journal of Hepatology, Nov. 2013, Refereed, Invited
Corresponding - Different effects of three interferons L on Toll-like receptor-related gene expression in HepG2 cells
Tatsuo Kanda; Xia Jiang; Shingo Nakamoto; Masato Nakamura; Tatsuo Miyamura; Shuang Wu; Osamu Yokosuka
CYTOKINE, Nov. 2013, Refereed, Not invited
Lead - Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection
Masahito Nakano; Takumi Kawaguchi; Shingo Nakamoto; Atsushi Kawaguchi; Tatsuo Kanda; Fumio Imazeki; Ryoko Kuromatsu; Shuji Sumie; Manabu Satani; Shingo Yamada; Takuji Torimura; Tatsuyuki Kakuma; Osamu Yokosuka; Michio Sata
Oncology Reports, Nov. 2013, Refereed, Not invited - Prevalence of Hepatitis C Virus Subgenotypes 1a and 1b in Japanese Patients: Ultra-Deep Sequencing Analysis of HCV NS5B Genotype-Specific Region
Shuang Wu; Tatsuo Kanda; Shingo Nakamoto; Xia Jiang; Tatsuo Miyamura; Sueli M. Nakatani; Suzane Kioko Ono; Azusa Takahashi-Nakaguchi; Tohru Gonoi; Osamu Yokosuka
PLOS ONE, Sep. 2013, Refereed, Not invited
Corresponding - Magnitude of contrast-enhanced ultrasonography as a noninvasive predictor for hepatic fibrosis: comparison with liver stiffness measurement and serum-based models
Akinobu Tawada; Hitoshi Maruyama; Hidehiro Kamezaki; Taro Shimada; Hiroyuki Ishibashi; Masanori Takahashi; Tatsuo Kanda; Keiichi Fujiwara; Fumio Imazeki; Osamu Yokosuka
HEPATOLOGY INTERNATIONAL, Jun. 2013, Refereed, Not invited - Emerging therapeutic options for hepatitis C
Masao Omata; Tatsuo Kanda
Emerging Therapeutic Options for Hepatitis C, May 2013, Not refereed, Not invited
Last - Foreword: Hepatitis C virus infection: From discovery to eradication
Masao Omata; Tatsuo Kanda
Emerging Therapeutic Options for Hepatitis C, May 2013, Not refereed, Not invited
Last - Interferons in clinical trials
Tatsuo Kanda; Osamu Yokosuka; Masao Omata
Emerging Therapeutic Options for Hepatitis C, May 2013, Refereed, Not invited
Lead - Acute liver failure associated with propylthiouracil in a pregnant 26-year-old woman
Tatsuo Miyamura; Tatsuo Kanda; Shoko Minemura; Masato Nakamura; Shingo Nakamoto; Xia Jiang; Shuang Wu; Shin Yasui; Makoto Arai; Osamu Yokosuka
Case Reports in Gastroenterology, May 2013, Refereed, Not invited
Corresponding - Treatment of hepatitis C virus infection in the future.
Tatsuo Kanda
Clinical and translational medicine, Apr. 2013, Refereed, Not invited
Lead - Platelet count and sustained virological response in hepatitis c treatment
Tatsuo Kanda; Tatsuo Miyamura; Daisuke Maruoka; Shuang Wu; Shingo Nakamoto; Makoto Arai; Keiichi Fujiwara; Fumio Imazeki; Osamu Yokosuka; Keizo Kato; Akihito Tsubota; Nobuo Takada; Takayoshi Nishino; Shigeru Mikami
World Journal of Hepatology, Apr. 2013, Refereed, Invited
Lead - Lipopolysaccharide blocks induction of unfolded protein response in human hepatoma cell lines
Xia Jiang; Tatsuo Kanda; Takeshi Tanaka; Shuang Wu; Shingo Nakamoto; Fumio Imazeki; Osamu Yokosuka
Immunology Letters, Apr. 2013, Refereed, Not invited
Corresponding - Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1
Tomoo Miyauchi; Tatsuo Kanda; Fumio Imazeki; Rintaro Mikata; Akinobu Tawada; Makoto Arai; Keiichi Fujiwara; Shingo Nakamoto; Shuang Wu; Takeshi Tanaka; Tatsuo Miyamura; Michio Kimura; Yasuo Hirai; Motohide Takashi; Shigeru Mikami; Nobuyuki Sugiura; Yutaka Natsuki; Ryosaku Azemoto; Noriaki Suzuki; Osamu Yokosuka
HEPATOLOGY INTERNATIONAL, Mar. 2013, Refereed, Not invited
Corresponding - Hepatitis C virus and hepatocellular carcinoma
Tatsuo Kanda; Osamu Yokosuka; Masao Omata
Biology, Jan. 2013, Not refereed, Not invited
Lead - Antiviral therapy for "difficult-to-treat" hepatitis C virus-infected patients
Tatsuo Kanda; Osamu Yokosuka; Masao Omata
Chinese Medical Journal, 2013, Refereed, Invited
Lead - Androgen Receptor and Hepatocellular Carcinoma
Tatsuo Kanda
Journal of Gastrointestinal & Digestive System, 2013, Refereed, Invited
Lead - Natural interferon-beta plus ribavirin therapy led to sustained virological response after seven unsuccessful courses of anti-viral treatment in a chronic hepatitis C patient
Tatsuo Kanda; Shingo Nakamoto; Makoto Arai; Tatsuo Miyamura; Shuang Wu; Keiichi Fujiwara; Osamu Yokosuka
Clinical Journal of Gastroenterology, 2013, Refereed, Not invited
Lead - Alanine Aminotransferase Elevation during Peginterferon Alpha-2a or Alpha-2b plus Ribavirin Treatment
Masato Nakamura; Tatsuo Kanda; Tatsuo Miyamura; Shuang Wu; Shingo Nakamoto; Osamu Yokosuka
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, Refereed, Not invited
Corresponding - Acute Liver Failure Occurring during the First Trimester of Pregnancy Successfully Treated with Living Donor Liver Transplantation.
Kanogawa N; Kanda T; Ohtsuka M; Nakamura M; Miyamura T; Yasui S; Arai M; Maruyama H; Fujiwara K; Shozu M; Oda S; Miyazaki M; Yokosuka O.
Case Rep Transplant., 2013, Refereed, Not invited
Corresponding - A Semi-Supervised Ensemble Learning Method for Finding Discriminative Motifs and its Application
Thi Nhan Le; Tu Bao Ho; Saori Kawasaki; Tatsuo Kanda; Katsuhiko Takabayashi; Shuang Wu; Osamu Yokosuka
JOURNAL OF UNIVERSAL COMPUTER SCIENCE, 2013, Refereed, Not invited - Efficacy of Lamivudine or Entecavir against Virological Rebound after Achieving HBV DNA Negativity in Chronic Hepatitis B Patients
Tomoo Miyauchi; Tatsuo Kanda; Masami Shinozaki; Hidehiro Kamezaki; Shuang Wu; Shingo Nakamoto; Kazuki Kato; Makoto Arai; Shigeru Mikami; Nobuyuki Sugiura; Michio Kimura; Nobuaki Goto; Fumio Imazeki; Osamu Yokosuka
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, Refereed, Not invited
Corresponding - Adherence to medication is a more important contributor to viral breakthrough in chronic hepatitis B patients treated with entecavir than in those with lamivudine
Hidehiro Kamezaki; Tatsuo Kanda; Makoto Arai; Shuang Wu; Shingo Nakamoto; Tetsuhiro Chiba; Hitoshi Maruyama; Keiichi Fujiwara; Fumihiko Kanai; Fumio Imazeki; Fumio Nomura; Osamu Yokosuka
International Journal of Medical Sciences, 2013, Refereed, Not invited
Corresponding - Peginterferon alfa-2a plus ribavirin in Japanese patients infected with hepatitis C virus genotype 2 who failed previous interferon therapy
Tatsuo Kanda; Shingo Nakamoto; Takayoshi Nishino; Nobuo Takada; Akihito Tsubota; Keizo Kato; Tatsuo Miyamura; Daisuke Maruoka; Shuang Wu; Takeshi Tanaka; Makoto Arai; Shigeru Mikami; Keiichi Fujiwara; Fumio Imazeki; Osamu Yokosuka
International Journal of Medical Sciences, Dec. 2012, Refereed, Not invited
Lead - Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation
Tatsuo Kanda; Shuang Wu; Tomoko Kiyohara; Shingo Nakamoto; Xia Jiang; Tatsuo Miyamura; Fumio Imazeki; Koji Ishii; Takaji Wakita; Osamu Yokosuka
Viral Immunology, Oct. 2012, Refereed, Not invited
Lead - Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan
Jun Yan; Tatsuo Kanda; Shuang Wu; Fumio Imazeki; Osamu Yokosuka
Hepatology Research, Oct. 2012, Refereed, Not invited
Corresponding - Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cells.
Wu S; Kanda T; Nakamoto S; Imazeki F; Yokosuka O
Anticancer research, Sep. 2012, Not refereed, Not invited - Knockdown of Receptor-Interacting Serine/Threonine Protein Kinase-2 (RIPK2) Affects EMT-associated Gene Expression in Human Hepatoma Cells
Shuang Wu; Tatsuo Kanda; Shingo Nakamoto; Fumio Imazeki; Osamu Yokosuka
ANTICANCER RESEARCH, Sep. 2012, Refereed, Not invited
Corresponding - Hepatitis B virus e antigen physically associates with receptor-interacting serine/threonine protein kinase 2 and regulates IL-6 gene expression.
Wu S; Kanda T; Imazeki F; Nakamoto S; Tanaka T; Arai M; Roger T; Shirasawa H; Nomura F; Yokosuka O
The Journal of infectious diseases, Aug. 2012, Refereed, Not invited
Corresponding - Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin
Tatsuo Miyamura; Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Xia Jiang; Makoto Arai; Keiichi Fujiwara; Fumio Imazeki; Osamu Yokosuka
VIRUSES-BASEL, Aug. 2012, Refereed, Not invited
Corresponding - Hepatitis A outbreak associated with a revolving sushi bar in Chiba, Japan: Application of molecular epidemiology
Atsuko Tominaga; Tatsuo Kanda; Taro Akiike; Hiroshi Komoda; Kenji Ito; Asami Abe; Akiko Aruga; Satoru Kaneda; Masaaki Saito; Tomoko Kiyohara; Takaji Wakita; Koji Ishii; Osamu Yokosuka; Nobuyuki Sugiura
HEPATOLOGY RESEARCH, Aug. 2012, Refereed, Not invited
Corresponding - Inhibition of cell viability by human IFN-beta is mediated by microRNA-431
Takeshi Tanaka; Shigeru Sugaya; Kazuko Kita; Makoto Arai; Tatsuo Kanda; Katsunori Fujii; Fumio Imazeki; Katsuo Sugita; Osamu Yokosuka; Nobuo Suzuki
INTERNATIONAL JOURNAL OF ONCOLOGY, May 2012, Refereed, Not invited - Acute liver failure in an antimitochondrial antibody-positive 63-year-old man.
Toru Wakamatsu; Tatsuo Kanda; Akinobu Tawada; Tatsuo Miyamura; Masanori Takahashi; Tetsuhiro Chiba; Makoto Arai; Hitoshi Maruyama; Keiichi Fujiwara; Fumio Imazeki; Osamu Yokosuka
Case reports in gastroenterology, May 2012, Refereed, Not invited
Corresponding - Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance
Makoto Arai; Seiko Togo; Tatsuo Kanda; Keiichi Fujiwara; Fumio Imazeki; Osamu Yokosuka
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, Apr. 2012, Refereed, Not invited - APASL consensus statements and management algorithms for hepatitis C virus infection
Masao Omata; Tatsuo Kanda; Ming-Lung Yu; Osamu Yokosuka; Seng-Gee Lim; Wasim Jafri; Ryosuke Tateishi; Saeed S. Hamid; Wan-Long Chuang; Anuchit Chutaputti; Lai Wei; Jose Sollano; Shiv Kumar Sarin; Jia-Horng Kao; Geoffrey W. McCaughan
HEPATOLOGY INTERNATIONAL, Apr. 2012, Refereed, Not invited - Possible widespread presence of hepatitis A virus subgenotype IIIA in Japan: Recent trend of hepatitis A causing acute liver failure
Tatsuo Miyamura; Koji Ishii; Tatsuo Kanda; Akinobu Tawada; Tadashi Sekimoto; Shuang Wu; Shingo Nakamoto; Makoto Arai; Keiichi Fujiwara; Fumio Imazeki; Tomoko Kiyohara; Takaji Wakita; Osamu Yokosuka
Hepatology Research, Mar. 2012, Refereed, Not invited
Corresponding - 【経口感染ウイルス肝炎の現状と展望】韓国流行株の解析からみた本邦におけるA型肝炎対策
神田 達郎; 太和田 暁之; 宮村 達雄; 呉 霜; 中本 晋吾; 藤原 慶一; 今関 文夫; 横須賀 收
消化器内科, Feb. 2012
Lead - Long-term cohort study of chronic hepatitis C according to interferon efficacy
Daisuke Maruoka; Fumio Imazeki; Makoto Arai; Tatsuo Kanda; Keiichi Fujiwara; Osamu Yokosuka
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Feb. 2012, Refereed, Not invited - Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long-term follow-up
D. Maruoka; F. Imazeki; M. Arai; T. Kanda; K. Fujiwara; O. Yokosuka
JOURNAL OF VIRAL HEPATITIS, Feb. 2012, Refereed, Not invited - Signaling pathways involved in molecular carcinogenesis of hepatocellular carcinoma
Tatsuo Kanda; Fumio Imazeki; Fumihiko Kanai; Motohisa Tada; Osamu Yokosuka; Masao Omata
Molecular Aspects of Hepatocellular Carcinoma, 2012, Refereed, Not invited
Lead - Hepatic sarcoidosis with an increased serum level of immunoglobulin G4
Masanori Inoue; Tetsuhiro Chiba; Yoh Zen; Hajime Yokota; Tatsuo Kanda; Sadahisa Ogasawara; Harutoshi Sugiyama; Makoto Arai; Fumihiko Kanai; Makoto Ogawa; Fumio Imazeki; Osamu Yokosuka
Internal Medicine, 2012, Refereed, Not invited - Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B
Tatsuo Kanda; Masami Shinozaki; Hidehiro Kamezaki; Shuang Wu; Shingo Nakamoto; Makoto Arai; Keiichi Fujiwara; Nobuaki Goto; Fumio Imazeki; Osamu Yokosuka
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, Refereed, Not invited
Lead - Hepatic STAT1-Nuclear Translocation and Interleukin 28B Polymorphisms Predict Treatment Outcomes in Hepatitis C Virus Genotype 1-Infected Patients
Tatsuo Miyamura; Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Keiichi Fujiwara; Fumio Imazeki; Osamu Yokosuka
PLOS ONE, Dec. 2011, Refereed, Not invited
Corresponding - Nuclear receptor mRNA expression by HBV in human hepatoblastoma cell lines
Shuang Wu; Tatsuo Kanda; Fumio Imazeki; Shingo Nakamoto; Hiroshi Shirasawa; Osamu Yokosuka
CANCER LETTERS, Dec. 2011, Refereed, Not invited
Corresponding - Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer
Takeshi Tanaka; Makoto Arai; Shuang Wu; Tatsuo Kanda; Hideaki Miyauchi; Fumio Imazeki; Hisahiro Matsubara; Osamu Yokosuka
Oncology Reports, Nov. 2011, Refereed, Not invited - Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2
Tatsuo Kanda; Fumio Imazeki; Ryosaku Azemoto; Yutaka Yonemitsu; Shigeru Mikami; Kazuhiko Kita; Motohide Takashi; Masahiko Sunaga; Shuang Wu; Shingo Nakamoto; Akinobu Tawada; Makoto Arai; Keizo Kato; Yu Yoshida; Yoshihiro Koma; Keiichi Fujiwara; Kenichi Fukai; Noriaki Suzuki; Osamu Yokosuka
DIGESTIVE DISEASES AND SCIENCES, Nov. 2011, Refereed, Not invited
Corresponding - Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B
S. Togo; M. Arai; A. Tawada; T. Chiba; T. Kanda; K. Fujiwara; F. Imazeki; O. Yokosuka
Journal of Viral Hepatitis, Oct. 2011, Refereed, Not invited - The Assessment of Serum Hepatitis C Virus RNA 12 Weeks After the End of Treatment Using TaqMan Polymerase Chain Reaction Is Less Relevant Than After 24 Weeks for Predicting Sustained Virological Response
Tatsuo Kanda; Fumio Imazeki; Shuang wu; Shingo Nakamoto; Osamu Yokosuka
HEPATOLOGY, Oct. 2011, Refereed, Not invited
Lead - Hepatitis C Virus Nonstructural 5A Protein Inhibits Lipopolysaccharide-Mediated Apoptosis of Hepatocytes by Decreasing Expression of Toll-Like Receptor 4
Ryo Tamura; Tatsuo Kanda; Fumio Imazeki; Shuang Wu; Shingo Nakamoto; Takeshi Tanaka; Makoto Arai; Keiichi Fujiwara; Kengo Saito; Thierry Roger; Takaji Wakita; Hiroshi Shirasawa; Osamu Yokosuka
JOURNAL OF INFECTIOUS DISEASES, Sep. 2011, Refereed, Not invited
Corresponding - Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: Virological breakthrough is also dependent on adherence to medication
Hidehiro Kamezaki; Tatsuo Kanda; Shuang Wu; Shingo Nakamoto; Makoto Arai; Hitoshi Maruyama; Keiichi Fujiwara; Fumio Imazeki; Osamu Yokosuka
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, Sep. 2011, Refereed, Not invited
Corresponding - Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test
T. Kanda; F. Imazeki; Y. Yonemitsu; S. Mikami; N. Takada; T. Nishino; M. Takashi; A. Tsubota; K. Kato; N. Sugiura; A. Tawada; S. Wu; T. Tanaka; S. Nakamoto; R. Mikata; M. Tada; T. Chiba; T. Kurihara; M. Arai; K. Fujiwara; F. Kanai; O. Yokosuka
JOURNAL OF VIRAL HEPATITIS, Jul. 2011, Refereed, Not invited
Lead - Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients
Shingo Nakamoto; Tatsuo Kanda; Fumio Imazeki; Shuang Wu; Makoto Arai; Keiichi Fujiwara; Osamu Yokosuka
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, Jul. 2011, Refereed, Not invited
Corresponding - Initial Virological Response and Viral Mutation with Adefovir Dipivoxil Added to Ongoing Lamivudine Therapy in Lamivudine-Resistant Chronic Hepatitis B
Shuang Wu; Kenichi Fukai; Fumio Imazeki; Makoto Arai; Tatsuo Kanda; Yutaka Yonemitsu; Osamu Yokosuka
DIGESTIVE DISEASES AND SCIENCES, Apr. 2011, Refereed, Not invited - Autoimmune fulminant liver failure in adults: Experience in a Japanese center
Keiichi Fujiwara; Shin Yasui; Akinobu Tawada; Koichiro Okitsu; Yutaka Yonemitsu; Tetsuhiro Chiba; Makoto Arai; Tatsuo Kanda; Fumio Imazeki; Masayuki Nakano; Shigeto Oda; Osamu Yokosuka
HEPATOLOGY RESEARCH, Feb. 2011, Refereed, Not invited - Discovering relationship between hepatitis C virus NS5A protein and interferon/ribavirin therapy
Saori Kawasaki; Tu Bao Ho; Tatsuo Kanda; Osamu Yokosuka; Katsuhiro Takabayashi; Nhan Le
Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 2011, Refereed, Not invited - Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion.
Wu S; Imazeki F; Kurbanov F; Fukai K; Arai M; Kanda T; Yonemitsu Y; Tanaka Y; Mizokami M; Yokosuka O
Journal of hepatology, Jan. 2011, Refereed, Not invited - Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B
Dan Bekku; Makoto Arai; Fumio Imazeki; Yutaka Yonemitsu; Tatsuo Kanda; Keiichi Fujiwara; Kenichi Fukai; Kenichi Sato; Sakae Itoga; Fumio Nomura; Osamu Yokosuka
Journal of Gastroenterology and Hepatology (Australia), 2011, Refereed, Not invited - Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C
T. Kanda; O. Yokosuka
JOURNAL OF NEPAL MEDICAL ASSOCIATION, Jan. 2011, Refereed, Not invited
Lead - Pegylated interferon-alfa-2a monotherapy in patients infected with HCV genotype 2 and importance of rapid virological response
Reiko Etoh; Fumio Imazeki; Tomoko Kurihara; Kenichi Fukai; Keiichi Fujiwara; Makoto Arai; Tatsuo Kanda; Rintaro Mikata; Yutaka Yonemitsu; Osamu Yokosuka
BMC Research Notes, 2011, Refereed, Not invited
Corresponding - Occurrence of Hepatocellular Carcinoma Was Not a Rare Event during and Immediately after Antiviral Treatment in Japanese HCV-Positive Patients
Tatsuo Kanda; Fumio Imazeki; Shigeru Mikami; Keizo Kato; Noritomo Shimada; Yutaka Yonemitsu; Tomoo Miyauchi; Makoto Arai; Keiichi Fujiwara; Akihito Tsubota; Nobuo Takada; Takayoshi Nishino; Motohide Takashi; Nobuyuki Sugiura; Michio Kimura; Kenichi Fukai; Osamu Yokosuka
ONCOLOGY, 2011, Refereed, Not invited
Lead - Analysis of 5' nontranslated region of hepatitis A viral RNA genotype I from South Korea: comparison with disease severities
Tatsuo Kanda; Sook-Hyang Jeong; Fumio Imazeki; Keiichi Fujiwara; Osamu Yokosuka
PLOS ONE, Dec. 2010, Refereed, Not invited
Lead - Hepatitis C Virus Infection Impairs IRF-7 Translocation and Alpha Interferon Synthesis in Immortalized Human Hepatocytes
Amit Raychoudhuri; Shubham Shrivastava; Robert Steele; Srikanta Dash; Tatsuo Kanda; Ranjit Ray; Ratna B. Ray
JOURNAL OF VIROLOGY, Nov. 2010, Refereed, Not invited - Hepatitis B Virus e Antigen Downregulates Cytokine Production in Human Hepatoma Cell Lines
Shuang Wu; Tatsuo Kanda; Fumio Imazeki; Makoto Arai; Yutaka Yonemitsu; Shingo Nakamoto; Keiichi Fujiwara; Kenichi Fukai; Fumio Nomura; Osamu Yokosuka
VIRAL IMMUNOLOGY, Oct. 2010, Refereed, Not invited
Corresponding - Hepatitis A virus (HAV) proteinase 3C inhibits HAV IRES-dependent translation and cleaves the polypyrimidine tract-binding protein
T. Kanda; V. Gauss-Mueller; S. Cordes; R. Tamura; K. Okitsu; W. Shuang; S. Nakamoto; K. Fujiwara; F. Imazeki; O. Yokosuka
JOURNAL OF VIRAL HEPATITIS, Sep. 2010, Refereed, Not invited
Lead - Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha
Lingli Yang; Tomoko Kiyohara; Tatsuo Kanda; Fumio Imazeki; Keiichi Fujiwara; Verena Gauss-Mueller; Koji Ishii; Takaji Wakita; Osamu Yokosuka
VIROLOGY JOURNAL, Sep. 2010, Refereed, Not invited
Corresponding - Corrigendum to: "Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development" [J Hepatol 2010;52:72-78] (DOI:10.1016/j.jhep.2009.10.001)
Shingo Nakamoto; Fumio Imazeki; Kenichi Fukai; Keiichi Fujiwara; Makoto Arai; Tatsuo Kanda; Yutaka Yonemitsu; Osamu Yokosuka
Journal of Hepatology, Apr. 2010, Refereed, Not invited - Internal ribosomal entry-site activities of clinical isolate-derived hepatitis A virus and inhibitory effects of amantadine
Tatsuo Kanda; Fumio Imazeki; Shingo Nakamoto; Kohichiroh Okitsu; Keiichi Fujiwara; Osamu Yokosuka
HEPATOLOGY RESEARCH, Apr. 2010, Refereed, Not invited
Lead - Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
Kenichi Ito; Makoto Arai; Fumio Imazeki; Yutaka Yonemitsu; Dan Bekku; Tatsuo Kanda; Keiichi Fujiwara; Kenichi Fukai; Kenichi Sato; Sakae Itoga; Fumio Nomura; Osamu Yokosuka
Scandinavian Journal of Gastroenterology, 2010, Refereed, Not invited - New antiviral therapies for chronic hepatitis C.
Kanda T; Imazeki F; Yokosuka O
Hepatology international, Jan. 2010, Refereed, Not invited
Lead - Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
Kenichi Ito; Makoto Arai; Fumio Imazeki; Yutaka Yonemitsu; Dan Bekku; Tatsuo Kanda; Keiichi Fujiwara; Kenichi Fukai; Kenichi Sato; Sakae Itoga; Fumio Nomura; Osamu Yokosuka
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, Refereed, Not invited - Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer
Kohichiroh Okitsu; Tatsuo Kanda; Fumio Imazeki; Yutaka Yonemitsu; Ratna B. Ray; Chawnshang Chang; Osamu Yokosuka
Genes and Cancer, 2010, Refereed, Not invited
Corresponding - Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development
Shingo Nakamoto; Fumio Imazeki; Kenichi Fukai; Keiichi Fujiwara; Makoto Arai; Tatsuo Kanda; Yutaka Yonemitsu; Osamu Yokosuka
JOURNAL OF HEPATOLOGY, Jan. 2010, Refereed, Not invited - Opportunistic infection in the patients with acute liver failure: A report of three cases with one fatality
Makoto Arai; Fumio Imazeki; Yutaka Yonemitsu; Tatsuo Kanda; Keiichi Fujiwara; Kenichi Fukai; Akira Watanabe; Takeyuki Sato; Shigeto Oda; Osamu Yokosuka
Clinical Journal of Gastroenterology, Dec. 2009, Refereed, Not invited - MBP-1 Inhibits Breast Cancer Growth and Metastasis in Immunocompetent Mice
Tatsuo Kanda; Amit Raychoudhuri; Robert Steele; John E. Sagartz; Cheri West; Ratna B. Ray
CANCER RESEARCH, Dec. 2009, Refereed, Not invited
Lead - Inhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic Mice
Tatsuo Kanda; Robert Steele; Ranjit Ray; Ratna B. Ray
JOURNAL OF VIROLOGY, Sep. 2009, Refereed, Not invited
Lead - Memories of studying life in Saint Louis
Tatsuo Kanda
Chiba medical journal, Aug. 2009 - Quantification of hepatitis C amino acid substitutions 70 and 91 in the core coding region by real-time amplification refractory mutation system reverse transcription-polymerase chain reaction
Shingo Nakamoto; Tatsuo Kanda; Yutaka Yonemitsu; Makoto Arai; Keiichi Fujiwara; Kenichi Fukai; Fumihiko Kanai; Fumio Imazeki; Osamu Yokosuka
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, Jul. 2009, Refereed, Not invited
Corresponding - Inhibition of HCV replication by small interfering RNA.
Tatsuo Kanda
Methods in molecular biology (Clifton, N.J.), Jan. 2009, Refereed, Not invited
Last - Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated Signaling
Tatsuo Kanda; Robert Steele; Ranjit Ray; Ratna B. Ray
JOURNAL OF VIROLOGY, Nov. 2008, Refereed, Not invited
Lead - Knockdown of MBP-1 in Human Foreskin Fibroblasts Induces p53-p21 Dependent Senescence
Asish K. Ghosh; Tatsuo Kanda; Robert Steele; Ratna B. Ray
PLOS ONE, Oct. 2008, Refereed, Not invited - Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: Comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients
Fumio Imazeki; Osamu Yokosuka; Kenichi Fukai; Tatsuo Kanda; Hiroshige Kojima; Hiromitsu Saisho
LIVER INTERNATIONAL, Mar. 2008, Refereed, Not invited - Hepatitis C virus genotype 1a growth and induction of autophagy
Malika Ait-Goughoulte; Tatsuo Kanda; Keith Meyer; Jan S. Ryerse; Ratna B. Ray; Ranjit Ray
JOURNAL OF VIROLOGY, Mar. 2008, Refereed, Not invited - Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis and hepatocellular carcinoma
Kai Yu Zhang; Fumio Imazeki; Kenichi Fukai; Makoto Arai; Tatsuo Kanda; Rintaro Mikata; Osamu Yokosuka
CANCER SCIENCE, Dec. 2007, Refereed, Not invited - Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human Hepatocytes
Tatsuo Kanda; Robert Steele; Ranjit Ray; Ratna B. Ray
JOURNAL OF VIROLOGY, Nov. 2007, Refereed, Not invited
Lead - Body mass index in Japanese patients with autoimmune liver disease: Overweight patients with primary biliary cirrhosis tend to be asymptomatic
Tatsuo Kanda; Osamu Yokosuka; Fumio Imazeki; Yuichi Hirasawa; Tetsu Ikeuchi; Rintaro Mikata; Kai Yu Zhang; Tomoko Kurihara; Makoto Arai; Kenichi Fukai; Hiromitsu Saisho; Shigeru Mikami; Ryosaku Azemoto; Yoshimi Ito
HEPATO-GASTROENTEROLOGY, Sep. 2007, Refereed, Not invited
Lead - Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe
KaiYu Zhang; Fumio Imazeki; Kenichi Fukai; Makoto Arai; Tatsuo Kanda; Rintaro Mikata; Osamu Yokosuka
JOURNAL OF MEDICAL VIROLOGY, Jun. 2007, Refereed, Not invited - Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells
Arnab Basu; Tatsuo Kanda; Aster Beyene; Kousuke Saito; Keith Meyer; Ranjit Ray
JOURNAL OF VIROLOGY, Apr. 2007, Refereed, Not invited - Small interfering RNA targeted to hepatitis C virus 5 ' nontranslated region exerts potent antiviral effect
Tatsuo Kanda; Robert Steele; Ranjit Ray; Ratna B. Ray
JOURNAL OF VIROLOGY, Jan. 2007, Refereed, Not invited
Lead - Inhibition of subgenomic hepatitis C virus RNA replication in HeLa cells
Tatsuo Kanda; Osamu Yokosuka; Rintaro Mikata; Kai Yu Zhang; Masamichi Tanaka; Motohisa Tada; Kenichi Fukai; Fumio Imazeki; Hiromitsu Saisho
HEPATO-GASTROENTEROLOGY, Jan. 2007, Refereed, Not invited
Lead - Analysis of genes upregulated by the demethylating agent 5-aza-2 '-deoxycytidine in gastric cancer cell lines
Rintaro Mikata; Osamu Yokosuka; Kenichi Fukai; Fumio Imazeki; Makoto Arai; Motohisa Tada; Tomoko Kurihara; Kaiyu Zhang; Tatsuo Kanda; Hiromitsu Saisho
INTERNATIONAL JOURNAL OF CANCER, Oct. 2006, Refereed, Not invited - Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-aza-2 '-deoxycytidine
M Arai; O Yokosuka; Y Hirasawa; K Fukai; T Chiba; F Imazeki; T Kanda; M Yatomi; Y Takiguchi; N Seki; H Saisho; T Ochiai
CANCER, Jun. 2006, Refereed, Not invited - Silencing of Hepatitis A virus infection by small interfering RNAs
Y Kusov; T Kanda; A Palmenberg; JY Sgro; Gauss-Muller, V
JOURNAL OF VIROLOGY, Jun. 2006, Refereed, Not invited - Generation of infectious hepatitis C virus in immortalized human hepatocytes
T Kanda; A Basu; R Steele; T Wakita; JS Ryerse; R Ray; RB Ray
JOURNAL OF VIROLOGY, May 2006, Refereed, Not invited
Lead - State of hepatitis C viral replication enhances activation of NF-kB- and AP-1-signaling induced by hepatitis B virus X
T Kanda; O Yokosuka; K Nagao; H Saisho
CANCER LETTERS, Mar. 2006, Refereed, Not invited
Lead - Hepatitis A protein VP1-2A reduced cell viability in Huh-7 cells with hepatitis C virus subgenomic RNA replication
T Kanda; O Yokosuka; F Imazeki; K Fujiwara; H Saisho
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Mar. 2006, Refereed, Not invited
Lead - Occurrence of autoimmune hepatitis during the course of primary biliary cirrhosis: Report of two cases
T Kanda; O Yokosuka; Y Hirasawa; F Imazeki; K Nagao; H Saisho
DIGESTIVE DISEASES AND SCIENCES, Jan. 2006, Refereed, Not invited
Lead - Serum osteopontin levels in patients with acute liver dysfunction
M Arai; O Yokosuka; T Kanda; K Fukai; F Imazeki; M Muramatsu; N Seki; M Miyazaki; T Ochiai; H Hirasawa; H Saisho
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, Jan. 2006, Refereed, Not invited - Evaluation of clinical usefulness of second-generation HCV core antigen assay: comparison with COBAS AMPLICOR HCV MONITOR assay version 2.0
O Yokosuka; S Kawai; Y Suzuki; K Fukai; F Imazeki; T Kanda; M Tada; R Mikata; A Hata; H Saisho
LIVER INTERNATIONAL, Dec. 2005, Refereed, Not invited - Enhanced sensitivity of human hepatoma cells to 5-fluorouracil by small interfering RNA targeting Bcl-2
T Kanda; O Yokosuka; F Imazeki; M Arai; H Saisho
DNA AND CELL BIOLOGY, Dec. 2005, Refereed, Not invited
Lead - Introduction of the Department of Medicine and Clinical Oncology (No. 2).(INTRODUCTION OF THE PROJECTS OF CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE)
Yokosuka Osamu; Imazeki Fumio; Fukai Kenichi; Kanda Tatsuo; Saisho Hiromitsu
Chiba medical journal, Oct. 2005 - 5-aza-2 '-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines
T Kanda; M Tada; F Imazeki; O Yokosuka; K Nagao; H Saisho
ONCOLOGY REPORTS, Oct. 2005, Refereed, Not invited
Lead - Lower incidence of hepatic failure than hepatocellular carcinoma in Japanese patients with chronic Hepatitis C
F Imazeki; O Yokosuka; K Fukai; S Kawai; T Kanda; H Kojima; H Saisho
LIVER INTERNATIONAL, Aug. 2005, Refereed, Not invited - Acute-onset autoimmune hepatitis resembling acute hepatitis: A case report and review of reported cases
T Kanda; O Yokosuka; Y Hirasawa; F Imazeki; K Nagao; Y Suzuki; H Saisho
HEPATO-GASTROENTEROLOGY, Jul. 2005, Refereed, Not invited
Lead - Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation
T Imamura; O Yokosuka; T Chiba; T Kanda; H Kojima; K Fukai; F Imazeki; M Nishimura; Y Saito; H Saisho
LEUKEMIA & LYMPHOMA, Jun. 2005, Refereed, Not invited - Effect of lamivudine in HBeAg-positive chronic hepatitis B: Discordant effect on HBeAg and HBV DNA according to pretreatment ALT level
Tomoko Kurihara; Fumio Imazeki; Osamu Yokosuka; Kenichi Fukai; Tatsuo Kanda; Shigenobu Kawai; Hiromitsu Saisho
WORLD JOURNAL OF GASTROENTEROLOGY, Jun. 2005, Refereed, Not invited - Fas polymorphisms influence susceptibility to autoimmune hepatitis
A Hiraide; F Imazeki; O Yokosuka; T Kanda; H Kojima; K Fukai; Y Suzuki; A Hata; H Saisho
AMERICAN JOURNAL OF GASTROENTEROLOGY, Jun. 2005, Refereed, Not invited - Prolonged acute hepatitis A mimicking autoimmune hepatitis
Rintaro Mikata; Osamu Yokosuka; Fumio Imazeki; Kenichi Fukai; Tatsuo Kanda; Hiromitsu Saisho
WORLD JOURNAL OF GASTROENTEROLOGY, Jun. 2005, Refereed, Not invited - Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells
T Kanda; O Yokosuka; F Imazeki; K Fujiwara; K Nagao; H Saisho
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Jun. 2005, Refereed, Not invited
Lead - Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosonial entry site
T Kanda; B Zhang; Y Kusov; O Yokosuka; Gauss-Muller, V
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, May 2005, Refereed, Not invited
Lead - Prolonged hepatitis caused by cytomegalovirus and non-alcoholic steatohepatitis in 16-year-old obese boy
T Kanda; O Yokosuka; Y Suzuki
EUROPEAN JOURNAL OF PEDIATRICS, Apr. 2005, Refereed, Not invited
Lead - Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B
Keiichi Fujiwara; Osamu Yokosuka; Hiroshige Kojima; Tatsuo Kanda; Hiromitsu Saisho; Hiroyuki Hirasawa; Hiroshi Suzuki
WORLD JOURNAL OF GASTROENTEROLOGY, Feb. 2005, Refereed, Not invited - Prevalence of obesity in patients with acute hepatitis; Is severe obesity a risk factor for fulminant hepatitis in Japan?
T Kanda; O Yokosuka; A Hiraide; H Kojima; A Honda; K Fukai; F Imazeki; K Nagao; H Saisho
HEPATO-GASTROENTEROLOGY, Jan. 2005, Refereed, Not invited
Lead - Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA
T Kanda; O Yokosuka; F Imazeki; M Tanaka; Y Shino; H Shimada; T Tomonaga; F Nomura; K Nagao; T Ochiai; H Saisho
JOURNAL OF VIRAL HEPATITIS, Nov. 2004, Refereed, Not invited
Lead - Severe hypercholesterolemia associated with primary biliary cirrhosis in a 44-year-old Japanese woman
Tatsuo Kanda; Osamu Yokosuka; Hiroshige Kojima; Fumio Imazeki; Keiich Nagao; Ichiro Tatsuno; Yasushi Saito; Hiromitsu Saisho
WORLD JOURNAL OF GASTROENTEROLOGY, Sep. 2004, Refereed, Not invited
Lead - Hepatitis C infection with history of tuberculosis in Japan: No association with progression of liver fibrosis
T Kanda; O Yokosuka; F Imazeki; H Saisho; K Nagao
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Jun. 2004, Refereed, Not invited
Lead - Hepatitis B virus X protein (HBx)-induced apoptosis in HuH-7 cells: Influence of HBV genotype and basal core promoter mutations
T Kanda; O Yokosuka; F Imazeki; Y Yamada; T Imamura; K Fukai; K Nagao; H Saisho
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, May 2004, Refereed, Not invited
Lead - Interference of hepatitis A virus replication by small interfering RNAs
T Kanda; Y Kusov; O Yokosuka; Gauss-Muller, V
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, May 2004, Refereed, Not invited
Lead - Acute hepatitis C virus infection, 1986-2001: A rare cause of fulminant hepatitis in Chiba, Japan
T Kanda; O Yokosuka; F Imazeki; H Saisho
HEPATO-GASTROENTEROLOGY, Mar. 2004, Refereed, Not invited
Lead - A case of severe acute hepatitis of unknown etiology treated with the Chinese herbal medicine Inchinko-to
M Arai; O Yokosuka; K Fukai; T Kanda; H Kojima; S Kawai; F Imazeki; H Hirasawa; H Saisho
HEPATOLOGY RESEARCH, Mar. 2004, Refereed, Not invited - Corticosteroids and lamivudine combined to treat acute severe flare-up in a chronic hepatitis B and C patient
T Kanda; O Yokosuka; F Imazeki; S Yoshida; Y Suzuki; K Nagao; H Saisho
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Feb. 2004, Refereed, Not invited
Lead - High sustained virologic response rate after interferon monotherapy in Japanese hepatitis C patients with a low HCV RNA titer and/or HCV genotype 2 - A prospective study
O Yokosuka; S Iwama; N Suzuki; M Takashi; Y Hirai; K Uchiumi; M Kimura; N Gotou; S Hino; A Hayasaka; T Kanda; S Kawai; K Fukai; F Imazeki; H Saisho
INTERVIROLOGY, 2004, Refereed, Not invited - Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan
T. Imamura; O. Yokosuka; T. Kurihara; T. Kanda; K. Fukai; F. Imazeki; H. Saisho
Gut, Nov. 2003, Refereed, Not invited - N-nitroso-fenfluramine hepatotoxicity resembling chronic hepatitis
T Kanda; O Yokosuka; M Tada; T Kurihara; S Yoshida; Y Suzuki; K Nagao; H Saisho
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Aug. 2003, Refereed, Not invited
Lead - Severe hepatotoxicity associated with Chinese diet product 'Onshidou-Genbi-Kounou'
T Kanda; O Yokosuka; O Okada; Y Suzuki; H Saisho
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Mar. 2003, Refereed, Not invited
Lead - Hepatitis A virus VP3 may activate serum response element associated transcription
T Kanda; O Yokosuka; N Kato; F Imazeki; K Fujiwara; S Kawai; H Saisho; M Omata
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, Mar. 2003, Refereed, Not invited
Lead - Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease
H Sumi; O Yokosuka; N Seki; M Arai; F Imazeki; T Kurihara; T Kanda; K Fukai; M Kato; H Saisho
HEPATOLOGY, Jan. 2003, Refereed, Not invited - Bezafibrate treatment: a new medical approach for PBC patients?
T Kanda; O Yokosuka; F Imazeki; H Saisho
JOURNAL OF GASTROENTEROLOGY, 2003, Refereed, Not invited
Lead - Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid
T Chiba; O Yokosuka; T Kanda; K Fukai; F Imazeki; H Saisho; M Nishimura; Y Saito
LIVER, Dec. 2002, Refereed, Not invited - Fulminant hepatic failure associated with benzbromarone treatment: A case report
M Arai; O Yokosuka; K Fujiwara; H Kojima; T Kanda; H Hirasawa; H Saisho
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, May 2002, Refereed, Not invited - Fulminant hepatic failure associated with triazolam
T Kanda; O Yokosuka; K Fujiwara; H Saisho; H Shiga; S Oda; K Okuda; Y Sugawara; M Makuuchi; H Hirasawa
DIGESTIVE DISEASES AND SCIENCES, May 2002, Refereed, Not invited
Lead - Roles of TT virus infection in various types of chronic hepatitis
T Ikeuchi; O Yokosuka; T Kanda; F Imazeki; T Seta; H Saisho
INTERVIROLOGY, Jul. 2001, Not refereed, Not invited - The prevalence of TT virus infection in renal transplant recipients in Brazil
O Yokosuka; T Ikeuchi; T Kanda; S Kawai; F Imazeki; H Saisho; M Mazzalli; G Alves; NF Nishimura; EC Soares
TRANSPLANTATION, Oct. 2000, Refereed, Not invited - Sequence-motif analysis of 5 '-untranslated region of GB virus-C in Japanese patients
T Kanda; O Yokosuka; S Kawal; F Imazeki; H Saisho
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Sep. 2000, Refereed, Not invited
Lead - Superinfection of TT virus and hepatitis C virus among chronic haemodialysis patients
T Ikeuchi; K Okuda; O Yokosuka; T Kanda; S Kobayashi; M Murata; H Hayashi; K Yokozeki; Y Ohtake; T Kashima; Y Irie
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Aug. 1999, Refereed, Not invited - [Clinical feature of TTV-related hepatitis].
Tatsuo Kanda
Nihon rinsho. Japanese journal of clinical medicine, Jun. 1999 - Quantification of hepatitis C virus by TaqMan PCR: Comparison with HCV Amplicor Monitor assay
S Kawai; O Yokosuka; T Kanda; F Imazeki; Y Maru; H Saisho
JOURNAL OF MEDICAL VIROLOGY, Jun. 1999, Refereed, Not invited - The role of TT virus infection in acute viral hepatitis
T Kanda; O Yokosuka; T Ikeuchi; T Seta; S Kawai; F Imazeki; H Saisho
HEPATOLOGY, Jun. 1999, Refereed, Not invited
Lead - Quantitative analysis of GBV-C RNA in liver and serum by strand-specific reverse transcription polymerase chain reaction
T Kanda; O Yokosuka; M Tagawa; S Kawai; F Imazeki; H Saisho
JOURNAL OF HEPATOLOGY, Nov. 1998, Refereed, Not invited
Lead - 第1回日本肝臓学会大会記録:ワークショップ (1) 非B非C型肝炎の実態と予後
神田 達郎; 横須賀 収; 小林 正和; 田中 栄司; 大崎 牧; 須磨崎 亮; 阿部 弘一; 石川 和克; 松下 栄紀; 金子 周一; 道尭 浩二郎; 堀池 典生; 鈴木 宏; 佐田 通夫; 坂本 雅史; 岡上 武; 茶山 一彰; 熊田 博光; 岡田 俊一; 赤羽 賢浩
肝臓, 1998 - GB virus-C infection among chronic haemodialysis patients: Clinical implications
K Okuda; T Kanda; O Yokosuka; H Hayashi; K Yokozeki; Y Ohtake; Y Irie
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Nov. 1997, Refereed, Not invited - GB virus-C RNA in Japanese patients with hepatocellular carcinoma and cirrhosis
T Kanda; O Yokosuka; F Imazeki; M Tagawa; T Ehata; H Saisho; M Omata
JOURNAL OF HEPATOLOGY, Sep. 1997, Refereed, Not invited
Lead - Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction
T Kanda; O Yokosuka; T Ehata; Y Maru; F Imazeki; H Saisho; Y Shiratori; M Omata
HEPATOLOGY, May 1997, Refereed, Not invited
Lead - [Clinical features of HGBV-C-related liver cancer].
Tatsuo Kanda
Nihon rinsho. Japanese journal of clinical medicine, Mar. 1997 - [A case of antiphospholipid syndrome associated with Buerger's disease and portal hypertension].
Tatsuo Kanda
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, Apr. 1995
MISC
- 当科における進行肝細胞癌に対するレゴラフェニブの初期使用経験 実臨床における課題は?
小笠原 定久; 千葉 哲博; 大岡 美彦; 鈴木 英一郎; 前田 隆宏; 横山 昌幸; 小林 和史; 清野 宗一郎; 中村 昌人; 齊藤 朋子; 中本 晋吾; 安井 伸; 太和田 暁之; 新井 誠人; 神田 達郎; 丸山 紀史; 加藤 直也
The Liver Cancer Journal, Jun. 2018, Not refereed, Not invited - HCV患者における経口剤による抗ウイルス療法後の早期発がんリスク因子
大岡 美彦; 千葉 哲博; 斎藤 朋子; 清野 宗一郎; 小林 和史; 中村 昌人; 小笠原 定久; 鈴木 英一郎; 安井 伸; 太和田 暁之; 新井 誠人; 神田 達郎; 今関 文夫; 横須賀 收; 加藤 直也
肝臓, Apr. 2018, Not refereed, Not invited - 時間依存ROC解析を用いた肝細胞癌根治治療後の再発リスクの検討
黒杉 茜; 小笠原 定久; 大岡 美彦; 井上 将法; 千葉 哲博; 鈴木 英一郎; 横山 昌幸; 前田 隆宏; 若松 徹; 小林 和史; 清野 宗一郎; 中村 昌人; 齊藤 朋子; 中本 晋吾; 安井 伸; 太和田 暁之; 新井 誠人; 神田 達郎; 丸山 紀史; 久保木 知; 大塚 将之; 加藤 直也
肝臓, Apr. 2018, Not refereed, Not invited - 本邦のB型慢性肝炎におけるTDFのHBs抗原低下作用
中本 晋吾; 神田 達郎; 中村 昌人; 安井 伸; 小笠原 定久; 鈴木 英一郎; 大岡 美彦; 太和田 暁之; 齊藤 朋子; 小林 和史; 清野 宗一郎; 千葉 哲博; 新井 誠人; 丸山 紀史; 加藤 直也
肝臓, Apr. 2018, Not refereed, Not invited - アルコール性・非アルコール性肝疾患におけるネフェロメトリー法による血清糖鎖欠損トランスフェリン(CDT)測定 多施設検討結果の報告
野村 文夫; 神田 達郎; 影山 洋子; 寺田 奈美; 山下 毅; 丸山 勝也
アルコールと医学生物学, Apr. 2018, Not refereed, Not invited - 代謝異常がA型肝炎ウイルス増殖および肝細胞MAPKシグナル伝達経路に与える影響
神田 達郎; Nwe Win Nan; 中村 昌人; 中本 晋吾; 岡本 宏明; 横須賀 收; 白澤 浩
糖尿病, Apr. 2017 - 早期から脾腎短絡路の発達を認めたAMA・M2抗体陰性の無症候性非硬変性原発性胆汁性胆管炎の一例
清野 宗一郎; 丸山 紀史; 小林 和史; 近藤 孝行; 嶋田 太郎; 高橋 正憲; 奥川 英博; 神田 達郎; 横須賀 收
肝臓, Jan. 2017 - 巨脾を伴った若年性非硬変性門亢症の一例
清野 宗一郎; 丸山 紀史; 小林 和史; 神田 達郎; 横須賀 收
日本門脈圧亢進症学会雑誌, Aug. 2016 - 診療最前線Q&A アルブミン定量
芳賀 祐規; 神田 達郎; 清宮 正徳; 野村 文夫; 横須賀 收
たんじゅうさん, Jun. 2015, Not refereed, Not invited - 【薬物性肝障害の新展開-疑問点の集約とその解決を探る】臨床的に示唆に富む病態 慢性C型肝炎に対する抗ウイルス療法施行中のトランスアミナーゼ上昇について
中村 昌人; 神田 達郎; 宮村 達雄; 呉 霜; 中本 晋吾; 横須賀 收
肝胆膵, Feb. 2014 - The state of asymptomatic HBV carriers with HBeAb positive in Japan
新井 誠人; 神田 達郎; 今関 文夫
消化器内科, Feb. 2014 - テラプレビルによる3剤併用療法時の消化器症状と胃排泄能との関連
小山田新; 新井誠人; 峯村荘子; 齊藤景子; 佐塚小百合; 坪井優; 丸岡大介; 田中健史; 松村倫明; 中川倫夫; 神田達郎; 勝野達郎; 横須賀收
肝臓, 2013 - HCV NS5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing Toll-like receptor 4 expression
田村 玲; 神田 達郎; 今関 文夫
消化器内科, Nov. 2011 - [HBeAg and HBV DNA in chronic hepatitis B].
Tatsuo Kanda
Nihon rinsho. Japanese journal of clinical medicine, 01 May 2011, Refereed, Not invited - Natural history of viral hepatitis
神田 達郎; 今関 文夫; 横須賀 收
綜合臨床, Jan. 2011 - 急性肝障害-薬物性肝障害とウイルス肝炎 2 急性肝障害を起こす疾患(2)ウイルス性急性肝障害とその治療 b.B型肝炎
丸岡大介; 神田達郎; 横須賀收
臨床消化器内科, Sep. 2010 - [Viral factors and host factors in pathogenesis of fulminant hepatitis, type B].
Tatsuo Kanda
Nihon rinsho. Japanese journal of clinical medicine, 01 Aug. 2004, Refereed, Not invited - A case of steatohepatitis associated with tamoxifen
Tatsuo Kanda; Osamu Yokosuka; Tetsuhiro Chiba; Hiroshige Kojima; Kenichi Fukai; Fumio Imazeki; Hiromitsu Saisho
Japanese Journal of Gastroenterology, 01 Sep. 2002, Refereed, Not invited
Books and other publications
- ★専門医のための消化器病学 第3版（下瀬川徹, 渡辺守監修, 木下芳一, 金子周一, 樫田博史, 村上和成, 安藤朗, 糸井隆夫編集）
Joint work, A型肝炎, 神田達郎; 森山光彦
医学書院, 2021, Refereed - 慢性ウイルス性肝炎および自己免疫性肝炎.
Jean-Michel Pawlotsky; 神田達郎; 神田達郎; ゴールドマン・セシル内科学 日本対応版. Online eBook Library
エルゼビア・ジャパン(東京都港区), 2021 - 健診で肝障害と言われました むかしの頭で診ていませんか？消化器診療をスッキリまとめました (加藤直也編集)
神田達郎, Contributor, 神田達郎
南江堂 (東京都文京区), 2020 - 肝臓専門医テキスト 改訂第3版 (日本肝臓学会編集)
改訂第; 版改訂者神田達郎, Contributor, 改訂第3版改訂者神田達郎
南江堂 (東京都文京区), 2020 - 肝の感染症 肝膿瘍 liver abscess 改訂第9版 内科学書 vol.4 消化管・腹膜疾患 肝・胆道・膵疾患 (南学正臣 総編集, 千葉勉, 持田智 部門編集)
神田達郎; 森山光彦, Contributor, 神田達郎; 森山光彦
中山書店(東京), 2019
Lectures, oral presentations, etc.
- Long-term follow up of patient with occurrence of autoimmune hepatitis post-COVID-19 vaccination.
Shuhei Arima; Tatsuo Kanda; Masayuki Honda; Mai Totsuka; Reina Sasaki-Tanaka; Shini Kanezawa; Tomotaka Ishii; Naoki Matsumoto; Ryota Masuzaki; Hiroaki Yamagami; Masahiro Ogawa; Hirofumi Kogure
The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver., Mar. 2024, Not invited - In vitro and in vivo hepatitis A virus infection models for anti-HAV drugs screening.
Reina Sasaki-Tanaka; Tatsuo Kanda; Noriko Nakajima; Hiroaki Okamoto
The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver., Mar. 2024, Not invited - Elderly patient with unresectable advanced HCC who received atezolizumab plus bevacizumab and achieved complete response by mRECIST Criteria
Tatsuo Kanda; Shuhei Arima; Masayuki Honda; Mai Totsuka; Reina Sasaki-Tanaka; Shini Kanezawa; Tomotaka Ishii; Naoki Matsumoto; Ryota Masuzaki; Hiroaki Yamagami; Masahiro Ogawa; Hirofumi Kogure
The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver, Mar. 2024, Not invited - Hepatitis A and E viruses: recent advances in research and clinical practice recommendations
Tatsuo Kanda
The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver, Mar. 2024, Invited - Powell-Sarin Achievement Award "Recent advances of viral hepatitis, and current situation of hepatitis A and E in Japan"
Tatsuo Kanda
The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver, Mar. 2024, Invited - アテゾリズマブ＋ベバシズマブ併用療法にてCRを得た進行肝細胞癌の一例
神田達郎; 有間修平; 本田真之; 松本直樹; 十束茉衣; 田中(佐々木)玲奈; 金澤芯依; 増﨑亮太; 小川眞広; 山上裕晃; 木暮宏史
第29回日本肝がん分子標的治療研究会, Jan. 2024, Not invited - ウイルス性肝炎と悪性腫瘍の治療など
神田達郎
SAKURA病診連携講演会, Nov. 2023, Invited - 講演4 肝疾患と腸内細菌
司会; 神田達郎
日本消化器病学会関東支部 第43回教育講演会, Nov. 2023, Invited - ウイルス性肝炎 最近の話題
神田達郎
Hepatology Seminar in Atami 2023, Nov. 2023, Invited - Workshop 13 Tumor Markers & Biochemistry, CCC, other
Tatsuo Kanda; Chair
APASL Oncology 2023, Oct. 2023, Invited - 慢性B型肝炎と総胆管結石に併発したE型肝炎の1例
平野怜; 神田達郎; 本田真之; 有間修平; 増崎亮太; 佐々木玲奈; 齋藤圭; 松本直樹; 小川眞広; 木暮宏史
日本内科学会関東支部主催 第690回関東地方会、アキバプラザ・Web, Oct. 2023, Not invited - 特別講演「ウイルス性肝炎撲滅を目指して～啓発・創薬研究から臨床応用へ～」田中靖人 先生
座長 神田達郎
第13回 首都圏Liver Forum, Oct. 2023, Invited - A型肝炎最近の話題
神田達郎; 田中(佐々木)玲奈
第13回 首都圏Liver Forum, Oct. 2023, Invited - 講演I 「早く見つけよう! 肝臓の病気」増﨑亮太
司会) 神田達郎
日本消化器病学会関東支部第128回市民公開講座, Sep. 2023, Invited - Chairs. Parallel Session 3.
Tatsuo Kanda; Shuhei Yamashina
JSH-ILC 2023. The 3rd JHS International Liver Conference, Hotel New Otani Tokyo, Tokyo, Japan., Sep. 2023, Invited - Clinical features of HCV-infected older patients treated with glecaprevir plus piblentasvir.
Tatsuo Kanda; Mai Totsuka; Shuhei Arima; Masayuki Honda; Reina Sasaki; Naoki Matsumoto; Ryota Masuzaki; Masahiro Ogawa; Hirofumi Kogure
JSH-ILC 2023. The 3rd JHS International Liver Conference, Hotel New Otani Tokyo, Tokyo, Japan., Sep. 2023, Not invited - Acute-on-chronic liver failure associated with alcohol-associated liver disease and hepatitis E virus infection
Tatsuo Kanda; Shuhei Arima; Mai Totsuka; Masayuki Honda; Reina Sasaki-Tanaka; Ryota Masuzaki; Naoki Matsumoto; Tomotaka Ishii; Masahiro Ogawa; Masaharu Takahashi; Hiroaki Okamoto; Hirofumi Kogure
JSH-ILC 2023. The 3rd JHS International Liver Conference, Hotel New Otani Tokyo, Tokyo, Japan., Sep. 2023, Not invited - 肝生検が診断に有用であり, ステロイドが著効した肝サルコイドーシスの1例
上原兼礼; 神田達郎; 本田真之; 十束茉衣; 有間修平; 金澤芯依; 佐々木玲奈; 松本直樹; 増﨑亮太; 山上裕晃; 木暮宏史; 羽尾裕之
日本消化器病学会関東支部第376回例会, 海運クラブ, 東京都千代田区, Sep. 2023, Not invited - Moderator. Session 5. Liver-directed Loco-regional therapies for advanced HCC.
Tatsuo Kanda
APASL Liver Cancer Preceptorship (ALCAP) Program., Aug. 2023 - グレカプレビル・ピブレンタスビル併用療法を行った80歳以上C型肝炎の特徴.
神田 達郎; 中島典子; 有間 修平; 佐々木 玲奈; 十束 茉衣; 石井 大雄; 本田 真之; 松本 直樹; 増崎 亮太; 小川 眞広; 木暮宏史
第19回消化器病における性差医学・医療研究会, Jul. 2023, Not invited - 75歳以上の高齢者C型肝炎に対するDAA治療の治療効果, 有害事象, 予後に関する検討
神田 達郎; 森山 光彦; 有間 修平; 佐々木 玲奈; 十束 茉衣; 石井 大雄; 本田 真之; 松本 直樹; 増崎 亮太; 小川 眞広; 木暮 宏史
第25回日本高齢消化器病学会総会, Jul. 2023, Not invited - 経口感染によるウイルス性肝炎（A型及びE型）の感染防止、病態解明、治療等に関する研究.
神田達郎
令和５年度肝炎等克服緊急対策研究事業（肝克）キックオフミーティング, Jul. 2023, Invited - COVID-19治療中に非昏睡型肝不全を併発したアラジール症候群の1例.
羽尾裕平; 神田達郎; 本田真之; 有間修平; 増崎亮太; 佐々木玲奈; 松本直樹; 山上裕晃; 小川眞広; 木暮宏史
第688回日本内科学会関東地方会, 第1会場, 日本都市センター6階・Web, Jul. 2023, Not invited - A型肝炎と抗ウイルス剤の開発
神田達郎; 佐々木玲奈
第5回ファーマラボEXPO東京内 第5回アカデミックフォーラム, Jul. 2023, Invited - アルコール依存症を伴うアルコール性肝障害患者に対するナルメフェンの効果
神田達郎; 佐々木玲奈; 増﨑亮太; 本田真之; 有間修平; 石井大雄; 松本直樹; 金澤芯依; 小川眞広; 木暮宏史
第59回日本肝臓学会総会, Jun. 2023, Not invited - 脂肪性肝疾患と慢性腎臓病における非侵襲的肝線維化指標の有用性.
増﨑亮太; 松本直樹; 小川眞広; 十束茉衣; 本田真之; 有間修平; 金澤芯依; 山上裕晃; 神田達郎; 木暮宏史
第59回日本肝臓学会総会, Jun. 2023, Not invited - 献血時HEV Nucleic acid Amplification Test陽性で来院した2症例について.
池上千香子; 神田達郎; 本田真之; 有間修平; 石井大雄; 佐々木玲奈; 増﨑亮太; 松本直樹; 山上裕晃; 金澤芯依; 小川眞広; 木暮宏史
特別企画4-2. 「研修医・専攻医セッション～症例から学ぶ～2」第59回日本肝臓学会総会, 第8会場（奈良県コンベンションセンター 2階 会議室202）, Jun. 2023, Not invited - MRエラストグラフィによる肝細胞癌腫瘍硬度のバイオマーカーとしての有用性.
阿部勇人; 岡村行泰; 神田達郎
第59回日本肝臓学会総会, Jun. 2023, Not invited - ドラッグリポジッショニングによるA型肝炎ウイルスに対する既存薬剤スクリーニング.
佐々木玲奈; 神田達郎; 木暮宏史
第59回日本肝臓学会総会, Jun. 2023, Not invited - 原因不明肝硬変の臨床的特徴の変遷
十束茉衣; 松本直樹; 本田真之; 有間修平; 増﨑亮太; 小川眞広; 神田達郎; 木暮宏史
特別企画1. 「ポスターシンポジウム関東 肝硬変の成因と病態の推移（発表）」第59回日本肝臓学会総会, ミニオーラル会場 ブース3（奈良県コンベンションセンター 1階 コンベンションホールB+C）, Jun. 2023, Not invited - アルコール性肝硬変に併発したE型肝炎重症化救命例について
神田達郎; 有間修平; 本田真之; 田中玲奈; 増﨑亮太; 石井大雄; 松本直樹; 小川眞広; 高橋雅春; 岡本宏明; 木暮宏史
第49回日本急性肝不全研究会, 奈良県コンベンションセンター 2階 会議室203, Jun. 2023, Not invited - 肝疾患治療を考える～C型肝炎とSVR後の諸問題～
神田達郎
【WEB Seminar】 明日の診療を考える, ギリアド・サイエンシズ株式会社本社, M3配信, Jun. 2023, Invited - 特別講演 肝疾患最近の話題～ウイルス性肝炎、C型肝炎を中心に～
神田達郎
第122回熊谷地区生活習慣病講演会, 熊谷市医師会, 熊谷市, May 2023, Invited - Lecture
神田達郎
第5回城北肝疾患セミナー, Mar. 2023, ギリアド・サイエンシズ株式会社 - Session 8- Primary prophylaxis of variceal bleeding and acute variceal bleeding.
Tatsuo Kanda
How do I treat in Hepatology- Case based algorithmic approach. APASL SCHOOL E-LARNING SEMINAR SERIES FOR STUDENTS/FELLOWS-SERIES 3, Feb. 2023, Institute of Liver and Biliary Sciences New Delhi, India, Invited - C型肝炎ウイルス持続陰性化後に発症した原発不明AFP産生腺癌の一例
池上千香子; 本田真之; 渋谷真史; 有間修平; 石井大雄; 佐々木玲奈; 金澤芯依; 國吉宣行; 藤澤真理子; 野村修三; 齋藤 圭; 増﨑亮太; 松本直樹; 山上裕晃; 小川眞広; 神田達郎; 岡村行泰; 木暮宏史.
日本消化器病学会関東支部第373回例会, Feb. 2023, 日本消化器病学会関東支部, Not invited - 肝疾患治療を考える～C型肝炎とSVR後の諸問題～
神田達郎
肝疾患治療を考える～, Dec. 2022, ギリアド・サイエンシズ株式会社, Invited - 座長. 講演1, 講演2.
神田達郎
SAKURA病診連携講演会, Dec. 2022, Invited - Active NASHを示唆する超音波Bモード所見の検討.
松本直樹; 田村祐; 金子真大; 渡邊幸信; 平山みどり; 増﨑亮太; 小川眞広; 神田達郎; 木暮宏史.
第44回日本肝臓学会東部会, Nov. 2022, Not invited - 乾燥濃縮人アンチトロンビンIIIを用いた門脈血栓溶解療法を施行した7症例.
石井大雄; 渋谷真史; 本田真之; 有間修平; 石井大雄; 金澤芯依; 佐々木玲奈; 松本直樹; 増﨑亮太; 山上裕晃; 小川眞広; 神田達郎; 木暮宏史.
第44回日本肝臓学会東部会, Nov. 2022, Not invited - Active NASHを示唆する超音波Bモード所見の検討.
松本直樹; 田村祐; 金子真大; 渡邊幸信; 平山みどり; 増﨑亮太; 小川眞広; 神田達郎; 木暮宏史.
第44回日本肝臓学会東部会, Nov. 2022, Not invited - C型非代償性肝硬変のDAA治療前後の末梢血好中球／リンパ球比について.
神田達郎; 松本直樹; 楡井和重; 石井大雄; 有間修平; 本田真之; 佐々木玲奈; 増﨑亮太; 小川眞広; 木暮宏史.
第44回日本肝臓学会東部会, Nov. 2022, Not invited - 一般演題「B型肝炎/ウイルス性肝炎」
神田達郎
第44回日本肝臓学会東部会, Nov. 2022, Invited - オートファジーを介したAmantadineのA型肝炎ウイルス抑制効果. パネルディスカッション 2 肝疾患に適応する新規科学技術をめぐって
佐々木(田中)玲奈; 神田達郎; 木暮宏史.
第44回日本肝臓学会東部会, Nov. 2022, Not invited - 肝内胆管癌と鑑別が困難であった術後15年目に肝転移再発をきたした子宮体癌の一例. 若手セッション.
渋谷真史; 松本直樹; 本田真之; 有間修平; 石井大雄; 佐々木玲奈; 金澤芯依; 増﨑亮太; 山上裕晃; 小川眞広; 神田達郎; 木暮宏史.
第44回日本肝臓学会東部会, Nov. 2022, Not invited - 特別講演. 『自治医科大学における進行肝細胞癌の治療戦略』 森本 直樹.
神田達郎
第5回板橋大山肝臓カロキアム 肝癌診療 Meet the Expert Web配信, Nov. 2022, エーザイ株式会社, Not invited - 肝硬変における利尿剤使用方法が腎機能に与える影響
松本直樹; 渋谷真史; 須田清一郎; 田村祐; 金子真大; 本田真之; 有間修平; 石井大雄; 渡邊幸信; 佐々木玲奈; 平山みどり; 金澤芯依; 増﨑亮太; 山上裕晃; 小川眞広; 神田達郎; 木暮宏史.
第64回日本消化器病学会大会, Oct. 2022, Not invited - 「肝硬変5」
神田達郎
第26回日本肝臓学会大会, Oct. 2022, Invited - 閉会の辞.
神田達郎.
第12回首都圏Liver Forum, Oct. 2022, Invited - 肝機能が比較的安定していたが肝発癌を認めたB型肝炎症例について.
神田達郎; 森山光彦; 有間修平; 本田真之; 石井大雄; 松本直樹; 佐々木玲奈; 増﨑亮太; 木暮宏史; 小川眞広.
第30回日本がん検診・診断学会総会, Sep. 2022, 第30回日本がん検診・診断学会総会, Not invited - 「多施設共同研究からみる肝疾患のReal world-LEN-TACE sequential療法の使用経験を含めて-」. 厚川正則.
神田達郎
第30回日本がん検診・診断学会総会イブニングセミナー, Sep. 2022, Invited - Poster Free Paper 2; “Viral Hepatitis-related HCC-HCV-related HCC”.
Tatsuo Kanda
APASL Oncology 2022 “Liver Cancer: Clinical and Basic Research”, Sep. 2022, The Asian Pacific Association of Study of the Liver, Invited - Short-Term Effects of Nalmefene as Needed Use in Alcoholism with or without Cirrhosis in the Northern Part of Tokyo, Japan.
Tatsuo Kanda; Shinji Shibuya; Shuhei Arima; Masayuki Honda; Tomotaka Ishii; Reina Sasaki-Tanaka; Shini Kanezawa; Ryota Masuzaki; Hirofumi Kogure; Masahiro Ogawa.
APASL Oncology 2022 “Liver Cancer: Clinical and Basic Research”, Sep. 2022, The Asian Pacific Association of Study of the Liver, Not invited - During the chemotherapy against lung cancer in patients with HCV and decompensated cirrhosis, DAA could support sufficient lung cancer treatment.
Tatsuo Kanda; Shinji Shibuya; Shuhei Arima; Masayuki Honda; Tomotaka Ishii; Reina Sasaki-Tanaka; Shini Kanezawa; Ryota Masuzaki; Naoki Matsumoto; Hirofumi Kogure; Hiroaki Yamagami; Masahiro Ogawa.
APASL Oncology 2022 “Liver Cancer: Clinical and Basic Research”, Sep. 2022, The Asian Pacific Association of Study of the Liver, Not invited - Successful retreatment of direct-acting antiviral therapy against hepatitis C virus infection in a patient who underwent a liver transplant from HLA-matched sibling donor.
Tatsuo Kanda; Reina Sasaki-Tanaka; Naoki Matsumoto; Tomotaka Ishii; Ryota Masuzaki; Masahiro Ogawa; Shintaro Yamazaki; Osamu Aramaki; Hirofumi Kogure; Yukiyasu Okamura.
APASL Oncology 2022 “Liver Cancer: Clinical and Basic Research”, Sep. 2022, The Asian Pacific Association of Study of the Liver, Not invited - Post-SVR Events, compared to the APASL HCV Guidelines 2019 of Virus Eradicated Patients by DAA on How to Monitor HCC Occurrence and HBV Reactivation.
Tatsuo Kanda
APASL Oncology 2022 “Liver Cancer: Clinical and Basic Research”, Sep. 2022, The Asian Pacific Association of Study of the Liver, Invited - Panelist. APASL Hepatology Webinar Episode 6-1. “Recent Advancement of HCV Beyond Cure”
APASL Hepatology Webinar Episode 6-1. “Recent Advancement of HCV Beyond Cure”, Jun. 2022, The Asian Pacific Association for the Study of the Liver [APASL], Invited - 最近経験したE型肝炎ウイルス感染の5例.
石井大雄; 山名陽一郎; 熊川まり子; 金澤芯依; 佐々木玲奈; 水谷卓; 増﨑亮太; 山上裕晃; 松本直樹; 楡井和重; 神田達郎; 森山光彦; 金子朋広.
第58回日本肝臓学会総会, Jun. 2022, 日本肝臓学会, Not invited - 肝疾患患者におけるLeg cramps (足のつり)に関する検討
神田達郎; 佐々木玲奈; 石井大雄; 本田真之; 有間修平; 山名陽一郎; 熊川まり子; 金澤芯依; 増﨑亮太; 水谷卓; 松本直樹; 楡井和重; 山上裕晃; 小川眞広; 森山光彦.
第58回日本肝臓学会総会, Jun. 2022, 日本肝臓学会, Not invited - FavipiravirによるHAV Genome RNAに対する塩基変異誘導効果. ワークショップ1 ウイルス肝炎研究 – ウイルスゲノム・ホストゲノム・免疫
佐々木玲奈; 神田達郎; 森山光彦.
第58回日本肝臓学会総会, Jun. 2022, 日本肝臓学会, Not invited - RNA結合蛋白ELAVL1のB型肝炎ウイルス複製と肝細胞癌増殖への関わり.
神崎洋彰; 千葉哲博; 興梠慧輔; 日下部裕子; 小林和史; 叶川直哉; 清野宗一郎; 中村昌人; 近藤孝行; 齊藤朋子; 中川良; 小笠原定久; 室山良介; 中本晋吾; 神田達郎; 丸山紀史; 加藤順; 關場一磨; 大塚基之; 大塚将之; 加藤直也.
第58回日本肝臓学会総会, Jun. 2022, 日本肝臓学会, Not invited - 司会. 口演1「C型肝炎臨床-1」
神田達郎
第58回日本肝臓学会総会, Jun. 2022, 日本肝臓学会, Not invited - C型肝炎治療～肝不全や肝発癌回避に向けて～.
神田達郎
第48回日本急性肝不全研究会 共催モーニングセミナー., Jun. 2022, 第48回日本急性肝不全研究会, Invited - A case of BRTO performed with Cerecon MP catheter and CANDIS together.ビデオワークショップ 2「How I do it (血管内治療)」
石井大雄; 本田真之; 有間修平; 松本直樹; 増崎亮太; 山上裕晃; 小川眞広; 神田達郎; 松岡俊一.
第58回日本肝癌研究会, May 2022, 日本肝癌研究会, Not invited - 非B非C肝硬変からの肝発癌リスク因子の検討. シンポジウム1「新たな肝癌サーベイランスモデルの構築(非ウイルス性慢性肝疾患のスクリーニングを中心に)」
松本直樹; 金子朋広; 金子真大; 本田真之; 有間修平; 石井大雄; 渡邊幸信; 増崎亮太; 山上裕晃; 小川眞広; 神田達郎; 松岡俊一; 木暮宏史.
第58回日本肝癌研究会, May 2022, 日本肝癌研究会 - A型肝炎ウイルス増殖制御におけるMAP2K3の役割について. ワークショップ9. ウイルス肝炎基礎研究の新たな展開.
神田達郎; 田中玲奈; 森山光彦.
第108回日本消化器病学会総会, Apr. 2022, 日本消化器病学会, Not invited - 座長. 消化器1 演題番号1～8 日本内科学会関東支部主催 第675回関東地方会
神田達郎
日本内科学会関東支部主催 第675回関東地方会, Feb. 2022, 日本内科学会関東支部, Invited - 原因不明消化管出血を機に診断された多発性骨髄腫の1例
笠巻敬太; 岩本真帆; 酒井康行; 田村めぐみ; 春田明子; 中島典子; 神田達郎; 森山光彦; 高橋宏道; 八田善弘
日本内科学会関東支部主催 第675回関東地方会, Feb. 2022, 日本内科学会関東支部, Not invited - C型非代償性肝硬変に対するDAA治療直後重症COVID-19肺炎を併発した1例
池上千賀子; 神田達郎; 本田真之; 石井大雄; 山名陽一郎; 松本直樹; 楡井和重; 山上裕晃; 水谷卓; 森山光彦
日本内科学会関東支部主催 第675回関東地方会, Feb. 2022, 日本内科学会関東支部, Not invited - Clinical Symptom of Liver Diseases: Pathogenesis and Treatment.
Tatsuo Kanda
APASL Oncology 2021 “Your Gateway to Oncology in Asia-Pacific Region”, Dec. 2021, APASL, Invited - 座長. 消化器2 演題番号21～25 日本内科学会関東支部主催 第674回関東地方会
神田達郎
日本内科学会関東支部主催 第674回関東地方会, Dec. 2021, 日本内科学会関東支部, Invited - 肝硬変を含む慢性肝疾患における皮膚掻痒症の意義と今後の対策
神田達郎; 佐々木 玲奈; 森山 光彦
第44回日本肝臓学会西部会, Nov. 2021, 日本肝臓学会, Not invited - 慢性肝疾患における皮膚掻痒症の頻度とその治療法について
神田達郎; 増崎 亮太; 佐々木 玲奈; 石井 大雄; 山名 陽一郎; 本田 真之; 水谷 卓; 松本 直樹; 楡井 和重; 森山 光彦
第25回日本肝臓学会大会, Nov. 2021, 日本肝臓学会, Not invited - 当院における慢性C型肝炎におけるSVR後発癌のサーベイランス
楡井 和重; 本田 真之; 増崎 亮太; 松本 直樹; 山上 裕晃; 神田 達郎; 森山 光彦
第25回日本肝臓学会大会, Nov. 2021, 日本肝臓学会, Not invited - デジタルポスターセッション肝5(肝臓学会) C型肝炎3
神田達郎(座長)
第25回日本肝臓学会大会, Nov. 2021, 日本肝臓学会, Invited - 非アルコール性脂肪肝(NAFL)と非アルコール性脂肪性肝炎(NASH)の鑑別における臨床・遺伝情報に基づく包括的 risk scoreの意義.
神田達郎; 森山光彦.
日本人類遺伝学会第66回大会 第28回日本遺伝子診療学会大会 合同開催, Oct. 2021, 日本人類遺伝学会,日本遺伝子診療学会 - C型肝炎・B型肝炎治療の最新の話題
神田達郎
ギリアド・サイエンシズ株式会社・社内研修会, Sep. 2021, ギリアド・サイエンシズ株式会社, Invited - 肝転移・肝門部リンパ節転移を伴う上咽頭癌にニボルマブによる肝障害と帯状疱疹を併発した1例.
十束茉衣; 神田達郎; 本田真之; 石井大雄; 山名陽一郎; 佐々木玲奈; 金澤芯依; 熊川まり子; 増崎亮太; 水谷卓; 松本直樹; 楡井和重; 山上裕晃; 三浦勝浩; 森山光彦.
日本消化器病学会関東支部第366回例会, Sep. 2021, 日本消化器病学会関東支部, Not invited - 基調講演. 高齢者C型肝炎の予後に関する検討. 楡井和重.
神田達郎
城北肝がんWEBセミナー, Sep. 2021, 中外製薬, Invited - Zinc chloride enhances dsRNA-induced beta-interferon promoter activity through the inhibition of Mitogen-activated protein kinase kinase 3 expression in human hepatocytes.
Tatsuo Kanda; Reina Sasaki Tanaka; Ryota Masuzaki; Naoki Matsumoto; Hiroaki Okamoto; Mitsuhiko Moriyama.
APASL Single Topic Conference 2021 in Osaka(Web), Sep. 2021, APASL, Not invited - 若年女性にみられたANA陰性, IgG値正常の自己免疫性肝炎の1例.
北原麻衣; 神田達郎; 石井大雄; 本田真之; 水谷卓; 山名陽一郎; 熊川まり子; 田中(佐々木)玲奈; 金澤芯依; 増崎亮太; 松本直樹; 楡井和重; 山上裕晃; 森山光彦.
日本消化器病学会関東支部第365回例会, Jul. 2021, 日本消化器病学会関東支部, Not invited - COVID-19 Era に息切れを主訴に来院する肝硬変患者について.
神田達郎
明日から役立つ 門脈圧亢進症に伴う肺高血圧症（PoPH）診療 消化器内科医が診るPoPH診断 Up to Date., Jul. 2021, ヤンセン, Invited - 小胞体シャペロン蛋白GRP78と亜鉛によるA型肝炎ウイルス増殖抑制作用について
神田達郎; 田中(佐々木)玲奈; 増崎亮太; 石井大雄; 松本直樹; 楡井和重; 小川眞広; 森山光彦.
第43回日本栄養アセスメント研究会, Jun. 2021, 日本栄養アセスメント研究会, Not invited - IgM HBc抗体陰性, トランスアミナーゼ正常で来院したB型急性肝炎の1例（研修医・専攻医セッション1 ）
青木央; 神田達郎; 山名陽一郎; 石井大雄; 本田真之; 金子朋弘; 高橋央; 増崎亮太; 佐々木玲奈; 熊川まり子; 金澤芯依; 楡井和重; 山上裕晃; 松本直樹; 森山光彦.
第57回日本肝臓学会総会, Jun. 2021, 日本肝臓学会, Not invited - 肝細胞において塩化亜鉛がTLRを含む自然免疫シグナル伝達経路に与える影響. (ミニオーラル5)
神田達郎; 佐々木玲奈; 森山光彦
第57回日本肝臓学会総会, Jun. 2021, 日本肝臓学会, Not invited - 司会. 特別企画3-1 研修医・専攻医セッション1
森山 光彦; 加藤 淳二; 神田 達郎
第57回日本肝臓学会総会, Jun. 2021, 日本肝臓学会, Invited - 肝疾患最近の話題～C型肝炎を中心に～
神田 達郎
SAKURA病診連携講演会, Jun. 2021, AbbVie, Invited - HCV Guidelines of Virus-Eradicated Patients by DAA on How to Monitor HCC Occurrence and HBV Reactivation.
Tatsuo Kanda
HCV Symposium, Istanbul Health and TECHNOLOGY UNIVERSITY (ISTUN), Jun. 2021, Istanbul Health and TECHNOLOGY UNIVERSITY (ISTUN), Invited - 肝疾患に伴うかゆみについて.
神田達郎
第18回 城北消化器病研究会, May 2021, 大日本住友製薬, Invited - 基調講演. 当院における集学的肝癌治療. 松本 直樹.
神田達郎
城北肝がんWEBセミナー on Hepatocellular Carcinoma, May 2021, 中外製薬, Invited - 特別講演. 『Multi-MTA時代におけるTACE不応・不適/進行肝細胞癌治療--Lenvatinibの効果を最大限にいかすために考えるべきこと--』川村 祐介 先生
神田達郎
第3回板橋大山肝臓カロキアム 肝癌診療 Meet the Expert, May 2021, エーザイ株式会社, Invited - APASL SCHOOL E-LEARNING SERIES FOR STUDENTS/FELLOWS-SERIES 2- HOW DO I DO IT IN HEPATOLOGY?
Tatsuo Kanda; Wasim Jafri; Ian Homer Y. Cua; Pier Amodio.
APASL SCHOOL E-LEARNING SERIES FOR STUDENTS/FELLOWS-SERIES 2- HOW DO I DO IT IN HEPATOLOGY?, Zoomにて, Apr. 2021, Institute of Liver and Biliary Sciences New Delhi, India, Web配信, Invited - 心窩部痛を主訴に来院したベンズブロマロンによる薬物性肝障害の一例.
星野慶次郎; 石井大雄; 本田真之; 金子朋弘; 山名陽一郎; 高橋央; 佐々木玲奈; 熊川まり子; 増崎亮太; 水谷卓; 松本直樹; 山上裕晃; 神田達郎; 森山光彦.
日本消化器病学会関東支部第364回例会, Apr. 2021, 日本消化器病学会関東支部, Not invited - サイトメガロウイルス初感染を併発した潰瘍性大腸炎の1例.
杵渕広志; 岩本真帆; 岩男彩; 田村めぐみ; 酒井康行; 山川俊; 春田明子; 中島典子; 神田達郎; 今津博雄; 森山光彦; 後藤田卓志.
日本消化器病学会関東支部第364回例会., Apr. 2021, 日本消化器病学会関東支部, Not invited - 肝疾患と脂質代謝異常改善について
神田達郎
KOWA Web Conference, Apr. 2021, 興和株式会社, Invited - Role of hepatitis A virus infection in acute-on-chronic liver failure.
Tatsuo Kanda; Reina Sasaki; Mitsuhiko Moriyama.
The 10th International Forum of The Japanese Society of Gastroenterology Acute-on-Chronic Liver Failure (ACLF): Difference among APASL, EASL, AASLD and Japan., Apr. 2021, 日本消化器病学会, Not invited - 心不全合併肝硬変症例の臨床的特徴.
松本直樹; 高橋央; 金子真大; 金子朋弘; 本田真之; 有間修平; 石井大雄; 佐々木玲奈; 熊川まり子; 渡邊幸信; 金澤芯依; 水谷卓; 増崎亮太; 山上裕晃; 楡井和重; 小川眞広; 神田達郎; 森山光彦.
第107回日本消化器病学会総会, Apr. 2021, 日本消化器病学会, Not invited - 肝細胞癌薬物治療の現状と今後～カボザンチニブへの期待～ 大久保裕直.
神田 達郎Takeda Expert Web Seminar Web配信, Mar. 2021, 武田薬品工業, Invited - 肝疾患・最近の話題～肝疾患に伴う痒みと治療について」～肝疾患に伴う痒みと治療について.
神田達郎.
大日本住友webセミナー., Mar. 2021, 大日本住友, Invited - メサラジンにより心タンポナーデをきたした潰瘍性大腸炎の1例.
北原麻衣; 岩本真帆; 岩男彩; 田村めぐみ; 酒井康行; 山川俊; 春田明子; 杵渕広志; 中島典子; 神田達郎; 今津博雄; 森山光彦; 後藤田卓志.
日本消化器病学会関東支部第363回例会., Feb. 2021, 日本消化器病学会関東支部, Not invited - Inhibitory effects of zinc chloride on hepatitis A virus replication through the cytokines in hepatocytes.
Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Naoki Matsumoto; Hiroaki Okamoto; Mitsuhiko Moriyama.
APASL 2021 Annual Meeting Bangkok (Web)., Feb. 2021, The Asian Pacific Association for the Study of the Liver [APASL], Not invited - Screening for inhibitors of hepatitis A virus internal ribosomal entry site and HAV replication.
Reina Sasaki; Tatsuo Kanda; Ryota Masuzaki; Naoki Matsumoto; Hiroaki Okamoto; Mitsuhiko Moriyama.
APASL 2021 Annual Meeting Bangkok (Web)., Feb. 2021, The Asian Pacific Association for the Study of the Liver [APASL], Not invited - アルコール性肝硬変にE型肝炎ウイルス(HEV) 感染とアルコール多飲をAcute insultとしたAcute on chronic liver failure (ACLF)の1例.
神田達郎; 石井大雄; 本田真之; 金子朋弘; 高橋央; 山名陽一郎; 熊川まり子; 佐々木玲奈; 金澤芯依; 増崎亮太; 山上裕晃; 楡井和重; 水谷卓; 松本直樹; 森山光彦.
第１回 劇症肝炎研究会., Jan. 2021, 劇症肝炎研究会, Not invited - 特別講演. LEN-TACE Sequential療法～今後の位置づけと具体的アプローチ～ 土谷 薫.
神田 達郎
第2回板橋大山肝臓カロキアム 肝癌診療 Meet the Expert Web配信, Jan. 2021, エーザイ株式会社, Invited - 肝細胞癌に対するレンバチニブ使用後の腫瘍血流評価, 後治療についての検討.
本田真之; 森山光彦; 松岡俊一; 有間修平; 石井大雄; 金子朋弘; 高橋央; 山名陽一郎; 水谷卓; 増崎亮太; 楡井和重; 山上裕晃; 松本直樹; 神田達郎.
第56回日本肝癌研究会, Dec. 2020, 日本肝癌研究会 - MRエラストグラフィーを用いた肝細胞癌根治術後の再発評価～ウイルス性肝炎患者を中心に～
阿部勇人; 緑川泰; 山崎慎太郎; 中山壽之; 森口正倫; 檜垣時夫; 岡田真広; 神田達郎; 森山光彦; 高山忠利.
第56回日本肝癌研究会, Dec. 2020, 日本肝癌研究会, Not invited - 多発肝細胞癌に対して41回のIVRとテガフール・ウラシル内服を服用し8年の長期生存を得た1例
有間修平; 金子朋弘; 高橋央; 石井大雄; 松本直樹; 楡井和重; 神田達郎; 松岡俊一; 森山光彦.
第56回日本肝癌研究会, Dec. 2020, 日本肝癌研究会, Not invited - Lenvatinib投与中増悪したHCCに対しB-TACEとLenvatinib併用治療に変更した症例.
石井大雄; 本田真之; 有間修平; 松本直樹; 神田達郎; 松岡俊一; 森山光彦.
第56回日本肝癌研究会, Dec. 2020, 日本肝癌研究会, Not invited - HBV再活性化の早期発見・早期治療介入の重要性について.
神田達郎; 松本直樹; 森山光彦.
第43回日本肝臓学会東部会, Dec. 2020, 日本肝臓学会, Not invited - 2018年以降当院でみられたA型肝炎症例について
本田真之; 神田達郎; 森山光彦.
第43回日本肝臓学会東部会, Dec. 2020, 日本肝臓学会, Not invited - 塩化亜鉛によるA型肝炎ウイルス感染肝細胞の炎症性サイトカイン抑制について
神田達郎; 佐々木玲奈; 森山光彦.
第43回日本肝臓学会東部会, Dec. 2020, 日本肝臓学会, Not invited - ワークショップ4 宿敵B型肝炎ウイルスに挑む.
村田一素、鈴木文孝、神田達郎
第43回日本肝臓学会東部会, Dec. 2020, 日本肝臓学会, Invited - グレカプレビル・ピブレンタスビル併用療法によりSVRが得られたHCV GT-4a肝硬変症例の1例
十束茉衣; 本田真之; 神田達郎; 水谷卓; 山名陽一郎; 有間修平; 石井大雄; 高橋央; 金子朋弘; 熊川まり子; 佐々木玲奈; 増崎亮太; 山上裕晃; 松本直樹; 楡井和重; 松岡俊一; 岡本宏明; 森山光彦.
第43回日本肝臓学会東部会, Dec. 2020, 日本肝臓学会, Not invited - 右腎盂癌に対するぺムブロリズマブ投与後, 急性肝不全を発症した1例
淺谷真也; 神田達郎; 金子朋弘; 本田真之; 石井大雄; 水谷卓; 松本直樹; 山上裕晃; 楡井和重; 森山光彦.
日本内科学会関東支部主催 第664回関東地方会, Nov. 2020, 日本内科学会関東支部主催, Not invited - 塩化亜鉛によるA型肝炎ウイルス増殖抑制効果の検討.
神田達郎; 佐々木玲奈; 増崎亮太; 高橋央; 熊川まり子; 松本直樹; 楡井和重; 小川眞広; 森山光彦.
第24回日本肝臓学会大会, Nov. 2020, 日本肝臓学会, Not invited - 特別講演. 肝癌診療マニュアル改訂のポイントとTACE不適に対する治療戦略 上嶋一臣.
神田達郎. 座長.
第1回板橋大山肝臓カロキアム 肝癌診療 Meet the Expert (第二報)Web配信, Oct. 2020, エーザイ株式会社, Invited - Acute-on-chronic liver failure (AARC vs. Japan).
Tatsuo Kanda
8th Annual Meeting of APASL-ACLF Research consortium. India (Zoom)., Oct. 2020, APASL, Not invited - 座長. Session 2. 当院におけるDAA治療実績と院内連携の取り組み.
神田達郎; 朝比奈靖浩.
Hepatology Summit In Tokyo ～C型肝炎の撲滅に向けて 肝臓専門医の取り組みを考える～, Oct. 2020, アッヴィ合同会社, Invited - Drug Development for Fatty Liver Diseases.
Arun Sanyal (USA)
APASL HEPATOLOGY Webinar Episode 3 [Session 7], Sep. 2020, APASL, Invited - 亜鉛化合物によるA型肝炎ウイルス増殖抑制効果の検討.
346.神田達郎; 高橋央; 本田真之; 金子朋弘; 有間修平; 佐々木玲奈; 熊川まり子; 金澤芯依; 増崎亮太; 石井大雄; 山名陽一郎; 水谷卓; 松本直樹; 樋口晃久; 中村仁美; 楡井和重; 山上裕晃; 小川眞広; 松岡俊一; 森山光彦.
第56回日本肝臓学会総会, Aug. 2020, 日本肝臓学会総会, Not invited - HAVによるAcute-on-chronic liver failureについて
神田達郎
第10回首都圏Liver Forum, Aug. 2020, アッヴィ合同会社, Invited - C型慢性肝疾患に対するグレカプレビル/ピブレンタスビル併用療法の実臨床成績について.
345.神田達郎; 高橋央; 本田真之; 金子朋弘; 有間修平; 佐々木玲奈; 熊川まり子; 金澤芯依; 増崎亮太; 石井大雄; 山名陽一郎; 水谷卓; 松本直樹; 樋口晃久; 中村仁美; 楡井和重; 山上裕晃; 小川眞広; 松岡俊一; 森山光彦.
第56回日本肝臓学会総会, Aug. 2020, 日本肝臓学会, Not invited - B型肝炎2, HBV 2.
神田達郎; 井上 淳.
第56回日本肝臓学会総会, Aug. 2020, 日本肝臓学会, Invited - C型肝炎
神田達郎
TBSテレビ『サンデージャポン』番組内コーナー『サンデージャンクション』, Mar. 2020, アッヴィ, Invited - 多量の胸腹水貯留を呈したCastleman病の1例.
笠巻敬太; 有間修平; 本田真之; 石井大雄; 水谷卓; 松本直樹; 楡井和重; 神田達郎; 松岡俊一; 森山光彦.
日本内科学会関東支部主催第657回関東地方会, Feb. 2020, 日本内科学会関東支部, Not invited - B型肝炎診療; 未来への展望を踏まえた現在の在り方.ワークショップ11 司会
第23回日本肝臓学会大会, Nov. 2019, 日本肝臓学会・日本消化器病学会, Invited - 各種分子標的薬が肝癌細胞株自然免疫シグナル伝達経路に与える影響に関する検討
神田達郎; 松本直樹; 森山光彦
第23回日本肝臓学会大会, Nov. 2019, 日本肝臓学会, Not invited - Different mechanism of action of regorafenib and lenvatinib on toll-like receptor-signaling pathways in human hepatoma cell lines.
Kanda T; Moriyama M.
AASLD The Liver Meeting 2019, Nov. 2019, AASLD, Not invited - 座長. <1部> B型肝疾患予防に関する最新の話題.
四柳 宏 座長.神田 達郎
HBV expert meeting, Nov. 2019, ギリアド・サイエンシズ株式会社, Invited - C型肝炎治療薬選択～非代償性肝硬変を含む～
神田達郎
城北Liver Forum, Oct. 2019, ギリアド・サイエンシズ株式会社, Invited - C型肝炎の最新の知見と治療
神田達郎
第21回みつわ台総合病院医療連携懇談会, Oct. 2019, みつわ台総合病院, 日本医師会生涯教育講座, Invited - 腎機能低下および透析症例に対するC型肝炎治療.
神田達郎
SAKURA肝腎ネットワーク講演会., Oct. 2019, Invited - 類洞性門脈圧亢進症による胃静脈瘤に対してバルーン下逆行性経静脈的塞栓術（BRTO）を施行した2症例の検討.
本田真之; 石井大雄; 有間修一; 山名陽一郎; 熊川まり子; 水谷卓; 松本直樹; 楡井和重; 今津博雄; 神田達郎; 山上裕晃; 松岡俊一; 森山光彦.
第26回日本門脈圧亢進症学会総会, Sep. 2019, 日本門脈圧亢進症学会, Not invited - 肝疾患～最近の話題から～
神田達郎
日本大学医師会. 令和元年度夏季医学講座 テーマ「総合診療のPitfall」, Jul. 2019, 日本大学医師会, Invited - 論文を書くことについて - 平成時代から令和時代へ –
神田達郎
千葉大学消化器内科特別セミナー, Jul. 2019, 千葉大学消化器内科, Invited - DEB-TACEとC-TACEの治療効果と副反応の比較検討
石井大雄; 松岡俊一; 高橋央; 金子朋弘; 本田真之; 有間修平; 山名陽一郎; 熊川まり子; 金澤芯依; 水谷卓; 上村慎也; 松本直樹; 樋口晃久; 楡井和重; 山上裕晃; 神田達郎; 森山光彦.
第55回日本肝癌研究会, Jul. 2019, 日本肝癌研究会, Invited - ミリプラチン水和物を使用したB-TACEの安全性の検討.
小川眞広; 金子真大; 渡邊幸信; 平山みどり; 三浦隆生; 松本直樹; 中河原浩史; 山本敏樹; 神田達郎; 松岡俊一; 森山光彦; 武藤晴臣.
第55回日本肝癌研究会, Jul. 2019, 日本肝癌研究会, Not invited - B型肝細胞癌患者におけるエンテカビル先発品と後発品薬品の有効性と安全性の比較検討.
高橋央; 神田達郎; 金子朋弘; 有間修平; 本田真之; 石井大雄; 金澤芯依; 水谷卓; 上村慎也; 樋口晃久; 山上裕晃; 松本直樹; 楡井和重; 松岡俊一; 森山光彦.
第55回日本肝癌研究会, Jul. 2019, 日本肝癌研究会, Not invited - 非B非C型肝細胞癌に対するスクリーニング方法の検討
平山みどり; 小川眞広; 金子真大; 渡邊幸信; 三浦隆生; 松本直樹; 中河原浩史; 山本敏樹; 神田達郎; 神田達郎; 松岡俊一; 森山光彦.
第55回日本肝癌研究会, Jul. 2019, 日本肝癌研究会, Not invited - レンバチニブが肝癌細胞Toll-like receptor関連シグナルに与える影響.
神田達郎; 松岡俊一; 小川眞広; 松本直樹; 上村慎也; 水谷卓; 有間修平; 本田真之; 金澤芯依; 金子朋弘; 高橋央; 山名陽一郎; 石井大雄; 樋口晃久; 山上裕晃; 中村仁美; 楡井和重; 森山光彦.
第55回日本肝癌研究会, Jul. 2019, 日本肝癌研究会, Not invited - ウイルス性肝炎の最新治療と診療連携
神田達郎
第3回千葉消化器疾患診療連携会, Jun. 2019, 千葉消化器疾患診療連携会, Invited - 味噌, 亜鉛のもつA型肝炎ウイルスに対する抗ウイルス作用に関する検討.
神田 達郎; 上村 慎也; 水谷 卓; 本田 真之; 金子 朋弘; 高橋 央; 藤澤 真理子; 松本 直樹; 楡井 和重; 松岡 俊一; 小川 眞広; 森山 光彦.
第42回日本栄養アセスメント研究会, Jun. 2019, 日本栄養アセスメント研究会, Not invited - 司会. ワークショップ3 成因不明の肝疾患，その実態を探る Investigate the actual condition of liver disease of unknown origin.
第55回日本肝臓学会総会, May 2019, 日本肝臓学会, Invited - レゴラフェニブの肝癌細胞Toll-like receptor関連シグナルに対する影響
319.神田達郎; 高橋央; 金子朋弘; 本田真之; 有間修平; 上村慎也; 金澤芯依; 山名陽一郎; 水谷卓; 松本直樹; 中村仁美; 石井大雄; 楡井和重; 山上裕晃; 小川眞広; 松岡俊一; 森山光彦
第55回日本肝臓学会総会, May 2019, 日本肝臓学会, Not invited - HBsAg陽性，かつanti-HBs陰性，anti-HBc陰性を示した4症例の検討.
神田 達郎; 松本 直樹; 森山 光彦.
ワークショップ3 成因不明の肝疾患，その実態を探る Investigate the actual condition of liver disease of unknown origin. 第55回日本肝臓学会総会, May 2019, 日本肝臓学会, Not invited - 司会. セッション15 B型肝炎1. HBV1.
第55回日本肝臓学会総会, May 2019, 日本肝臓学会, Invited - 亜鉛による小胞体ストレス蛋白GRP78増加とA型肝炎増殖抑制に関する検討
神田達郎; 松岡俊一; 森山 光彦
第55回日本肝臓学会総会, May 2019, 日本肝臓学会, Not invited - ジエノタイプ2型C型肝炎に対するソフォスブビル・リバビリン療法再燃例のNS5B領域塩基配列の検討.
金子朋弘; 神田達郎; 高橋央; 本田真之; 有間修平; 石井大雄; 山名陽一郎; 熊川まり子; 金澤芯依; 水谷卓; 上村慎也; 田村彰教; 松本直樹; 樋口晃久; 中村仁美; 山上裕晃; 松岡俊一; 森山光彦.
第105回日本消化器病学会総会, May 2019, 日本消化器病学会, Not invited - 核酸アナログ投与前または投与中に急性増悪を来したHBV Genotype C全塩基配列解析
高橋央; 神田達郎; 金子朋弘; 本田真之; 有間修平; 熊川まり子; 山名陽一郎; 金澤芯依; 水谷卓; 上村慎也; 田村彰教; 樋口晃久; 山上裕晃; 松本直樹; 中村仁美; 松岡俊一; 森山光彦
第105回日本消化器病学会総会, May 2019, 日本消化器病学会, Not invited - HCC (1)
APASL Single Topic Conference on Liver Immunology and Genetics, Apr. 2019, APASL, Invited - Effects of regorafenib on the toll-like receptor signaling pathways in HCC.
Tatsuo Kanda; Naoki Matsumoto; Hiroaki Yamagami; Shunichi Matsuoka; Mitsuhiko Moriyama.
APASL Single Topic Conference on Liver Immunology and Genetics, Apr. 2019, APASL, Invited - SVR in HCV GT1b-patient with alanine aminotransferase elevation who discontinued grazoprevir/elbasvir combination treatment at week 8.
Tatsuo Kanda; Kazushige Nirei; Masahiro Ogawa; Shunichi Matsuoka; Mitsuhiko Moriyama
APASL Single Topic Conference on Liver Immunology and Genetics, Apr. 2019, APASL, Invited - Effects of knockdown of ARRDC3 on inflammasome-associated pathways in human hepatocytes.
Tatsuo Kanda; Naoki Matsumoto; Masahiro Ogawa; Shunichi Matsuoka; Mitsuhiko Moriyama.
APASL Single Topic Conference on Liver Immunology and Genetics, Apr. 2019, APASL, Invited - Inhibitory effects of HAV infection on HBV replication in hepatocytes and Japanese rice-koji miso has inhibitory effects on HAV replication.
Tatsuo Kanda; Naoki Matsumoto; Masahiro Ogawa; Shunichi Matsuoka; Mitsuhiko Moriyama.
APASL Single Topic Conference on Liver Immunology and Genetics, Apr. 2019, APASL, Invited - Zinc sulfate inhibits HAV replication.
Tatsuo Kanda; Shingo Nakamoto; Shunichi Matsuoka; Hiroaki Okamoto; Mitsuhiko Moriyama.
APASL Single Topic Conference on Liver Immunology and Genetics, Apr. 2019, APASL, Invited - Analysis of sorafenib-regorafenib sequential therapy in patients with advanced hepatocellular carcinoma using baseline date of sorafenib
Sae Yumita; Sadahisa Ogasawara; Yoshihiko Ooka; Kazufumi Kobayashi; Susumu Maruta; Hiroaki Kanzaki; Kengo Kanayama; Takahiro Maeda; Yuko Kusakabe; Soichiro Kiyono; Masato Nakamura; Tomoko Saito; Eiichiro Suzuki; Shingo Nakamoto; Shin Yasui; Akinobu Tawada; Tetsuhiro Chiba; Makoto Arai; Tatsuo Kanda; Hitoshi Maruyama; Naoya Kato
JOURNAL OF HEPATOLOGY, Apr. 2019, ELSEVIER, Not invited - Post progression survival in patients with intermediate-stage hepatocellular carcinoma after receiving transarterial chemoembolization
Yukiko Shima; Sadahisa Ogasawara; Yoshihiko Ooka; Kazufumi Kobayashi; Susumu Maruta; Hiroaki Kanzaki; Kengo Kanayama; Takahiro Maeda; Yuko Kusakabe; Soichiro Kiyono; Masato Nakamura; Tomoko Saito; Eiichiro Suzuki; Shingo Nakamoto; Shin Yasui; Akinobu Tawada; Tetsuhiro Chiba; Makoto Arai; Tatsuo Kanda; Hitoshi Maruyama; Naoya Kato
JOURNAL OF HEPATOLOGY, Apr. 2019, ELSEVIER - Survival among patients with advanced hepatocellular carcinoma in the pre-TKI versus TKI eras
Miyuki Sensui; Sadahisa Ogasawara; Yoshihiko Ooka; Kazufumi Kobayashi; Susumu Maruta; Hiroaki Kanzaki; Kengo Kanayama; Takahiro Maeda; Yuko Kusakabe; Soichiro Kiyono; Masato Nakamura; Tomoko Saito; Eiichiro Suzuki; Shingo Nakamoto; Shin Yasui; Akinobu Tawada; Tetsuhiro Chiba; Makoto Arai; Tatsuo Kanda; Hitoshi Maruyama; Naoya Kato
JOURNAL OF HEPATOLOGY, Apr. 2019, ELSEVIER - Analysis of the relationship between serum creatinine/cystatin C ratio and muscle mass in patients with hepatocellular carcinoma
Hirotaka Oura; Sadahisa Ogasawara; Yoshihiko Ooka; Kazufumi Kobayashi; Susumu Maruta; Hiroaki Kanzaki; Kengo Kanayama; Takahiro Maeda; Yuko Kusakabe; Soichiro Kiyono; Masato Nakamura; Tomoko Saito; Eiichiro Suzuki; Shingo Nakamoto; Shin Yasui; Akinobu Tawada; Tetsuhiro Chiba; Makoto Arai; Tatsuo Kanda; Hitoshi Maruyama; Naoya Kato
JOURNAL OF HEPATOLOGY, Apr. 2019, ELSEVIER - Transition to the era of direct-acting antiviral changes in the prognosis of patients with hepatitis C virus-related hepatocellular carcinoma
Yoshifumi Miura; Sadahisa Ogasawara; Yoshihiko Ooka; Kazufumi Kobayashi; Susumu Maruta; Hiroaki Kanzaki; Kengo Kanayama; Takahiro Maeda; Soichiro Kiyono; Yuko Kusakabe; Masato Nakamura; Eiichiro Suzuki; Tomoko Saito; Shingo Nakamoto; Shin Yasui; Akinobu Tawada; Tetsuhiro Chiba; Makoto Arai; Tatsuo Kanda; Hitoshi Maruyama; Naoya Kato
JOURNAL OF HEPATOLOGY, Apr. 2019, ELSEVIER - The real world practice of systemic therapies in patients with advanced hepatocellular carcinoma in Japan: what has changed since lenvatinib approval?
Susumu Maruta; Sadahisa Ogasawara; Yoshihiko Ooka; Masanori Inoue; Norio Itokawa; Masamichi Obu; Atsuyoshi Seki; Yuki Haga; Shinichiro Okabe; Ei Itobayashi; Masanori Atsukawa; Ryosaku Azemoto; Hideaki Mizumoto; Nobuyuki Sugiura; Takahiro Maeda; Kazufumi Kobayashi; Eiichiro Suzuki; Shingo Nakamoto; Shin Yasui; Akinobu Tawada; Tetsuhiro Chiba; Makoto Arai; Tatsuo Kanda; Hitoshi Maruyama; Naoya Kato
JOURNAL OF HEPATOLOGY, Apr. 2019, ELSEVIER - ウイルス性肝炎の最新治療と診療連携
神田達郎
第3回千葉消化器疾患診療連携会., Mar. 2019, 国立病院機構 千葉医療センター, Invited - 特別講演 C型肝炎最新知見
神田達郎
第3回熊谷HCVセミナー, Mar. 2019, アッヴィ合同会社, Invited - Arrestin domain-containing protein 3 is associated with NAFLD and NASH development.
Tatsuo Kanda; Masahiro Ogawa; Naoki Matsumoto; Shunichi Matsuoka; Mitsuhiko Moriyama.
28th Annual Conference, Asian Pacific Association for the Study of the Liver “Soaring to New Heights in Hepatology”, Feb. 2019, APASL, Not invited - B型・C型肝炎ウイルス増殖抑制～基礎的検討から～ 特別講演I
神田 達郎
第2回城東B型肝炎セミナー, Feb. 2019, ギリアド・サイエンシズ, Invited - C型肝炎治療の現状と問題点
神田達郎
第1回城北肝疾患セミナー, Dec. 2018, Invited - 特別講演 明日から役立つ肝炎診療
神田 達郎
新潟肝性脳症講演会2018 -How to use Rifaximin-, Dec. 2018, Invited - 味噌, 亜鉛によるHAV増殖抑制の検討
神田達郎
平成 30 年度 年度末 国立研究開発法人 日本医療研究開発機構(AMED) 肝炎等克服実用化研究事業(肝炎等克服緊急対策研究事業)「経口感染によるウイルス性肝炎(A 型及び E 型)の感染防止、病態解明、治療等に関する研究」班会議, Dec. 2018, 日本医療研究開発機構(AMED), Invited - C型肝炎
神田達郎
平成30年度日本肝臓学会後期教育講演会, Dec. 2018, 日本肝臓学会, Invited - 味噌抽出液のA型肝炎ウイルス増殖抑制効果に関する検討
神田達郎; 中本晋吾; 森山光彦
第42回日本肝臓学会東部会 シンポジウム3「ゲノミクス・メタボロミクスからバイオマーカ・創薬への展開」, Dec. 2018, 日本肝臓学会, Invited - 高度進行肝癌に対しIVR治療を継続しえたビリルビン5mg/dL超のChild分類C肝硬変症
有間修平; 松岡俊一; 本田真之; 石井大雄; 山名陽一郎; 水谷卓; 上村慎也; 中村仁美; 樋口晃久; 山上裕晃; 神田達郎; 森山光彦
第42回日本肝臓学会東部会, Dec. 2018, 日本肝臓学会東部会, Not invited - シンポジウム3「ゲノミクス・メタボロミクスからバイオマーカ・創薬への展開」
加藤淳二; 神田達郎
第42回日本肝臓学会東部会, Dec. 2018, 日本肝臓学会, Invited - 今年当院でみられたA型肝炎症例について
本田真之; 松岡俊一; 水谷卓; 山名陽一郎; 有間修平; 石井大雄; 高橋央; 金子朋弘; 金澤芯依; 上村慎也; 中村仁美; 樋口晃久; 山上裕晃; 松本直樹; 神田達郎; 森山光彦
第42回日本肝臓学会東部会, Dec. 2018, 日本肝臓学会, Not invited - A型肝炎ウイルスのMiso extractsによる増殖抑制の検討
神田 達郎; Nan Nwe Win; 中本 晋吾; 菅波 晃子; 田村 裕; 加藤直也; 白澤 浩; 松岡 俊一; 森山 光彦
第49回日本消化吸収学会総会, Nov. 2018, 日本消化吸収学会総会, Not invited - Pre and post-Transplant HBV treatment, HBIG Prophylaxis.
Tatsuo Kanda
APASL Single Topic Conference “Non Responders: Chronic Viral Hepatitis Liver Cirrhosis HCC”, Sep. 2018, Asian Pacific Association for the Study of the Liver, Invited - A型肝炎重症化阻止を目指した対策の開発とその検証：味噌によるHAV増殖抑制に関する検討と最近経験したA型肝炎について
神田 達郎
平成30 年度 第1 回 国立研究開発法人 日本医療研究開発機構(AMED) 感染症実用化研究事業 肝炎等克服実用化研究事業(肝炎等克服緊急対策研究事業) 「経口感染によるウイルス性肝炎(A 型及びE 型)の感染防止、病態解明、治療等に関する研究」班会議, Aug. 2018, 日本医療研究開発機構(AMED), Not invited - 肝がんの予防
神田達郎
平成30年度 肝がん撲滅運動 市民公開講座「肝がんを防ぐ、治す!」, Jul. 2018, 日本肝臓学会, Invited - C型肝炎の病態と治療の最前線
神田達郎
市民公開講座 健康セミナー肝炎について勉強しよう! ～肝炎は検査から。早期発見、早期治療が肝要～, Jul. 2018, ギリアド・サイエンシズ株式会社 BSフジ, Invited - ウイルス性肝炎治療と治療後の問題点
神田達郎
平成30年度第1回医療従事者肝疾患研修会, Jul. 2018, 肝疾患診療拠点病院(武蔵野赤十字病院), Invited - 非アルコール性脂肪肝炎病態進展におけるARRDC3の役割
神田達郎; 樋口晃久; 中村仁美; 松本直樹; 高橋央; 金子朋弘; 藤澤真理子; 金澤芯依; 山名陽一郎; 水谷卓; 上村慎也; 山上裕晃; 今津博雄; 松岡俊一; 森山光彦
第41回日本栄養アセスメント研究会, Jul. 2018, Not invited - ジエノタイプ2型C型肝炎に対するソフォスブビル・リバビリン療法再燃例のNS5B領域塩基配列の検討
金子朋弘; 神田達郎; 山崎元美; 芝田敏克; 高橋央; 佐々木翔一; 石井大雄; 有間修平; 熊川まり子; 金澤芯依; 水谷卓; 上村慎也; 松本直樹; 中村仁美; 樋口晃久; 楡井和重; 山上裕晃; 黒田和道; 森山光彦
第54回日本肝臓学会総会, Jun. 2018, 日本肝臓学会, Not invited - HAMP遺伝子低下が肝細胞サイトカイン産生および肝癌進展に及ぼす影響
神田達郎; 松岡俊一; 楡井和重; 松本直樹; 中村仁美; 熊川まり子; 金澤芯依; 上村慎也; 樋口晃久; 山上裕晃; 高橋央; 金子朋弘; 森山光彦
第54回日本肝臓学会総会, Jun. 2018, 日本肝臓学会, Not invited - 司会. ME8. Meet the Expert 8
第54回日本肝臓学会総会, Jun. 2018, 日本肝臓学会, Not invited - Arrestin domain-containing protein 3 (ARRDC3)はNASH・NAFLD増悪因子の一つである
神田達郎; 佐々木翔一; 森山光彦
第54回日本肝臓学会総会, Jun. 2018, 日本肝臓学会, Not invited - Acute exacerbationをきたした慢性B型肝炎2例のGenotype C HBV遺伝子解析
高橋央; 神田達郎; 金子朋弘; 佐々木翔一; 山崎元美; 芝田敏克; 熊川まり子; 金澤芯依; 上村慎也; 田村彰教; 樋口晃久; 松本直樹; 中村仁美; 楡井和重; 黒田和道; 松岡俊一; 森山光彦
第54回日本肝臓学会総会, Jun. 2018, 日本肝臓学会, Not invited - C型肝炎合併自己免疫性肝疾患に対するDAA治療効果
神田達郎; 森山光彦; 安井伸; 中村昌人; 中本晋吾; 加藤直也
第54回日本肝臓学会総会, Jun. 2018, 日本肝臓学会, Not invited - 肝疾患 最近の話題
神田達郎
第64回日本大学医学部消化器肝臓内科・糖尿病内科創立記念式典 記念講演, May 2018, Invited - 膵癌進展におけるアンドロゲン受容体, 小胞体ストレス蛋白GRP78の関与
神田達郎; 松岡俊一; 森山光彦
第104回日本消化器病学会総会, Apr. 2018, 日本消化器病学会, Not invited - 当院のC型肝炎に対するDAA治療効果、治療後RASと有害事象の検討
金子朋弘; 楡井和重; 森山光彦; 高橋央; 佐々木翔一; 石井大雄; 有間修平; 山名陽一郎; 金澤芯依; 水谷卓; 上村慎也; 松本直樹; 樋口晃久; 中村仁美; 山上裕晃; 神田達郎
第104回日本消化器病学会総会, Apr. 2018, Not invited - G蛋白質共役受容体制御因子ARRDC3はNASH線維化進展に関与する
佐々木翔一; 神田達郎; 森山光彦
第104回日本消化器病学会総会, Apr. 2018, 日本消化器病学会, Not invited - 本邦のB型慢性肝炎におけるTDFのHBs抗原低下作用
中本 晋吾; 神田 達郎; 中村 昌人; 安井 伸; 小笠原 定久; 鈴木 英一郎; 大岡 美彦; 太和田 暁之; 齊藤 朋子; 小林 和史; 清野 宗一郎; 千葉 哲博; 新井 誠人; 丸山 紀史; 加藤 直也
肝臓, Apr. 2018, (一社)日本肝臓学会, Not invited - HCV患者における経口剤による抗ウイルス療法後の早期発がんリスク因子
大岡 美彦; 千葉 哲博; 斎藤 朋子; 清野 宗一郎; 小林 和史; 中村 昌人; 小笠原 定久; 鈴木 英一郎; 安井 伸; 太和田 暁之; 新井 誠人; 神田 達郎; 今関 文夫; 横須賀 收; 加藤 直也
肝臓, Apr. 2018, (一社)日本肝臓学会, Not invited - HCV-147. Successful retreatment of 12-week combination regimen of grazoprevir and elbasvir for HCV GT1b patient, who failed to be treated by sofosbuvir/ledipasvir due to ventricular tachycardia.
Tatsuo Kanda; Mitsuhiko Moriyama; Shingo Nakamoto; Masato Nakamura; Tetsuhiro Chiba; Hitoshi Maruyama; Shunichi Matsuoka; Naoya Kato.
27th Annual Conference, Asian Pacific Association for the Study of the Liver “Hepatology: The Next Genre”, Mar. 2018, Asian Pacific Association for the Study of the Liver, Not invited - HCV-148. Successful retreatment with grazoprevir plus elbasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior DAA treatment.
Tatsuo Kanda; Mitsuhiko Moriyama; Masato Nakamura; Shin Yasui; Shingo Nakamoto; Tetsuhiro Chiba; Hitoshi Maruyama; Naoya Kato.
27th Annual Conference, Asian Pacific Association for the Study of the Liver “Hepatology: The Next Genre”, Mar. 2018, Asian Pacific Association for the Study of the Liver, Not invited - Hepatovirology Symposium: Hepato-Virology Symposium: Viral Hepatitis Testing: Way Forward. Drug Resistance Testing in the Era of DAA: Is there a Need?
Tatsuo Kanda
27th Annual Conference, Asian Pacific Association for the Study of the Liver “Hepatology: The Next Genre”, Mar. 2018, Asian Pacific Association for the Study of the Liver, Invited - HBV-B25. RNA sequencing analysis of diversity of hepatitis B virus transcripts in hepatocytes derived from chimeric mice.
Shingo Nakamoto; Tatsuo Kanda; Shuang Wu; Koji; Takahashi; Masato Nakamura; Shin Yasui; Sadahisa Ogasawara; Eiichiro Suzuki; Yoshihiko Ooka; Akinobu; Tawada; Tetsuhiro Chiba; Makoto Arai; Kazufumi Kobayashi; Soichiro Kiyono; Hitoshi Maruyama; Naoya Kato; Hiroshi Shirasawa.
27th Annual Conference, Asian Pacific Association for the Study of the Liver “Hepatology: The Next Genre”, Mar. 2018, Asian Pacific Association for the Study of the Liver, Not invited - HAV-1. Japanese miso extract suppresses HAV replication with the upregulation of glucose-regulated protein 78.
Tatsuo Kanda; Nan Nwe Win; Shingo Nakamoto; Xia Jiang; Mitsuhiko Moriyama; Yutaka Tamura; Akiko Suganami; Hiroshi Shirasawa; Hiroaki Okamoto.
27th Annual Conference, Asian Pacific Association for the Study of the Liver “Hepatology: The Next Genre”, Mar. 2018, Asian Pacific Association for the Study of the Liver, Not invited - HCC-64. Initial experiences with sorafenib and regorafenib sequential therapies in Japanese patients with advanced hepatocellular carcinoma.
Sadahisa Ogasawara; Tetsuhiro Chiba; Yoshihiko Ooka; Eiichiro Suzuki; Takahiro Maeda; Masayuki Yokoyama; Kazufumi Kobayashi; Soichiro Kiyono; Masato Nakamura; Tomoko Saito; Shingo Nakamoto; Shin Yasui; Akinobu Tawada; Makoto Arai; Tatsuo Kanda; Hitoshi Maruyama; Osamu Yokosuka; Naoya Kato.
27th Annual Conference, Asian Pacific Association for the Study of the Liver “Hepatology: The Next Genre”,, Mar. 2018, Asian Pacific Association for the Study of the Liver, Not invited - Chairpersons. Oral Papers Session: Acute Liver Failure and Acute on chronic Liver failure.
Tatsuo Kanda; S.K. Sinha; Abby Phillips.
27th Annual Conference, Asian Pacific Association for the Study of the Liver “Hepatology: The Next Genre”, Mar. 2018, Asian Pacific Association for the Study of the Liver, Invited - General Hepatology (Symposium Session 2): Viral Hepatitis C – Challenges in Treatment Of HCV infection. Newer Options for Treatment for HCV infection: Drugs and Schedules.
Tatsuo Kanda
27th Annual Conference, Asian Pacific Association for the Study of the Liver “Hepatology: The Next Genre”, Mar. 2018, Asian Pacific Association for the Study of the Liver, Invited - 肝臓のエラストグラフィ
松本直樹
城北肝疾患 Meeting 2018, Mar. 2018, Invited - 肝細胞ヘプシジンとサイトカイン産生に関する考察
神田達郎; 松岡俊一; 楡井和重; 松本直樹; 中村仁美; 熊川まり子; 金澤芯衣; 上村慎也; 樋口晃久; 山上裕晃; 森山光彦
第12回肝免疫フォーラム, Feb. 2018, Not invited - 新しいC型肝炎の治療とHCV排除後の問題点
神田 達郎
SAKURA病診連携勉強会, Jan. 2018, Invited - Session 3: Special Lectures. Topic 2: Recovery of immune function after HCV eradication from patients. Outcome of chronically hepatitis C virus-infected patients treated with direct antiviral agents.
T. Kanda.
Concurrent USJCMSP Panel Meetings: Hepatitis Panel Meeting (36th US-Japan Hepatitis Panel Meeting New Approaches to HBV Therapy Shenzhen, China January 10-11, 2018)., Jan. 2018, Invited - HCV Clearance by Antivirals Makes Changes in the Immune Related Cytokines.
T. Kanda; R. Sasaki.
20th International Conference on Emerging Infectious Diseases in the Pacific Rim., Jan. 2018, Invited - Poster Session: HCV Clearance by Antivirals Makes Changes in the Immune Related Cytokines.
T. Kanda; R. Sasaki.
20th International Conference on Emerging Infectious Diseases in the Pacific Rim., Jan. 2018, Invited - GRP78誘導剤によるHAV増殖抑制の検討
神田 達郎
平成29年度年度末 国立研究開発法人 日本医療研究開発機構(AMED) 肝炎等克服実用化研究事業 (肝炎等克服緊急対策研究事業) 「経口感染によるウイルス性肝炎(A型及びE型)の感染防止、病態解明、治療等に関する研究」班会議, Dec. 2017, Not invited - Effects of interferon-free treatment on chronic hepatitis C patients with autoimmune liver diseases.
141.Tatsuo Kanda; Masato Nakamura; Shin Yasui; Makoto Arai; Shingo Nakamoto; Tetsuhiro Chiba; Hitoshi Maruyama; Mitsuhiko Moriyama; Naoya Kato.
The Liver Meeting 2017. The 68th Annual Meeting of The American Association for the Study of Liver Diseases, Oct. 2017, AASLD, Not invited - Inhibition of microRNA-200b/c improved liver inflammation and liver fibrosis in NASH model mice.
Masato Nakamura; Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Shin Yasui; Hitoshi Maruyama; Naoya Kato.
The Liver Meeting 2017. The 68th Annual Meeting of The American Association for the Study of Liver Diseases, Oct. 2017, AASLD, Not invited - HLA-DRB1-DQB1 haplotypes and BTNL2 gene associate with response to a hepatitis B vaccine.
143.Nao Nishida; Masaya Sugiyama; Hiromi Sawai; Shoji Nishina; Aiko Sakai; Keisuke Kakisaka; Keisuke Hino; Ryo Sumasaki; Yasuhiro Takikawa; Kazumoto Murata; Tatsuo Kanda; Osamu Yokosuka; Katsushi Tokunaga; Masashi Mizokami.
The Liver Meeting 2017. The 68th Annual Meeting of The American Association for the Study of Liver Diseases, Oct. 2017, AASLD, Not invited - C型慢性肝炎の最新治療～肝硬変・肝がん撲滅を目指して
神田 達郎
平成29年日本大学医学会秋季学術大会 シンポジウム「慢性疾患の病態・治療研究の最前線, Oct. 2017, Not invited - デジタルポスターセッション20 (肝臓学会) 原発性肝癌（分子標的治療）2
神田 達郎
第21回日本肝臓学会大会, Oct. 2017, Not invited - Effects of interferon-free treatment on chronic hepatitis C patients with autoimmune liver diseases
Tatsuo Kanda; Masato Nakamura; Shin Yasui; Makoto Arai; Shingo Nakamoto; Tetsuhiro Chiba; Hitoshi Maruyama; Mitsuhiko Moriyama; Naoya Kato
HEPATOLOGY, Oct. 2017, WILEY, Not invited - Inhibition of microRNA-200b/c improved liver inflammation and liver fibrosis in NASH model mice
Masato Nakamura; Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Shin Yasui; Hitoshi Maruyama; Naoya Kato
HEPATOLOGY, Oct. 2017, WILEY, Not invited - 奇静脈結合と門脈結合を合併した下大静脈低形成の一例
清野 宗一郎; 丸山 紀史; 小林 和史; 中村 昌人; 安井 伸; 神田 達郎; 小笠原 定久; 鈴木 英一郎; 大岡 美彦; 千葉 哲博; 加藤 直也
日本門脈圧亢進症学会雑誌, Aug. 2017, (一社)日本門脈圧亢進症学会 - Effects of interferon-free treatment on chronic hepatitis C patients with autoimmune liver diseases.
Tatsuo Kanda
Saint Louis University, Oct. 2015, Ratna Ray, Ranjit Ray, Invited - Panelist, Zoom Webinar
Tatsuo Kanda
APASL Hepatology Webinar APASL Liver Cancer Preceptorship (ALCAP) Program, Feb. 2024, Invited
Affiliated academic society
Research Themes
- Study of Prevention, Pathological Development and Treatment for Hepatitis A and E Virus Infection
Japan Agency for Medical Research and Development (AMED), 肝炎等克服実用化研究事業・肝炎等克服緊急対策研究事業, Apr. 2023 - Mar. 2026
神田達郎; 國田智; 岡本宏明; 四柳宏; 鈴木亮介; 李天成; 田中玲奈 - 肝線維化進展機序解明を目的としたインテグリンβ１と細胞接着に関する研究
日本学術振興会, 科学研究費助成事業, Apr. 2020 - Mar. 2023
増崎 亮太; 神田 達郎; 森山 光彦 - Research and development of infection prevention, pathological mechanism, diagnosis and treatment for hepatitis A and E viruses
国立研究開発法人日本医療研究開発機構, 肝炎等克服実用化研究事業 肝炎等克服緊急対策研究事業, Apr. 2020 - Mar. 2023
神田達郎; 國田智; 岡本宏明; 四柳宏; 石井孝司; 李天成; 田中玲奈 - Sorafenib resistance and c-Jun in hepatocellular carcinoma
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Apr. 2017 - Mar. 2020
KANDA Tatsuo - Investigate the gain of immune function after hepatitis C virus eradication from patients
日本医療研究開発機構(AMED), 日本医療研究開発機構研究費・国際戦略推進課・地球規模保健課題解決推進のための研究事業(日米医学協力計画の若手・女性育成のための日米共同研究公募), 2016 - 2017
Tatsuo Kanda; Ranjit Ray - Involvement of androgen receptor and unfolded protein response in human liver and pancreatic cancers
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Apr. 2012 - Mar. 2015
KANDA TATSUO - Elucidation of the molecular mechanisms on the pathology and treatment of hepatitis by computational approach
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Apr. 2011 - Mar. 2014
TU・BAO Ho; TAKABAYASHI Katsuhiko; YOKOSUKA Osamu; KANDA Tatsuo; DAM Hieu Chi; KAWASAKI Saori - Androgen receptor signaling in liver and pancreatic cancer
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Apr. 2009 - Mar. 2012
KANDA Tatsuo - 若手研究者の自立的研究環境整備促進-優れた若手研究型教員の人材育成システム（千葉大学）
文部科学省, 科学技術振興調整費テニュア・トラックシステム研究経費, 2009 - 2012
神田達郎 - B型肝炎ウイルス感染症におけるバイオマーカーとしてのMicro-RNAの同定
かなえ医薬振興財団, かなえ医薬振興財団第40回かなえ医薬振興財団アジア・オセアニア交流研究助成金, 2012
神田達郎 - Finding Medical Knowledge from Clinical Data based on Interpretations
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, 2009 - 2011
KAWASAKI Saori; TU Bao Ho; TAKABAYASHI Katsuhiko; KANDA Tatsuo - Internal ribosomal entry-site activities of clinical isolate-derived hepatitis A virus and inhibitory effects of amantadine
（社）日本肝臓学会, （社）日本肝臓学会研究奨励賞, 2011
神田達郎 - C型肝炎ウイルスNS5Aを介した肝内自然免疫の抑制
(財）ウイルス肝炎研究財団, 平成21年度肝炎に関する研究助成事業「研究奨励金」, 2010 - HCV core蛋白はandrogen receptor-mediated signalingを活性化する
財団法人国際科学振興財団, 財団法人国際科学振興財団（分子消化器病研究会）助成金, 2009 - RNA干渉による肝炎ウイルス増殖抑制効果の検討
日本学術振興会, 科学研究費助成事業, Apr. 2003 - Mar. 2005
神田 達郎 - Analysis of Viral and host factors influencing the pathophysiology and effect of therapy of pesisitent hepatitis virus infection
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, 2004 - 2005
YOKOSUKA Osamu; IMAZEKI Fumio; FUKAI Kenichi - siRNAおよびアマンタジンを用いたHAV IRES-mediated translation、HAV増殖抑制の検討
財団法人国際科学振興財団, 財団法人国際科学振興財団（分子消化器病研究会）助成金, 2005 - 慢性C型肝炎の病態進展と結核既往との関連について研究奨励金
結核予防会, 平成15年度結核予防千葉基金助成金, 2003
Industrial Property Rights
Others
- 医学部６年生が日本内科学会 第 688 回関東地方会奨励賞受賞！！
Jan. 2024 - Present - 消化器肝臓内科学分野の田中 (佐々木) 玲奈研究員及び神田達郎診療教授らの研究グループは， オートファジーがA型肝炎ウイルス増殖を抑制し，HAVの生活環で重要な役割をはたしている ことを明らかにした研究成果を発表しました。
Sep. 2022 - Present - C型肝炎 TBSテレビ『サンデージャポン』番組内コーナー『サンデージャンクション』
Mar. 2020 - 教えてドクター C型肝炎は服薬で治せる時代 一度はウイルス検査を受けましょう
Jan. 2019 - 認知症と診断されたら肝臓の検査を
Nov. 2018 - 第578回医心伝身 異常行動を起こす「肝性脳症」は認知症と間違えやすいので注意
Oct. 2018 - トレンド◎食品媒介感染症が性感染症として流行 感染拡大中のA型肝炎を見逃すな
Sep. 2018 - C型肝炎 疾患啓発ラジオ番組 「笑顔の毎日を送るために」
Jul. 2016 - 誤解や偏見はNG! 正しく知りたいウイルス性肝炎
2014
